Form 485APOS GLENMEDE FUND INC
As filed with the Securities and Exchange Commission on June 30, 2025
Registration Nos. 33-22884
811-05577
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM N-1A
| REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 | ☒ | |
| Pre-Effective Amendment No. | ☐ | |
| Post-Effective Amendment No. 124 | ☒ |
and
| REGISTRATION STATEMENT UNDER THE INVESTMENT COMPANY ACT OF 1940 | ☒ |
Amendment No. 126
The Glenmede Fund, Inc.
(Exact Name of Registrant as Specified in Charter)
One Congress Street, Suite 1
Boston, MA 02114
(Address of Principal Executive Offices)
Registrant’s Telephone Number:
1-800-442-8299
Joshua M. Lindauer, Esq.
Secretary
Faegre Drinker Biddle & Reath LLP
1177 Avenue of the Americas
41st Floor New York, New York 10036
(Name and Address of Agent for Service)
It is proposed that this filing will become effective (check appropriate box)
| ☐ | immediately upon filing pursuant to paragraph (b) |
| ☐ | on _________ pursuant to paragraph (b) |
| ☒ | 60 days after filing pursuant to paragraph (a)(i) |
| ☐ | on __________ pursuant to paragraph (a)(i) |
| ☐ | 75 days after filing pursuant to paragraph (a)(ii) |
| ☐ | on ____________ pursuant to paragraph (a)(ii) of rule 485. |
If appropriate, check the following box:
| ☐ | this post-effective amendment designates a new effective date for a previously filed post-effective amendment. |
Preliminary Prospectus
Dated June 30, 2025
Subject to Completion
The information in this prospectus is not complete and may be changed. We may not sell these securities until the registration statement filed with the Securities and Exchange Commission is effective. This prospectus is not an offer to sell these securities and is not soliciting an offer to buy these securities in any state where the offer or sale is not permitted.
THE GLENMEDE FUND, INC.
Prospectus
[●], 2025
Equity Portfolios
SMID Core Equity Portfolio (formerly, Women in Leadership U.S. Equity Portfolio)
Advisor Shares - GWILX
Institutional Shares – [●]
Investment Advisor
Glenmede Investment Management LP
The Securities and Exchange Commission has not approved or disapproved the Portfolio’s securities or determined if this Prospectus is accurate or complete. It is a criminal offense to state otherwise.
| 1 |
| 2 |
SMID Core Equity Portfolio (formerly, Women in Leadership U.S. Equity Portfolio)
(Advisor Shares)
Investment Objective
Long-term capital appreciation consistent with reasonable risk to principal.
Fees and Expenses of the Portfolio
This table describes the fees and expenses that you may pay if you buy, hold, and sell Advisor Shares of the Portfolio. You may pay brokerage commissions and other fees to financial intermediaries which are not reflected in the table and example below.
| Advisor Shares | ||
|
Annual Portfolio Operating Expenses (expenses that you pay each year as a percentage of the value of your investment) |
||
| Management Fees | 0.55% | |
|
Other Expenses (includes 0.20% shareholder servicing fees payable to Glenmede Trust) |
0.66% | |
| Total Annual Portfolio Operating Expenses | 1.21% | |
| Fee Waivers and Expense Reimbursements1 | 0.36% | |
| Net Expenses | 0.85% |
1 Glenmede Investment Management LP (the “Advisor”) has contractually agreed to waive its fees and/or reimburse expenses to the extent that the Portfolio’s annual total operating expenses exceed 0.85% of the Portfolio’s Advisor Shares’ average daily net assets (excluding Acquired Fund fees and expenses, brokerage commissions, extraordinary items, interest and taxes). The Advisor has contractually agreed to these waivers and/or reimbursements until at least [●], 2026 and may discontinue this arrangement at any time thereafter. This contractual fee waiver agreement may not be terminated before [●], 2026 without the approval of The Glenmede Fund, Inc.’s (the “Fund”) Board of Directors (the “Board”).
Example
This Example is intended to help you compare the cost of investing in the Portfolio’s Advisor Shares with the cost of investing in other mutual funds. The Example assumes that you invest $10,000 in the Portfolio for the time periods indicated and then hold or redeem all of your shares at the end of those periods. The Example also assumes that your investment has a 5% return each year and that the Portfolio’s operating expenses remain the same, taking into account the fee waiver in the first year of each period. Although your actual costs may be higher or lower, based on these assumptions your costs would be:
| 1 Year | 3 Years | 5 Years | 10 Years | |||
| $87 | $348 | $630 | $1,434 |
Portfolio Turnover
The Portfolio pays transaction costs, such as commissions, when it buys and sells securities (or “turns over” its portfolio). A higher portfolio turnover rate may indicate higher transaction costs and may result in higher taxes when Portfolio shares are held in a taxable account. These costs, which are not reflected in annual portfolio operating expenses or in the Example, affect the Portfolio’s performance. The Portfolio may actively trade portfolio securities to achieve its principal investment strategies. During the most recent fiscal year, the Portfolio’s portfolio turnover rate was 80% of the average value of its portfolio.
| 3 |
Principal Investment Strategies
Under normal market circumstances, the Portfolio invests at least 80% of the value of its net assets (including borrowings for investment purposes) in equity securities, such as common stocks and preferred stocks, of U.S. small and medium (“SMID”) cap companies that the Advisor believes are undervalued. SMID cap companies include companies with the market capitalizations, at the time of purchase, that are within the market capitalization range of the smallest stock in the Russell 2500 Index to the largest stock in the Russell Midcap Index. That capitalization range was $7.8 million to $279.5 billion as of April 30, 2025.
The Advisor uses a combination of quantitative and fundamental research to select securities. The Advisor uses a quantitative proprietary multi-factor computer model which identifies a list of attractive securities having revenue and earnings growth potential with reasonable valuations, then applies fundamental research to select which securities to buy and sell for this Portfolio. The Advisor considers material environmental, social, and governance (ESG) criteria in the context of long-term investor decision making.
Principal Investment Risks
All investments carry a certain amount of risk and the Portfolio cannot guarantee that it will achieve its investment objective. In addition, the strategies that the Advisor uses may fail to produce the intended result. Each risk summarized below is considered a “principal risk” of investing in the Portfolio, regardless of the order in which it appears. Different risks may be more significant at different times depending on market conditions and other factors. An investment in the Portfolio is not a bank deposit and is not insured or guaranteed by the Federal Deposit Insurance Corporation or any other government agency. Therefore, you could lose money by investing in the Portfolio.
The Portfolio may be appropriate for you if you are investing for goals several years away and are comfortable with stock market risks. The Portfolio would not be appropriate for you if you are investing for short-term goals, or are mainly seeking current income.
Market Risk: Stocks may decline over short or even extended periods of time. Equity markets tend to be cyclical: there are times when stock prices generally increase, and other times when they generally decrease. In addition, the Portfolio is subject to the additional risk that the particular types of stocks held by the Portfolio will underperform other types of securities. Market risks, including political, regulatory, market, economic and social developments, and developments that impact specific economic sectors, industries or segments of the market, can affect the value of the Portfolio’s investments. Natural disasters, public health emergencies (including pandemics and epidemics such as COVID-19), war, military conflict, terrorism and other global unforeseeable events may lead to instability in world economies and markets, may lead to market volatility, and may have adverse long-term effects. The Portfolio cannot predict the effects of such unforeseeable events in the future on the economy, the markets or the Portfolio’s investments.
Value Style Risk: Although the Portfolio invests in stocks the Advisor believes to be undervalued, there is no guarantee that the prices of these stocks will not move even lower. In addition, the value investment style can shift into and out of favor with investors, depending on market and economic conditions. As a result, the Portfolio may at times outperform or underperform other funds that invest more broadly or employ a different investment style.
Small Cap Risk: The Portfolio is subject to the risk that the stocks of smaller and newer issuers can be more volatile and more speculative than the stocks of larger issuers. Smaller companies tend to have limited resources, product lines and market share. As a result, their share prices tend to fluctuate more than those of larger companies. Their shares may also trade less frequently and in limited volume, making them potentially less liquid. The price of small company stocks might fall regardless of trends in the broader market.
Mid Cap Risk: The portfolio is subject to the risk that the stocks of mid cap companies can be more volatile and riskier than the stocks of larger issuers. Mid cap companies tend to have more limited resources, product lines and market share than larger more established businesses. As a result, their share prices tend to fluctuate more than those of larger companies. Their shares may also trade less frequently and in limited volume,
| 4 |
making them potentially less liquid. The price of mid cap company stocks might fall regardless of trends in the broader market.
Frequent Trading Risk: A high rate of portfolio turnover involves correspondingly high transaction costs, which may adversely affect the Portfolio’s performance over time. In addition, in connection with the Fund’s reposition on [September 2,] 2025, shareholders should be aware that the Portfolio will experience a higher-than-normal portfolio turnover rate. High portfolio turnover may also result in the realization of short-term capital gains. Distributions derived from such gains will be treated as ordinary income for Federal income tax purposes.
Performance Information
The bar chart and table below provide some indication of the risks of investing in the Portfolio. The bar chart shows how the performance of the Portfolio’s Advisor Shares has varied from year to year. The table shows how the average annual total returns for one year, five years and since inception of the Portfolio’s Advisor Shares compare to those of selected market indices.
Effective [September 2], 2025, the Portfolio underwent a change to its investment objective and principal investment strategy (the “Repositioning”). In connection with the Repositioning, the Portfolio will be repositioned to invest in undervalued equity securities, such as common stocks and preferred stocks, of U.S. SMID cap companies. Accordingly, the performance of the Portfolio shown prior to [September 2], 2025 reflects the Portfolio’s prior principal investment strategy and objective; the Portfolio’s performance would have differed if the Portfolio’s current principal investment strategy and objective had been in place.
The Portfolio’s past performance, before and after taxes, does not necessarily indicate how it will perform in the future. Performance reflects expense reimbursements and/or fee waivers in effect. If such expense reimbursements or fee waivers were not in place, the Portfolio’s performance would be reduced. Updated performance information is available by visiting www.glenmedeim.com or by calling 1-800-442-8299.
SMID Core Equity Portfolio (formerly, the Women in Leadership U.S. Equity Portfolio) (Advisor Shares)

During the periods shown in the bar chart, the highest quarterly return was 20.58% (for the quarter ended June 30, 2020) and the lowest quarterly return was -27.56% (for the quarter ended March 31, 2020).
After-tax returns for the Portfolio are calculated using the historical highest individual Federal marginal income tax rates, and do not reflect the impact of state and local taxes. Actual after-tax returns depend on the investor’s tax situation and may differ from those shown. After-tax returns are not relevant to investors who hold their Portfolio shares through tax-deferred arrangements such as 401(k) plans or individual retirement accounts (“IRAs”).
| 5 |
Average Annual Total Returns (for the periods ended December 31, 2024)
|
Past 1 Year |
Past 5 Years |
Since Inception (December 22, 2015) | |
| Return Before Taxes – Advisor Shares | 15.78% | 9.52% | 10.98% |
| Return After Taxes on Distributions | 12.47% | 7.43% | 9.56% |
| Return After Taxes on Distributions and Sale of Fund Shares | 11.82% | 7.33% | 8.84% |
| Russell 3000® Index1 (reflects no deduction for fees, expenses or taxes) | 23.81% | 13.86% | 13.97% |
| Russell 1000® Index1 (reflects no deduction for fees, expenses or taxes) | 24.51% | 14.28% | 14.28% |
| Russell 2500® Index2 (reflects no deduction for fees, expenses or taxes) | 11.99% | 8.77% | 10.25% |
| Morningstar Large Value Average2 | 14.28% | 9.20% | 10.01% |
1 Effective [September 2], 2025, due to the Repositioning, the Portfolio’s primary broad-based index changed from the Russell 1000 Index to the Russell 3000 Index.
2 Effective [September 2], 2025, due to the Repositioning, the Portfolio’s performance measurement index changed from the Morningstar Large Cap Value Average to the Russell 2500 Index. The Russell 2500 Index is provided so that investors may compare the performance of the Portfolio with an index composed of securities similar to those held by the Portfolio.
Investment Adviser
Glenmede Investment Management LP serves as investment advisor to the Portfolio.
Portfolio Managers
Jordan Irving, Portfolio Manager and Matthew Shannon, CFA, Portfolio Manager, of the Advisor, have managed the Portfolio since [September 2], 2025.
Tax Information
The Portfolio’s distributions are taxable and will generally be taxed as ordinary income or capital gains, unless you are purchasing through a tax-deferred arrangement, such as a 401(k) plan or IRA. Such tax-deferred arrangements may be taxed later upon withdrawal of monies from those arrangements.
Purchase and Sale of Portfolio Shares
There are no minimum initial or subsequent investment requirements for the Portfolio. The Glenmede Trust Company, N.A. (“Glenmede Trust”) has informed the Fund that it and its affiliated companies’ (“Affiliates”) minimum initial investment requirements for their clients’ investments in the Portfolio is $1,000, which may be reduced or waived from time to time. Approved brokers and other institutions that purchase shares on behalf of their clients may have their own minimum initial and subsequent investment requirements. You may redeem shares at any time by contacting Glenmede Trust by telephone or facsimile or contacting the institution through which you purchased your shares.
Financial Intermediary Compensation
If you purchase shares of the Portfolio through a broker-dealer or other financial intermediary (such as a bank), the Portfolio and its related companies may pay the intermediary for the sale of Portfolio shares and related services. These payments may create a conflict of interest by influencing the broker-dealer or other intermediary and your salesperson to recommend the Portfolio over another investment. Ask your salesperson or visit your financial intermediary’s Web site for more information.
| 6 |
SUMMARY SECTION
SMID Core Equity Portfolio (formerly, Women in Leadership U.S. Equity Portfolio)
(Institutional Shares)
Investment Objective
Long-term capital appreciation consistent with reasonable risk to principal.
Fees and Expenses of the Portfolio
This table describes the fees and expenses that you may pay if you buy, hold, and sell Institutional Shares of the Portfolio. You may pay brokerage commissions and other fees to financial intermediaries which are not reflected in the table and example below.
|
Annual Portfolio Operating Expenses (expenses that you pay each year as a percentage of the value of your investment) |
Institutional Shares | |
| Management Fees | 0.55% | |
| Other Expenses | 0.46% | |
| Total Annual Portfolio Operating Expenses | 1.01% | |
| Fee Waivers and Expense Reimbursements1 | 0.36% | |
| Net Expenses | 0.65% |
1 Glenmede Investment Management LP (the “Advisor”) has contractually agreed to waive its fees and/or reimburse expenses to the extent that the Portfolio’s annual total operating expenses exceed 0.65% of the Portfolio’s Institutional Shares’ average daily net assets (excluding Acquired Fund fees and expenses, brokerage commissions, extraordinary items, interest and taxes). The Advisor has contractually agreed to these waivers and/or reimbursements until at least [●], 2026 and may discontinue this arrangement at any time thereafter. This contractual fee waiver agreement may not be terminated before [●], 2026 without the approval of The Glenmede Fund, Inc.’s (the “Fund”) Board of Directors (the “Board”).
Example
This Example is intended to help you compare the cost of investing in the Portfolio’s Institutional Shares with the cost of investing in other mutual funds. The Example assumes that you invest $10,000 in the Portfolio for the time periods indicated and then hold or redeem all of your shares at the end of those periods. The Example also assumes that your investment has a 5% return each year and that the Portfolio’s operating expenses remain the same, taking into account the fee waiver in the first year of each period. Although your actual costs may be higher or lower, based on these assumptions your costs would be:
| 1 Year | 3 Years | 5 Years | 10 Years | |||
| $66 | $286 | $523 | $1,204 |
Portfolio Turnover
The Portfolio pays transaction costs, such as commissions, when it buys and sells securities (or “turns over” its portfolio). A higher portfolio turnover rate may indicate higher transaction costs and may result in higher taxes when Portfolio shares are held in a taxable account. These costs, which are not reflected in annual portfolio operating expenses or in the Example, affect the Portfolio’s performance. The Portfolio may actively trade portfolio securities to achieve its principal investment strategies. During the most recent fiscal year, the Portfolio’s portfolio turnover rate was 80% of the average value of its portfolio.
Principal Investment Strategies
Under normal market circumstances, the Portfolio invests at least 80% of the value of its net assets (including borrowings for investment purposes) in equity securities, such as common stocks and preferred stocks, of U.S. small and medium (“SMID”) cap companies that the Advisor believes are undervalued. SMID cap companies include
| 7 |
companies with the market capitalizations, at the time of purchase, that are within the market capitalization range of the smallest stock in the Russell 2500 Index to the largest stock in the Russell Midcap Index. That capitalization range was $7.8 million to $279.5 billion as of April 30, 2025.
The Advisor uses a combination of quantitative and fundamental research to select securities. The Advisor uses a quantitative proprietary multi-factor computer model which identifies a list of attractive securities having revenue and earnings growth potential with reasonable valuations, then applies fundamental research to select which securities to buy and sell for this Portfolio. The Advisor considers material environmental, social, and governance (ESG) criteria in the context of long-term investor decision making.
Principal Investment Risks
All investments carry a certain amount of risk and the Portfolio cannot guarantee that it will achieve its investment objective. In addition, the strategies that the Advisor uses may fail to produce the intended result. Each risk summarized below is considered a “principal risk” of investing in the Portfolio, regardless of the order in which it appears. Different risks may be more significant at different times depending on market conditions and other factors. An investment in the Portfolio is not a bank deposit and is not insured or guaranteed by the Federal Deposit Insurance Corporation or any other government agency. Therefore, you could lose money by investing in the Portfolio.
The Portfolio may be appropriate for you if you are investing for goals several years away and are comfortable with stock market risks. The Portfolio would not be appropriate for you if you are investing for short-term goals, or are mainly seeking current income.
Market Risk: Stocks may decline over short or even extended periods of time. Equity markets tend to be cyclical: there are times when stock prices generally increase, and other times when they generally decrease. In addition, the Portfolio is subject to the additional risk that the particular types of stocks held by the Portfolio will underperform other types of securities. Market risks, including political, regulatory, market, economic and social developments, and developments that impact specific economic sectors, industries or segments of the market, can affect the value of the Portfolio’s investments. Natural disasters, public health emergencies (including pandemics and epidemics such as COVID-19), war, military conflict, terrorism and other global unforeseeable events may lead to instability in world economies and markets, may lead to market volatility, and may have adverse long-term effects. The Portfolio cannot predict the effects of such unforeseeable events in the future on the economy, the markets or the Portfolio’s investments.
Value Style Risk: Although the Portfolio invests in stocks the Advisor believes to be undervalued, there is no guarantee that the prices of these stocks will not move even lower. In addition, the value investment style can shift into and out of favor with investors, depending on market and economic conditions. As a result, the Portfolio may at times outperform or underperform other funds that invest more broadly or employ a different investment style.
Small Cap Risk: The Portfolio is subject to the risk that the stocks of smaller and newer issuers can be more volatile and more speculative than the stocks of larger issuers. Smaller companies tend to have limited resources, product lines and market share. As a result, their share prices tend to fluctuate more than those of larger companies. Their shares may also trade less frequently and in limited volume, making them potentially less liquid. The price of small company stocks might fall regardless of trends in the broader market.
Mid Cap Risk: The portfolio is subject to the risk that the stocks of mid cap companies can be more volatile and riskier than the stocks of larger issuers. Mid cap companies tend to have more limited resources, product lines and market share than larger more established businesses. As a result, their share prices tend to fluctuate more than those of larger companies. Their shares may also trade less frequently and in limited volume, making them potentially less liquid. The price of mid cap company stocks might fall regardless of trends in the broader market.
Frequent Trading Risk: A high rate of portfolio turnover involves correspondingly high transaction costs, which may adversely affect the Portfolio’s performance over time. In addition, in connection with the Fund’s reposition on [September 2], 202], shareholders should be aware that the Portfolio will experience a higher-than-normal
| 8 |
portfolio turnover rate. High portfolio turnover may also result in the realization of short-term capital gains. Distributions derived from such gains will be treated as ordinary income for Federal income tax purposes.
Performance Information
The bar chart and table below provide some indication of the risks of investing in the Portfolio. The bar chart shows how the performance of the Portfolio has varied from year to year. The table shows how average annual total returns for one year, five years and since inception compare to those of selected market indices. The Portfolio’s past performance, before and after taxes, does not necessarily indicate how it will perform in the future. Performance reflects expense reimbursements and/or fee waivers in effect. If such expense reimbursements or fee waivers were not in place, the Portfolio’s performance would be reduced. Updated performance information is available by visiting www.glenmedeim.com or by calling 1-800-442-8299.
Effective [September 2], 2025, the Portfolio underwent a change to its investment objective and principal investment strategy (the “Repositioning”). In connection with the Repositioning, the Portfolio will be repositioned to invest in undervalued equity securities, such as common stocks and preferred stocks, of U.S. SMID cap companies.
As of the date of this Prospectus, the Portfolio had not yet offered Institutional Shares to investors. Accordingly, the performance of the Portfolio shown prior to [September 2], 2025 reflects the Advisor Shares’ prior principal investment strategy and objective. The Portfolio’s performance would have differed if the Portfolio’s current principal investment strategy and objective had been in place. Institutional Shares and Advisor Shares of the Portfolio should have returns that are substantially the same because they represent investments in the same portfolio of securities and differ only to the extent that they have different expenses.
SMID Core Equity Portfolio (formerly, the Women in Leadership U.S. Equity Portfolio)

During the periods shown in the bar chart, the highest quarterly return was 20.58% (for the quarter ended June 30, 2020) and the lowest quarterly return was -27.56% (for the quarter ended March 31, 2020).
After-tax returns for the Portfolio are calculated using the historical highest individual Federal marginal income tax rates, and do not reflect the impact of state and local taxes. Actual after-tax returns depend on the investor’s tax situation and may differ from those shown. After-tax returns are not relevant to investors who hold their Portfolio shares through tax-deferred arrangements such as 401(k) plans or individual retirement accounts (“IRAs”).
| 9 |
Average Annual Total Returns (for the periods ended December 31, 2024)
|
Past 1 Year |
Past 5 Years |
Since Inception (December 22, 2015) | |
| Return Before Taxes – Institutional Shares | 15.78% | 9.52% | 10.98% |
| Return After Taxes on Distributions | 12.47% | 7.43% | 9.56% |
| Return After Taxes on Distributions and Sale of Fund Shares | 11.82% | 7.33% | 8.84% |
| Russell 3000® Index1 (reflects no deduction for fees, expenses or taxes) | 23.81% | 13.86% | 13.97% |
| Russell 1000® Index1 (reflects no deduction for fees, expenses or taxes) | 24.51% | 14.28% | 14.28% |
| Russell 2500® Index2 (reflects no deduction for fees, expenses or taxes) | 11.99% | 8.77% | 10.25% |
| Morningstar Large Value Average2 | 14.28% | 9.20% | 10.01% |
1 Effective [September 2], 2025, due to the Repositioning, the Portfolio’s primary broad-based index changed from the Russell 1000 Index to the Russell 3000 Index.
2 Effective [September 2], 2025, due to the Repositioning, the Portfolio’s performance measurement index changed from the Morningstar Large Cap Value Average to the Russell 2500 Index. The Russell 2500 Index is provided so that investors may compare the performance of the Portfolio with an index composed of securities similar to those held by the Portfolio.
Investment Adviser
Glenmede Investment Management LP serves as investment advisor to the Portfolio.
Portfolio Managers
Jordan Irving, Portfolio Manager and Matthew Shannon, CFA, Portfolio Manager, of the Advisor, have managed the Portfolio since [September 2], 2025.
Tax Information
The Portfolio’s distributions are taxable and will generally be taxed as ordinary income or capital gains, unless you are purchasing through a tax-deferred arrangement, such as a 401(k) plan or IRA. Such tax-deferred arrangements may be taxed later upon withdrawal of monies from those arrangements.
Purchase and Sale of Portfolio Shares
The minimum initial investment is $10,000,000, which may be reduced or waived in some cases from time to time. There is no minimum for subsequent investments. Approved brokers and other institutions that purchase shares on behalf of their clients may have their own minimum initial and subsequent investment requirements. You may redeem shares at any time by contacting The Glenmede Trust Company, N.A. (“Glenmede Trust”) by telephone or facsimile or contacting the institution through which you purchased your shares.
Financial Intermediary Compensation
If you purchase shares of the Portfolio through a broker-dealer or other financial intermediary (such as a bank), the Portfolio and its related companies may pay the intermediary for the sale of Portfolio shares and related services. These payments may create a conflict of interest by influencing the broker-dealer or other intermediary and your salesperson to recommend the Portfolio over another investment. Ask your salesperson or visit your financial intermediary’s Web site for more information.
| 10 |
ADDITIONAL INFORMATION ABOUT INVESTMENTS
Objective, Principal Strategies and Risks
To help you decide which Portfolio is appropriate for you, this section looks more closely at the Portfolio’s investment objectives, policies and risks. You should carefully consider your own investment goals, time horizon and risk tolerance before investing in a Portfolio.
The Portfolio’s investment objectives and strategies may be changed by the Board without shareholder approval.
The Portfolio may, from time to time, take temporary defensive positions that are inconsistent with its principal investment strategies in response to adverse market, economic, political, or other conditions. Such investments may include, for example, cash, various short-term instruments, such as money market securities (including commercial paper, certificates of deposit, banker’s acceptances and time deposits), U.S. Government securities and repurchase agreements. U.S. Government securities include a variety of securities issued by the U.S. Treasury or by U.S. Government-related entities. While certain U.S. Government-related entities (such as the Federal National Mortgage Association or Federal Home Loan Mortgage Corporation) may be chartered or sponsored by Acts of Congress, their securities are neither issued nor guaranteed by the U.S. Treasury. To the extent that the Portfolio employs a temporary defensive investment strategy, it may not achieve its investment objective. A defensive position, taken at the wrong time, would have an adverse impact on the Portfolio’s performance.
SMID Core Equity Portfolio
The Advisor attempts to achieve the Portfolio’s objective to provide long-term capital appreciation consistent with reasonable risk to principal by investing, under normal market circumstances, at least 80% of the value of its net assets (including borrowings for investment purposes) in equity securities, such as common stocks and preferred stocks, of U.S. SMID cap companies that the Advisor believes are undervalued. SMID cap companies include companies with the market capitalizations, at the time of purchase, that are within the market capitalization range of the smallest stock in the Russell 2500 Index to the largest stock in the Russell Midcap Index. That capitalization range was $7.8 million to $279.5 billion as of April 30, 2025. This is a non-fundamental investment policy that can be changed by the Portfolio upon 60 days’ prior notice to shareholders.
The Portfolio currently offers two classes of shares: the Advisor Shares and the Institutional Shares. Shares of each class of the Portfolio represent equal pro rata interests in the Portfolio. The difference between the two classes is their shareholder service fee and minimum initial investment: the Advisor Shares class of the Portfolio charges a 0.20% fee and has no minimum initial investment, and the Institutional Shares class of the Portfolio does not charge a shareholder service fee and has a $10,000,000 minimum initial investment. This minimum initial investment amount may be reduced or waived in some cases from time to time. Although shares of each class accrue dividends and calculate NAV and performance quotations in the same manner, the NAV, dividends and other distributions, and performance of each class is expected to differ due to different actual expenses and will be quoted separately.
Principal Investment Risks
Market Risk
Stocks may decline over short or even extended periods of time. Equity markets tend to be cyclical; there are times when stock prices generally increase, and other times when they generally decrease. In addition, the Portfolio is subject to the additional risk that the particular types of stocks held by the Portfolio will underperform other types of securities. Market risks, including political, regulatory, market, economic and social developments, and developments that impact specific sectors, industries or segments of the market, can affect the value of the Portfolio’s investments. Natural disasters, public health emergencies (including pandemics and epidemics such as COVID-19), war, military conflict, terrorism and other unforeseeable global events may lead to instability in world economies and markets, may lead to market volatility and may have adverse long-term effects. Periods of unusually high financial market volatility and restrictive credit conditions, at times limited to a particular sector or geographic area, have occurred in the past and may be expected to recur in the future. Some countries, including the United States, have adopted or have signaled protectionist trade measures, relaxation of the financial industry regulations that followed the financial crisis, and/or
| 11 |
reductions to corporate taxes. The scope of these policy changes is still developing, but the equity and debt markets may react strongly to expectations of change, which could increase volatility, particularly if a resulting policy runs counter to the market’s expectations. The Portfolio cannot predict the effects of such unforeseeable events in the future on the economy, the markets or the Portfolio’s investments.
Deteriorating market conditions can cause a general weakness in the market that reduces the prices of securities in the market. To the extent that the Portfolio emphasizes issuers from any given industry or sector, it could be hurt if that industry or sector does not do well. Additionally, the Portfolio could lose value if the individual stocks in which it holds positions and/or the overall stock markets on which the stocks trade decline in price. Stocks and stock markets may experience short-term volatility (fluctuations in price) as well as extended periods of price decline or increase. Individual stocks are impacted by many factors, including corporate earnings, production, management, sales, and market trends, including investor demand for a particular type of stock, such as growth or value stocks, small or large capitalization stocks, or stocks within a particular industry.
Advancements in technology may also adversely impact markets and the overall performance of the Portfolio. For instance, the economy may be significantly impacted by the advanced development and increased regulation of artificial intelligence. As the use of technology grows, liquidity and market movements may be affected. As artificial intelligence is used more widely, the profitability and growth of the Portfolio’s holdings may be impacted, which could significantly impact the overall performance of the Portfolio.
Value Style Risk
The Portfolio invests in stocks that the Advisor believes are reasonably priced, although there is no guarantee that the prices of these stocks will not move lower after purchase by the Portfolio. If the Advisor’s assessment of a company’s quality or intrinsic value or its prospects for exceeding earnings expectations or market conditions is inaccurate, the Portfolio could suffer losses or produce poor performance relative to other funds. In addition, the stocks of quality companies can continue to be undervalued by the market for long periods of time. The value investment style can also shift into and out of favor with investors, dependent on market and economic conditions. As a result, a Portfolio may at times outperform or underperform other funds that invest more broadly or employ a different investment style.
Small Cap Risk
The Portfolio is subject to the risk that the stocks of smaller and newer issuers can be more volatile and more speculative than the stocks of larger issuers. Smaller companies tend to have limited resources, product lines and market share. As a result, their share prices tend to fluctuate more than those of larger companies. Their shares may also trade less frequently and in limited volume, making them potentially less liquid. The price of small company stocks might fall regardless of trends in the broader market. Furthermore, while securities of small capitalization companies may offer greater opportunity for capital appreciation than larger companies, investment in such companies presents greater risks than investment in larger, more established companies. Historically, small capitalization stocks have been more volatile in price than larger capitalization stocks. Among the reasons for the greater price volatility of these securities are the lower degree of liquidity in the markets for such stocks, and the potentially greater sensitivity of such small companies to changes in or failure of management, and to many other changes in competitive, business, industry and economic conditions, including risks associated with limited product lines, markets, management depth, or financial resources. Besides exhibiting greater volatility, micro and small company stocks may, to a degree, fluctuate independently of larger company stocks. Small company stocks may decline in price as large company stocks rise, or rise in price as large company stocks decline. Investors should therefore expect that the price of the Portfolio’s shares will be more volatile than the shares of a fund that invests in larger capitalization stocks. Additionally, while the markets in securities of small companies have grown rapidly in recent years, such securities may trade less frequently and in smaller volume than more widely held securities. The values of these securities may fluctuate more sharply than those of other securities, and the Portfolio may experience some difficulty in establishing or closing out positions in these securities at prevailing market prices. There may be less publicly available information about the issuers of these securities or less market interest in such securities than in the case of larger companies, and it may take a longer period of time for the prices of such securities to reflect the full value of their issuers’ underlying earnings potential or assets.
| 12 |
Mid Cap Risk
The portfolio is subject to the risk that the stocks of mid cap companies can be more volatile and riskier than the stocks of larger issuers. The Portfolio’s investments in midsize companies may entail greater risks than investments in larger, more established companies. Mid cap companies tend to have narrower product lines, fewer financial resources, and a more limited trading market for their securities, as compared to larger companies. They may also experience greater price volatility than securities of larger capitalization companies because growth prospects for these companies may be less certain and the market for such securities may be smaller. Some mid cap companies may not have established financial histories; may have limited product lines, markets, or financial resources; may depend on a few key personnel for management; and may be susceptible to losses and risks of bankruptcy.
Frequent Trading Risk
The Portfolio may engage in active and frequent trading of portfolio securities to achieve its investment objective. A high rate of portfolio turnover may result in greater transaction costs, which may reduce the Portfolio’s performance. The sale of securities from the Portfolio may also result in greater realization and/or distribution to shareholders of gains or losses as compared to a fund with less active trading, which may include short-term gains taxable at ordinary income rates. In addition, in connection with the Repositioning, shareholders should be aware that the Portfolio will experience a higher-than-normal portfolio turnover rate.
Non-Principal Risks
Foreign Securities
ADRs involve risks similar to those accompanying direct investment in foreign securities. There are substantial risks involved in investing in foreign securities. These risks include differences in accounting, auditing and financial reporting standards, generally higher commission rates on foreign transactions, the possibility of expropriation or confiscatory taxation, adverse changes in investment or exchange control regulations, political instability, and potential restrictions on the flow of international capital. The dividends payable on the Portfolio’s foreign portfolio securities may be subject to foreign withholding taxes, thus reducing the income available for distribution to the Portfolio’s shareholders. Foreign securities often trade with less frequency and volume than domestic securities and, therefore, may exhibit greater price volatility. Changes in foreign exchange rates will affect the value of those securities in the Portfolio which are denominated or quoted in currencies other than the U.S. dollar. In many countries there is less publicly available information about issuers than is available in reports about companies in the United States.
Brokerage commissions, custodial services, and other costs relating to investment in foreign securities markets are generally more expensive than in the United States. Foreign securities markets have different clearance and settlement procedures, and in certain markets there have been times when settlements have been unable to keep pace with the volume of securities transactions, making it difficult to conduct such transactions. Delays in settlement could prevent the Portfolio from investing the proceeds of the sale. Inability to dispose of portfolio securities due to settlement problems could expose the Portfolio to losses due either to subsequent declines in the value of the portfolio security or, if the security has been sold, to claims by the purchaser.
Investing in foreign securities includes the risk of possible losses through the holding of securities in domestic and foreign custodian banks and depositories. Additionally, many countries are dependent on a healthy U.S. economy, and are adversely affected when the U.S. economy weakens or its markets decline. In addition, the risks of loss and volatility have increased over the past few years and may continue because of high levels of debt and other economic distress in various countries.
International war or conflicts (including Russia’s invasion of Ukraine and the Israel-Hamas war) and geopolitical events in foreign countries, along with instability in regions such as Asia, Eastern Europe and the Middle East, possible terrorist attacks in the United States or around the world, and other similar events could adversely affect the U.S. and foreign financial markets. As a result, whether or not the Portfolio invests in securities located in or with significant exposure to the countries directly affected, the value and liquidity of the Portfolio’s investments may be negatively
| 13 |
impacted. Further, due to closures of certain markets and restrictions on trading certain securities, the value of certain securities held by the Portfolio could be significantly impacted.
Investments in Other Investment Companies
To the extent permitted by the Investment Company Act of 1940, as amended (the “1940 Act”), the Portfolio may invest in shares of other registered investment companies, including ETFs. If the Portfolio invests in shares of another registered investment company, shareholders would bear not only their proportionate share of the Portfolio’s expenses, but also management fees and other expenses paid by the other fund. Any investment in an ETF generally presents the same primary risks as an investment in a conventional open-end fund that has the same investment objectives, strategies and policies. Additionally, the risks of owning an ETF generally reflect the risks of owning the underlying securities that the ETF invests in or is designed to track, although the lack of liquidity of an ETF could result in it being more volatile. In addition, ETFs and closed-end funds do not necessarily trade at the NAV of their underlying securities, which means that these funds could potentially trade above or below the value of their underlying portfolios and may result in a loss. Finally, because ETFs and closed-end funds trade like stocks on exchanges, they are subject to trading and commission costs.
The Securities and Exchange Commission (“SEC”) has adopted revisions to the rules permitting funds to invest in other investment companies to streamline and enhance the regulatory framework applicable to fund of funds arrangements. While the rule permits more types of fund of fund arrangements without reliance on an exemptive order or no-action letters, it imposes new conditions, including limits on control and voting of acquired funds’ shares, evaluations and findings by investment advisers, fund investment agreements, and limits on most three-tier fund structures. Rule 12d1-4 of the 1940 Act went into effect on January 19, 2021. The rescission of the applicable exemptive orders and the withdrawal of the applicable no-action letters was effective on January 19, 2022.]]
Repurchase Agreements
The Portfolio may enter into collateralized repurchase agreements with qualified brokers, dealers, banks and other financial institutions deemed creditworthy by the Advisor. Such agreements can be entered into for periods of one day or for a fixed term.
In a repurchase agreement, the Portfolio purchases a security and simultaneously commits to resell that security at a future date to the seller (a qualified bank or securities dealer) at an agreed upon price plus an agreed upon market rate of interest (itself unrelated to the coupon rate or date of maturity of the purchased security). The seller under a repurchase agreement will be required to maintain the value of the securities which are subject to the agreement and held by the Portfolio at not less than the agreed upon repurchase price. If the seller defaults on its repurchase obligation, the Portfolio holding such obligation suffers a loss to the extent that the proceeds from a sale of the underlying securities (including accrued interest) is less than the repurchase price (including accrued interest) under the agreement. In the event that such a defaulting seller files for bankruptcy or becomes insolvent, disposition of such securities by the Portfolio might be delayed pending court action.
Portfolio Turnover
The Portfolio may engage in active and frequent trading of portfolio securities. High portfolio turnover may involve correspondingly greater expenses to the Portfolio, including brokerage commissions or dealer mark-ups and other transaction costs on the sale of securities and reinvestments in other securities. Higher portfolio turnover may also increase share price volatility and result in realization of taxable capital gains to shareholders with taxable accounts, including short-term capital gains, and may adversely impact the Portfolio’s after-tax returns. Trading costs and tax effects associated with portfolio turnover may adversely affect the Portfolio’s performance.
Selection of Investments
The Advisor evaluates the rewards and risks presented by all securities purchased by the Portfolio and how they may advance the Portfolio’s investment objective. It is possible that these evaluations will prove to be inaccurate.
| 14 |
Other Types of Investments and Risks
In addition to the Portfolio’s principal investment strategies and risks, and the particular types of securities which the Portfolio may select for investment described above, the Portfolio may make other types of investments and pursue other investment strategies in support of its overall investment goal. Information about some of these investments and strategies and other risks is provided below. More information about these and other supplemental investment strategies and the risks involved are described in the Statement of Additional Information (“SAI”).
Foreign Securities: The Portfolio intends to remain, for the most part, fully invested in equity securities which may include, as a non-principal investment, ADRs listed on the NYSE. The risks of ADRs are described above under “Foreign Securities.”
Investments in Other Investment Companies: The Portfolio may also invest in shares of other investment companies, including ETFs. The risks of registered investment company investments are described above under “Investments in Other Investment Companies.”
Real Estate Investment Trusts: The Portfolio may invest in real estate investment trusts (“REITs”). REITs are pooled investment vehicles which invest primarily in real estate or real estate related loans. REITs are generally classified as equity REITs, mortgage REITs or a combination of equity and mortgage REITs. Equity REITs invest the majority of their assets directly in real property and derive income primarily from the collection of rents. Equity REITs can also realize capital gains by selling properties that have appreciated in value. Mortgage REITs invest the majority of their assets in real estate mortgages and derive income from the collection of interest payments. Hybrid REITs combine the characteristics of both equity and mortgage REITs. The Portfolio will indirectly bear its proportionate share of any expenses paid by REITs in which it invests in addition to the expenses paid by the Portfolio.
Investing in REITs involves certain unique risks. Equity REITs may be affected by changes in the value of the underlying property owned by such REITs, while mortgage REITs may be affected by the quality of any credit extended. REITs are dependent upon management skills, are not diversified (except to the extent the Code requires), and are subject to the risks of financing projects. REITs are subject to heavy cash flow dependency, default by borrowers, self-liquidation, and the possibilities of failing to qualify for the exemption from tax for distributed income under the Code and failing to maintain their exemptions from the 1940 Act. REITs (especially mortgage REITs) are also subject to interest rate risks.
Investing in REITs also involves risks similar to those associated with investing in small capitalization companies. That is, they may have limited financial resources, may trade less frequently and in a limited volume and may be subject to abrupt or erratic price movements in comparison to larger capitalization companies.
Securities Lending: In order to generate additional income, the Portfolio may lend its securities to qualified brokers, dealers, banks and other financial institutions. Such loans are required at all times to be continuously secured by collateral consisting of cash, securities of the U.S. Government or its agencies or letters of credit equal to at least the market value of the loaned securities. The cash collateral received may be invested in short-term investments in accordance with terms approved by the Board. The value of the securities loaned may not exceed one-third of the value of the total assets of the Portfolio (including the loan collateral). A Portfolio could experience a delay in recovering its securities or a possible loss of income or value if the borrower fails to return the securities when due.
Cyber Security Risk: The Portfolio and its service providers may be prone to operational and information security risks resulting from breaches in cyber security. A breach in cyber security refers to both intentional and unintentional events that may cause the Portfolio to lose proprietary information, suffer data corruption, or lose operational capacity. Breaches in cyber security include, among other behaviors, stealing or corrupting data maintained online or digitally, denial of service attacks on websites, the unauthorized release of confidential information or various other forms of cyber-attacks. Cyber security breaches affecting the Portfolio or its advisers, custodian, transfer agent, intermediaries and other third-party service providers may adversely impact the Portfolio. For instance, cyber security breaches may interfere with the processing of shareholder transactions, impact the Portfolio’s ability to calculate its NAV, cause the release of private shareholder information or confidential business information, impede trading, subject the Portfolio to regulatory fines or financial losses and/or cause reputational damage. The Portfolio may also incur additional costs for cyber security risk management purposes. Similar types of cyber security risks are also present for issuers of
| 15 |
securities in which the Portfolio may invest, which could result in material adverse consequences for such issuers and may cause the Portfolio’s investment in such companies to lose value.
COVID-19 Risk: The impact of COVID-19 has negatively affected the worldwide economy, as well as the economies of individual countries, the financial health of individual companies and the market in general in significant and unforeseen ways over the period since the virus responsible for the global pandemic was first detected in December of 2019. On May 5, 2023, the World Health Organization declared the end of the global emergency status for COVID-19, and the United States subsequently ended the federal COVID-19 public health emergency declaration effective May 11, 2023. Although vaccines for COVID-19 are widely available, the full impact of COVID-19 and any current or future variants is currently unknown, and it may exacerbate other risks that apply to the Portfolio, including political, social and economic risks. Any such impact could adversely affect the Portfolio’s performance and the performance of the securities in which the Portfolio invests. The impact of these events and other epidemics or pandemics in the future could adversely affect the Portfolio’s performance.
Large Shareholder Risk: From time to time, shareholders of the Portfolio (which may include institutional investors or financial intermediaries acting on behalf of their clients) may make relatively large redemptions or purchases of the Portfolio’s shares. These transactions may, among other things, cause the Portfolio to sell securities or invest additional cash, as the case may be, at disadvantageous prices. While the Fund maintains credit facilities with State Street Bank and Trust Company that can be used to help limit the disruption from redemptions, there could be adverse effects on the Portfolio’s performance to the extent that the Portfolio may be required to sell securities or invest cash at times it would not otherwise do so. Selling portfolio securities to meet a large redemption request also may increase transaction costs or have adverse tax consequences for Portfolio shareholders. In addition, a large redemption could result in the Portfolio’s current expenses being allocated over a smaller asset base, leading to an increase in the Portfolio’s expense ratio.
Portfolio Holdings
The Advisor may publicly disclose information concerning the securities held by the Portfolio in accordance with regulatory requirements, such as periodic portfolio disclosure in filings with the SEC. In addition, the Advisor may post the Portfolio’s month-end, top-ten portfolio holdings no earlier than ten calendar days after the end of each month, and/or the complete quarter-end portfolio holdings no earlier than ten calendar days after the end of each calendar quarter, on its website, www.glenmedeim.com. This information will generally remain available on the website at least until the Fund files with the SEC its annual/semi-annual shareholder report that includes such period or its report on Form N-PORT for the last month of the Fund’s first or third fiscal quarters. The Fund may terminate or modify this policy at any time without further notice to shareholders.
A further description of the Fund’s policies and procedures with respect to the disclosure of portfolio holdings is available in the SAI.
The price of shares issued by the Portfolio is based on its NAV. The Portfolio’s NAV per share is determined on a per class basis as of the close of regular trading hours of the NYSE, currently 4:00 p.m. (Eastern Time), on each day that the NYSE is open for business. The time at which shares are priced may be changed in case of an emergency or if regular trading on the NYSE is stopped at a time other than 4:00 p.m. (Eastern Time). In addition, the Board has approved that the Portfolio may determine to price their shares on weekdays that the NYSE is temporarily closed due to emergency circumstances.
The Portfolio’s investments generally are valued at market value or, when market quotations are not readily available or when events occur that make established valuation methods unreliable, at fair value as determined in good faith using methods determined by the Board. The Board has designated the Advisor to serve as the valuation designee (the “Valuation Designee”) with respect to the Portfolio’s securities for which valuations are not readily available. The Valuation Designee works with State Street Bank and Trust Company, the Fund’s custodian, to regularly test the accuracy of the fair value prices by comparing them with values that are available from other sources. At each regularly scheduled Board meeting, a report by the Valuation Designee is submitted describing any security that has been fair valued and the basis for the fair value determination.
| 16 |
Securities listed on a foreign exchange and unlisted foreign securities are valued at the latest quoted price available when assets are valued. Foreign securities may trade on days when shares of the Portfolio are not priced; as a result, the value of such securities may change on days when you will not be able to purchase or redeem the Portfolio’s shares. Foreign currency amounts are translated into U.S. dollars at the bid prices of such currencies against U.S. dollars last quoted by a major bank.
The following are examples of situations that may constitute significant events that could render a market quotation for a specific security “not readily available” and require fair valuation of such security: (i) the security’s trading has been halted or suspended; (ii) the security has been de-listed from a national exchange; (iii) the security’s primary trading market is temporarily closed at a time when under normal conditions it would be open; (iv) the security has not been traded for an extended period of time; (v) the security’s authorized pricing sources are not able or willing to provide a price; (vi) an independent price quote from two or more broker-dealers is not available; (vii) trading of the security is subject to local government-imposed restrictions; (viii) foreign security has reached a pre-determined range of trading set by a foreign exchange (“limit up” or “limit down” price), and no trading has taken place at the limit up price or limit down price; (ix) natural disasters, armed conflicts, and significant government actions; (x) significant events that relate to a single issuer or to an entire market sector, such as significant fluctuations in domestic or foreign markets or between the current and previous days’ closing levels of one or more benchmark indices approved by the Board; (xi) the security’s sales have been infrequent or a “thin” market in the security exists; and/or (xii) with regard to over-the-counter securities, the validity of quotations from broker-dealers appears questionable or the number of quotations indicates that there is a “thin” market in the security.
The frequency with which the Portfolio’s investments are valued using fair value pricing is primarily a function of the types of securities and other assets in which the Portfolio invests pursuant to its investment objective, strategies and limitations. Investments in other registered mutual funds, if any, are valued based on the NAV of those mutual funds (which may use fair value pricing as discussed in their prospectuses).
Valuing the Portfolio’s investments using fair value pricing will result in using prices for those investments that may differ from current market prices. Accordingly, fair value pricing could result in a difference between the prices used to calculate the Portfolio’s NAV and the prices used by other investment companies, investors and the Portfolio’s benchmark index to price the same investments.
ADDITIONAL INFORMATION ON THE PURCHASE AND REDEMPTION OF SHARES
The Portfolio may appoint one or more intermediaries as its agent to receive purchase and redemption orders of shares of the Portfolio and cause these orders to be transmitted, on an aggregated basis, to the Portfolio’s transfer agent. Orders placed through these intermediaries will be deemed to have been received and accepted by the Portfolio when the intermediary accepts the order. Therefore, the purchase or redemption order will reflect the NAV per share next determined after receipt of the order by the intermediary, if the intermediary successfully transmits the order to the Portfolio’s transfer agent by the next business morning.
Purchase of Shares
Shares of the Portfolio are sold without a sales commission on a continuous basis to Glenmede Trust acting on behalf of its clients or the clients (“Clients”) of its affiliated companies (“Affiliates”) and to certain approved employee benefit plans and institutions, including brokers acting on behalf of their clients (“Institutions”), at the NAV per share next determined after receipt, in proper order, of the purchase order by the Fund’s transfer agent. We consider orders to be in “proper order” when all required documents are properly completed, signed and received. Beneficial ownership of shares will be reflected on books maintained by Glenmede Trust or the Institutions. Glenmede Trust has informed the Fund that it and its Affiliates’ minimum and subsequent investment requirements for their Clients’ investments in the Portfolio are the same as those for the Portfolios. Other Institutions may have their own minimum initial and subsequent investment requirements. If you wish to purchase shares in a Portfolio, you should contact Glenmede Trust by telephone or facsimile or contact your Institution.
The Portfolio reserves the right, in its sole discretion, to reject any purchase order, when, in the judgment of management, such rejection is in the best interests of the Portfolio and its shareholders.
| 17 |
Your Institution may charge you for purchasing or selling shares of a Portfolio. There is no transaction charge for shares purchased directly from the Portfolio through Glenmede Trust.
Shares may also be available on brokerage platforms of firms that have agreements with the Fund’s distributor to offer such shares solely when acting as an agent for the investor. An investor transacting in shares in these programs may be required to pay a commission and/or other forms of compensation to the broker. Shares of the Portfolio are available in other share classes that have different fees and expenses.
Purchases of the Portfolio’s shares will be made in full and fractional shares of the Portfolio calculated to three decimal places. In the interest of economy and convenience, certificates for shares will not be issued except upon your written request. Certificates for fractional shares, however, will not be issued.
The Fund reserves the right, in its sole discretion, to suspend the offering of shares of the Portfolio or to reject purchase orders when, in the judgment of the Advisor, such suspension or rejection is in the best interests of the Portfolio. Subject to the Board’s discretion, the Advisor will monitor the Portfolio’s total assets and may decide to close any of the Portfolio at any time to new investments or to new accounts due to concerns that a significant increase in the size of a Portfolio may adversely affect the implementation of the Portfolio’s investment strategy. Subject to the Board’s discretion, once closed, the Advisor may also choose to reopen a Portfolio to new investments at any time, and may subsequently close such Portfolio again should concerns regarding the Portfolio’s size recur. If a Portfolio closes to new investments, generally that Portfolio would be offered only to certain existing shareholders of the Portfolio and certain other persons, who may be generally subject to cumulative, maximum purchase amounts.
The Fund, however, reserves the right to reopen a closed Portfolio to new investments from time to time at its discretion.
Redemption of Shares
You may redeem Institutional or Advisor shares of the Portfolio at any time, without cost, at the NAV per share next determined after the Fund’s transfer agent receives your redemption order. Generally, a properly signed written order is all that is required. If you wish to redeem your shares, you should contact Glenmede Trust by telephone or facsimile or contact your Institution.
You will typically be paid your redemption proceeds within one business day after the Fund’s transfer agent receives your redemption order in proper form; however, payment of redemption proceeds may take up to seven days. The Fund may suspend the right of redemption or postpone the date of payment under any emergency circumstances as determined by the SEC.
Redemption proceeds are typically paid in cash from the proceeds of the sale of portfolio securities. The Fund also maintains credit facilities that serve as additional sources of liquidity for meeting redemption requests. The Fund also has the right to limit each shareholder to cash redemptions of $250,000 or 1% of such Portfolio’s NAV, whichever is less, within a 90-day period or, subject to the approval of the Board of Directors, in other circumstances identified by the Advisor. Any additional redemption proceeds would be made in readily marketable securities (“in-kind redemptions”). In-kind redemptions may be in the form of pro-rata slices of the Portfolio’s portfolio, individual securities or a representative basket of securities in conformity with applicable rules of the SEC and the Fund’s Policy and Procedures Related to the Processing of In-Kind Redemptions. A shareholder will be exposed to market risk until the readily marketable securities are converted to cash, generally will incur brokerage charges on the sale of portfolio securities so received in the payment of redemptions and may incur other transaction expenses in converting these securities to cash. These redemption methods are used regularly and may also be used in stressed market conditions.
Frequent Purchases and Redemptions of Portfolio Shares
Mutual fund market timing involves the frequent purchase and redemption of shares of mutual funds within short periods of time with the intention of capturing short-term profits resulting from market volatility. Market timing may disrupt portfolio management strategies; harm the performance of the Portfolio; dilute the value of Portfolio shares
| 18 |
held by long-term shareholders; increase brokerage and administrative costs; and for the Portfolio that invests to a significant extent in foreign securities, foster time-zone arbitrage.
The Fund does not knowingly accommodate frequent purchases and redemptions of Portfolio shares by shareholders. Pursuant to a policy adopted by the Board to discourage market timing of the Portfolio’s shares, the Fund has established the following procedures designed to discourage market timing of the Portfolio. The Fund will enforce its policies and procedures to discourage market timing of the Portfolio’s shares equitably on all shareholders. There is no guarantee that the Fund will be able to identify individual shareholders who may be market timing the Portfolio or curtail its trading activity in every instance, particularly if they are investing through financial intermediaries.
Shares of the Portfolio may be sold through omnibus account arrangements with financial intermediaries. Omnibus account information generally does not identify the underlying investors’ trading activity on an individual basis. In an effort to identify and deter market timing in omnibus accounts, Glenmede Trust and the Advisor periodically review trading activity at the omnibus level and will seek to obtain underlying account trading activity information from the financial intermediaries when, in their judgment, the trading activity suggests possible market timing. Requested information relating to trading activity will be reviewed to identify accounts that may be engaged in excessive trading based on criteria established by Glenmede Trust or the Advisor, as applicable. If this information shows that an investor’s trading activity suggests market timing, Glenmede Trust or the Advisor, as applicable, will contact the financial intermediary and follow its procedures, including but not limited to, warnings, restricting the account from further trading and/or closing the account. Financial intermediaries may also monitor their customers’ trading activities in the Portfolio using criteria that may differ from the criteria established by Glenmede Trust and the Advisor and there is no assurance that the procedures used by the financial intermediaries will be able to curtail excessive trading. If a third-party financial intermediary does not provide underlying account trading activity information upon request, Glenmede Trust or the Advisor, as applicable, will determine what action to take, including terminating the relationship with the financial intermediary.
The Portfolio normally distributes substantially all of its net investment income to shareholders in the form of a quarterly dividend.
The Portfolio normally distributes any realized net capital gains at least once a year.
Dividends and capital gains distributions are paid in cash or reinvested in additional shares at the option of the shareholder.
ADDITIONAL INFORMATION ABOUT TAXES
The following is a summary of certain United States tax considerations relevant under current law, which may be subject to change in the future. Except where otherwise indicated, the discussion relates to investors who are individual United States citizens or residents. You should consult your tax adviser for further information regarding Federal, state, local and/or foreign tax consequences relevant to your specific situation. Additional information about taxes is contained in the SAI.
Distributions
The Portfolio contemplates distributing as dividends each year all or substantially all of its taxable income, including its net capital gain (the excess of net long-term capital gain over net short-term capital loss). Except as discussed below, you will be subject to Federal income tax on Portfolio distributions regardless of whether they are paid in cash or reinvested in additional shares. Portfolio distributions attributable to short-term capital gains and net investment income will generally be taxable to you as ordinary income, except as discussed below.
Distributions attributable to the net capital gain of the Portfolio will be taxable to you as long-term capital gain, no matter how long you have owned your Portfolio shares. The maximum long-term capital gain rate applicable to individuals, estates, and trusts is currently 23.8% (which includes a 3.8% Medicare tax). You will be notified annually of the tax status of distributions to you.
| 19 |
Distributions of “qualifying dividends” will also generally be taxable to you at long-term capital gain rates, as long as certain requirements are met. In general, if 95% or more of the gross income of the Portfolio (other than net capital gain) consists of dividends received from domestic corporations or “qualified” foreign corporations (“qualifying dividends”), then all distributions paid by the Portfolio to individual shareholders will be taxed at long-term capital gain rates. But if less than 95% of the gross income of a Portfolio (other than net capital gain) consists of qualifying dividends, then distributions paid by the Portfolio to individual shareholders will be qualifying dividends only to the extent they are derived from qualifying dividends earned by the Portfolio. For the lower rates to apply, you must have owned your Portfolio shares for at least 61 days during the 121-day period beginning on the date that is 60 days before the Portfolio’s ex-dividend date (and the Portfolio will need to have met a similar holding period requirement with respect to the shares of the corporation paying the qualifying dividend). The amount of the Portfolio’s distributions that qualify for this favorable treatment may be reduced as a result of the Portfolio’s securities lending activities, if any, certain options transactions, if any, a high portfolio turnover rate or investments in debt securities or “non-qualified” foreign corporations.
Distributions from the Portfolio will generally be taxable to you in the taxable year in which they are paid, with one exception. Distributions declared by the Portfolio in October, November or December and paid in January of the following year are taxed as though they were paid on December 31.
A portion of distributions paid by the Portfolio to shareholders who are corporations may also qualify for the dividends-received deduction for corporations, subject to certain holding period requirements and debt financing limitations. The amount of the dividends qualifying for this deduction may, however, be reduced as a result of the Portfolio’s securities lending activities, if any, by a high portfolio turnover rate, or by investments in non-U.S. corporations.
If you purchase shares just before a distribution, the purchase price will reflect the amount of the upcoming distribution, but you will be taxed on the entire amount of the distribution received, even though, as an economic matter, the distribution simply constitutes a return of capital. This adverse tax result is known as “buying into a dividend.”
Sales and Redemptions
You will generally recognize taxable gain or loss for Federal income tax purposes on a sale or redemption of your shares based on the difference between your tax basis in the shares and the amount you receive for them. Generally, you will recognize long-term capital gain or loss if you have held your Portfolio shares for over 12 months at the time you dispose of them.
Certain special tax rules may apply to losses realized in some cases. Any loss realized on shares held for six months or less will be treated as a long-term capital loss to the extent of any capital gain dividends that were received on the shares. Additionally, any loss realized on a disposition of shares of the Portfolio may be disallowed under “wash sale” rules to the extent the shares disposed of are replaced with other shares of the same Portfolio within a period of 61 days beginning 30 days before and ending 30 days after the shares are disposed of, such as pursuant to a dividend reinvestment in shares of the Portfolio. If disallowed, the loss will be reflected in an upward adjustment to the basis of the shares acquired.
For shares acquired on or after January 1, 2012, the Portfolio (or relevant broker or financial advisor) is required to compute and report to the Internal Revenue Service (“IRS”) and furnish to Portfolio shareholders cost basis information when such shares are sold. The Portfolio has elected to use the average cost method, unless you instruct the Portfolio to use a different IRS- accepted cost basis method or you choose to specifically identify your shares at the time of each sale. If your account is held by your broker or other financial advisor, they may select a different cost basis method. In these cases, please contact your broker or other financial advisor to obtain information with respect to the available methods and elections for your account. You should carefully review the cost basis information provided by the Portfolio and make any additional basis, holding period or other adjustments that are required when reporting these amounts on your Federal and state income tax returns. Portfolio shareholders should consult with their tax advisors to determine the best IRS- accepted cost basis method for their tax situation and to obtain more information about how the cost basis reporting requirements apply to them.
| 20 |
IRAs and Other Tax-Qualified Plans
The one major exception to the preceding tax principles is that distributions on, and sales and redemptions of, shares held in an IRA (or other tax-qualified plan) will not be currently taxable unless it borrowed to acquire the shares.
Backup Withholding
The Portfolio may be required in certain cases to withhold and remit to the IRS a percentage of taxable dividends or gross proceeds realized upon sale payable to shareholders who have failed to provide a correct tax identification number in the manner required, who are subject to withholding by the IRS for failure to properly include on their return payments of taxable interest or dividends, or who have failed to certify to the Portfolio that they are not subject to backup withholding when required to do so or that they are “exempt recipients.” The current backup withholding rate is 24%.
U.S. Tax Treatment of Foreign Shareholders
Generally, nonresident aliens, foreign corporations and other foreign investors are subject to 30% withholding tax on dividends paid by a U.S. corporation, although the rate may be reduced for an investor that is a qualified resident of a foreign country with an applicable tax treaty with the United States. In the case of regulated investment companies such as the Portfolio, however, certain categories of dividends are exempt from the 30% withholding tax. These generally include dividends attributable to the Portfolio’s net capital gains (the excess of net long-term capital gains over net short-term capital losses), dividends attributable to the Portfolio’s interest income from U.S. obligors and dividends attributable to net short-term capital gains of the Portfolio.
Foreign shareholders will generally not be subject to U.S. tax on gains realized on the sale or redemption of shares in the Portfolio, except that a nonresident alien individual who is present in the United States for 183 days or more in a calendar year will be taxable on such gains and on capital gain dividends from the Portfolio.
In contrast, if a foreign investor conducts a trade or business in the United States and the investment in the Portfolio is effectively connected with that trade or business, then the foreign investor’s income from the Portfolio will generally be subject to U.S. Federal income tax at graduated rates in a manner similar to the income of a U.S. citizen or resident.
The Portfolio will also generally be required to withhold 30% tax on certain payments to foreign entities that do not provide a Form W-8BEN-E that evidences their compliance with, or exemption from, specified information reporting requirements under the Foreign Account Tax Compliance Act.
All foreign investors should consult their own tax advisors regarding the tax consequences in their country of residence of an investment in the Portfolio.
State and Local Taxes
You may also be subject to state and local taxes on distributions, sales and redemptions. State income taxes may not apply, however, to the portions of the Portfolio’s distributions, if any, that are attributable to interest on U.S. Government securities. You should consult your tax adviser regarding the tax status of distributions in your state and locality.
ADDITIONAL INFORMATION ABOUT MANAGEMENT OF THE PORTFOLIO
Investment Advisor
Glenmede Investment Management LP, with principal offices at One Liberty Place, 1650 Market Street, Suite 4000, Philadelphia, Pennsylvania 19103, serves as investment advisor to the Portfolio. The Advisor, a limited partnership, is wholly-owned by Glenmede Trust. As of December 31, 2024, the Advisor oversaw approximately $7.1 billion in assets.
| 21 |
Under Investment Advisory Agreement with the Fund, the Advisor, subject to the control and supervision of the Board and in conformance with the stated investment objective and policies of the Portfolio, manages the investment and reinvestment of the assets of the Portfolio. It is the responsibility of the Advisor to make investment decisions for the Portfolio and to place the Portfolio’s purchase and sale orders.
For the fiscal year ended October 31, 2024, the Portfolio paid management fees to the Advisor for its investment advisory services, calculated daily and paid monthly, at the following annual percentage rates of the Portfolio’s average daily net assets, as shown in the following table.
|
Portfolio |
Percentage of Average Daily Net Assets* | |
| SMID Core Equity Portfolio | 0.55%* |
* The Advisor has contractually agreed to waive its fees and/or reimburse expenses to the extent that the Portfolio’s Institutional Shares and Advisor Shares annual total operating expenses exceed 0.65% and 0.85%, respectively, of such Portfolio’s average daily net assets (excluding Acquired Fund fees and expenses, brokerage commissions, extraordinary items, interest and taxes). The Advisor has contractually agreed to these waivers and/or reimbursements, which may not be terminated without the approval of the Board, until at least [●], 2026. Shareholders will be notified if these waivers and/or reimbursements are discontinued after that date.
A discussion regarding the Board’s basis for renewing the Investment Advisory Agreement is available in the Fund’s financial statements on Form N-CSR for the fiscal year ended October 31, 2024.
Shareholders in the Portfolio who are clients of Glenmede Trust, or its Affiliates, pay fees which vary, depending on the capacity in which Glenmede Trust or its Affiliate provides fiduciary and investment services to the particular Client (e.g., personal trust, estate settlement, advisory and custodian services) (“Client Fees”). Glenmede Trust and its Affiliates currently intend to exclude the portion of their Clients’ assets invested in the Portfolio when calculating Client Fees. Shareholders in the Portfolio who are customers of other Institutions may pay fees to those Institutions.
The Advisor and/or Glenmede Trust may pay additional compensation from time to time, out of their assets, and not as an additional charge to the Portfolio, to selected Institutions that provide services to the Institution’s customers who are beneficial owners of the Portfolio and other persons in connection with servicing and/or sales of Portfolio shares and other accounts managed by the Advisor or Glenmede Trust.
[PM BIO TO BE UPDATED IN A SUBSEQUENT AMENDMENT]
If you have any questions regarding the Portfolio, contact the Fund at the address or telephone number stated on the back cover page.
| 22 |
The financial highlights table is intended to help you understand the Portfolio’s financial performance for the past 5 years. As of the date of this Prospectus, Institutional Class shares of the Portfolio had not been offered to investors and therefore financial highlights are not available for those shares. The financial highlights tables shown below reflect the financial performance of the Portfolio’s existing Advisor Class shares and are intended to provide a long-term perspective as to the Portfolio’s financial history. Certain information reflects financial results for a single Advisor Class share of the Portfolio. The total returns in the table represent the rate that an investor would have earned or lost on an investment in Advisor Class shares of the Portfolio (assuming reinvestment of all dividends and distributions). The information for the fiscal year ended October 31, 2024 has been audited by [●], the funds independent registered public accounting firm, whose report, along with the Portfolio’s financial statements, is included in the Annual Report, which is available upon request. Information for the fiscal years ended October 31, 2023, 2022, 2021 and 2020 was audited by another independent registered public accounting firm. The information for the period ended April 30, 2025 is included in the Semi-Annual Report, which is available upon request. This information along with the Portfolio’s financial statements, is included in the Semi-Annual Report, which is available upon request.
SMID Core Equity Portfolio – Advisor Shares
| For the Period Ended April 30, 2025 | For the Year Ended October 31, | |||||||||||
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |||||||
| Net asset value, beginning of year | $13.82 | $13.70 | $19.27 | $13.52 | $13.98 | |||||||
| Income from investment operations: | ||||||||||||
| Net investment income1 | 0.15 | 0.15 | 0.19 | 0.18 | 0.16 | |||||||
| Net realized and unrealized gain (loss) on investments | 4.03 | 0.41 | (2.33) | 5.75 | (0.47) | |||||||
| Total from investment operations | 4.18 | 0.56 | (2.14) | 5.93 | (0.31) | |||||||
| Distributions to shareholders from: | ||||||||||||
| Net investment income | (0.16) | (0.16) | (0.19) | (0.18) | (0.15) | |||||||
| Net realized capital gains | (0.65) | (0.28) | (3.24) | — | — | |||||||
| Total distributions | (0.81) | (0.44) | (3.43) | (0.18) | (0.15) | |||||||
| Net asset value, end of year | $17.19 | $13.82 | $13.70 | $19.27 | $13.52 | |||||||
| Total return2 | 31.05% | 4.14% | (13.15)% | 43.94% | (2.15)% | |||||||
| Ratios to average net assets/Supplemental data: | ||||||||||||
| Net assets, at end of year (in 000s) | $22,857 | $19,515 | $22,172 | $27,887 | $21,678 | |||||||
|
Ratio of operating expenses before waiver/ reimbursement to average net assets |
1.16% | 1.06% | 1.05% | 1.04% | 1.08% | |||||||
|
Ratio of operating expenses after waiver/ reimbursement to average net assets |
0.85%3 | 0.85% | 0.85%3 | 0.85%3 | 0.85% | |||||||
| Ratio of net investment income to average net assets | 0.93% | 1.04% | 1.27% | 1.01% | 1.19% | |||||||
| Portfolio turnover rate | 80% | 83% | 105% | 81% | 105% | |||||||
| 1 | Per share net investment income (loss) has been calculated using the average shares outstanding during the period. |
| 2 | The Total Return reflects fee waivers and/or expense reimbursements in effect and would have been lower in their absence. |
| 3 | The ratio of operating expenses after waiver/reimbursement excluding interest expense was 0.85%, 0.85% and 0.85% for the years ended October 31, 2024, 2022 and 2021, respectively. |
| 23 |
Where to find more information
More Portfolio information is available to you upon request and without charge:
Annual and Semi-Annual Report
The Annual and Semi-Annual Reports provide additional information about the Portfolio’s investments. The Annual Report also contains a discussion of the market conditions and investment strategies that significantly affected the Portfolio’s performance during the last fiscal year.
Statement of Additional Information (“SAI”)
The SAI includes additional information about the Portfolio’s investment policies, organization and management. It is legally part of this Prospectus (it is incorporated by reference).
You can get free copies of the Portfolio’s Annual Report, Semi-Annual Report or SAI by calling or writing to the address shown below. These documents are also available on Glenmede Investment Management LP’s website at www.glenmedeim.com.
To reduce the volume of mail you receive, only one copy of financial reports, prospectuses, other regulatory materials and other communications will be mailed to your household (if you share the same last name and address). You can call us at 1-800-442-8299, or write to us at the address listed below, to request (1) additional copies free of charge, or (2) that we discontinue our practice of mailing regulatory materials together.
You may also request other information about the Portfolio, and make inquiries as follows:
Write to:
The Glenmede Fund, Inc.
1650 Market Street
Suite 4000
Philadelphia, PA 19103
By phone:
1-800-442-8299
Reports and other information about the Portfolio are available on the EDGAR Database on the SEC’s Internet site at http://www.sec.gov. Copies of this information may be obtained, upon payment of a duplicating fee, by electronic request at the following e-mail address: [email protected].
The Glenmede Fund, Inc.’s Investment Company Act File No. is 811-05577.
The third party marks appearing above are the marks of their respective owners.
| 24 |
The information in this Statement of Additional Information is not complete and may be changed. We may not sell these securities until the registration statement filed with the Securities and Exchange Commission is effective. This Statement of Additional Information is not an offer to sell these securities and is not soliciting an offer to buy these securities in any jurisdiction where the offer or sale is not permitted.
SUBJECT TO COMPLETION, DATED JUNE 30, 2025
THE GLENMEDE FUND, INC.
(800) 442-8299
STATEMENT OF ADDITIONAL INFORMATION
[●], 2025
This Statement of Additional Information (“SAI”) is not a prospectus but should be read in conjunction with The Glenmede Fund, Inc.’s (“Glenmede Fund” or the “Fund”) Prospectus dated [●], 2025, as amended or supplemented from time to time (the “Prospectus”). This SAI is for the SMID Core Equity Portfolio (formerly, Women in Leadership U.S. Equity Portfolio) (Advisor Shares (GTLOX) and Institutional Shares ([●])) (the “Portfolio”). No investment in shares of the Portfolio should be made without first reading the Prospectus of the Portfolio. This SAI is incorporated by reference in its entirety into the Prospectus. The Fund’s audited financial statements and financial highlights appearing in the 2024 Annual Financial Statements are incorporated by reference into this SAI. No other parts of the Annual Financial Statements is incorporated by reference herein. The Fund’s Financial Statements for the six-month period ended April 30, 2025, and the financial highlights for each of the respective periods presented, appearing in the [2025 Semi-Annual Financial Statements], are incorporated by reference in this SAI. No other parts of the 2025 Semi-Annual Financial Statements are incorporated herein. A copy of the Fund’s Prospectus, Annual Financial Statements and Semi-Annual Financial Statements are available without charge, upon request, by calling the Fund at the above telephone number.
Capitalized terms used in this SAI and not otherwise defined have the same meanings given to them in the Fund’s Prospectus.
| 1 |
| 2 |
The Glenmede Fund was organized as a Maryland corporation on June 30, 1988. The Glenmede Fund’s Articles of Incorporation, as amended, authorize its Board of Directors (the “Board” and the members thereof, “Directors”) to issue 6,000,000,000 shares of common stock, with a $.001 par value. The Board has the power to subdivide these shares into one or more investment portfolios from time to time. The Board also has the power to designate separate classes of shares within the same Portfolio. As of the date hereof, the Glenmede Fund is offering shares of 14 Portfolios: Equity Income Portfolio, Global Secured Options Portfolio (Advisor Shares and Institutional Shares), Disciplined International Equity Portfolio (Advisor Shares and Institutional Shares), Disciplined U.S. Equity Portfolio (Advisor Shares and Institutional Shares), Disciplined U.S. Growth Equity Portfolio (Advisor Shares and Institutional Shares), Long/Short Equity Portfolio (Advisor Shares and Institutional Shares), Disciplined U.S. Value Equity Portfolio, Disciplined U.S. Small Cap Equity Portfolio (Advisor Shares and Institutional Shares), Environmental Accountability Portfolio, Secured Options Portfolio (Advisor Shares and Institutional Shares), Small Cap Equity Portfolio (Advisor Shares and Institutional Shares), Strategic Equity Portfolio, Total Market Plus Equity Portfolio and SMID Core Equity Portfolio (formerly, the Women in Leadership U.S. Equity Portfolio) (Advisor Shares and Institutional Shares). This SAI relates to the SMID Core Equity Portfolio only.
The Fund is an open-end, management investment company and each Portfolio of the Glenmede Fund is “diversified” as defined in Section 5(b) the Investment Company Act of 1940, as amended (the “1940 Act”).
The following investment strategies supplement those set forth in the Fund’s Prospectus. Unless specified below and except as described under “Investment Limitations,” the following investment strategies are not fundamental and the Board may change such strategies without shareholder approval.
SMID Core Equity Portfolio
From time to time, Glenmede Investment Management LP (“GIM” or the “Advisor”) may revise its equity computer model programs to try to maintain or enhance the Portfolio’s performance.
The SMID Core Equity Portfolio intends to remain, for the most part, fully invested in equity securities which may include, as a non-principal investment, American Depositary Receipts (“ADRs”) listed on the New York Stock Exchange (“NYSE”).
The SMID Core Equity Portfolio will not engage in “market timing” transactions. However, for temporary defensive purposes, the Portfolio may invest a portion of its assets (up to 20%) in short- term money market instruments issued by U.S. or foreign issuers, denominated in dollars or any foreign currency, including short-term certificates of deposit (including variable rate certificates of deposit), time deposits with a maturity no greater than 180 days, bankers’ acceptances, commercial paper rated A-1 by S&P Global Ratings (“S&P”) or Prime-1 by Moody’s Investors Service, Inc. (“Moody’s”), or in similar money market securities.
COMMON INVESTMENT POLICIES AND RISKS
Borrowing
As a temporary measure for extraordinary or emergency purposes, the Portfolio may borrow money from banks in amounts not exceeding one-third of total assets. The Portfolio will not borrow money for speculative purposes. If the market value of the Portfolio’s securities should decline, the Portfolio may experience difficulty in repaying the borrowing.
As required by the 1940 Act, the Portfolio must maintain continuous asset coverage (total assets, including assets acquired with borrowed funds, less liabilities exclusive of borrowings) of 300% of all amounts borrowed. If, at any time, the value of the Portfolio’s assets should fail to meet this 300% coverage test, the Portfolio, within three days (not including Sundays and holidays), will reduce the amount of its borrowings to the extent necessary to meet this 300% coverage. Maintenance of this percentage limitation may result in the sale of portfolio securities at a time
| 3 |
when investment considerations otherwise indicate that it would be disadvantageous to do so. Borrowing of securities in connection with short sales and derivative transactions such as options, futures and swaps are not subject to this limitation. The Portfolio is authorized to pledge portfolio securities to the lender as collateral in connection with any borrowings. Reverse repurchase agreements constitute borrowings, and leverage is a related risk.
Moreover, interest costs on borrowings may fluctuate with changing market rates of interest and may partially offset or exceed the returns on the borrowed funds. Unless profits on assets acquired with borrowed funds exceed the costs of borrowing, the use of borrowing will diminish the investment performance of the Portfolio. Under adverse conditions, the Portfolio may have to sell portfolio securities to meet interest or principal payments at a time investment considerations would not favor such sales. The Portfolio may lose money as a result of its borrowing activities. Lastly, the interests of persons with whom the Portfolio enters into leverage arrangements will not necessarily be aligned with the interests of such Portfolio’s shareholders and such persons will have claims on the Portfolio’s assets that are senior to those of the Portfolio’s shareholders.
Credit Risks
Because the Portfolio may invest in fixed-income securities, it is subject to “credit risk” — the risk that an issuer will be unable or unwilling to make principal and interest payments when due. U.S. Government securities are generally considered to be the safest type of investment in terms of credit risk. Municipal obligations generally rank between U.S. Government securities and corporate debt securities in terms of credit safety. Corporate debt securities, particularly those rated below investment grade, may present the highest credit risk.
Depositary Receipts
The Portfolio may invest in ADRs. Depositary receipts are receipts, typically issued by a bank or trust company, which evidence ownership of underlying securities issued by a foreign corporation. ADRs are depositary receipts issued in registered form by a U.S. bank or trust company evidencing ownership of underlying securities issued by a foreign company. ADRs may be listed on a national securities exchange or may be traded in the over-the-counter (“OTC”) market. ADR prices are denominated in U.S. dollars although the underlying securities are denominated in a foreign currency.
Generally, depositary receipts in registered form are designed for use in the U.S. securities market and depositary receipts in bearer form are designed for use in securities markets outside the United States. Depositary receipts may not necessarily be denominated in the same currency as the underlying securities into which they may be converted.
Investments in ADRs involve risks similar to those accompanying direct investments in foreign securities.
Exchange-Traded Funds
The Portfolio may invest in shares of registered open-end or closed-end investment companies, including exchange-traded funds (“ETFs”). Some ETFs seek to track the performance of a particular market index, and are a type of index fund bought and sold on a securities exchange. These indices include not only broad-market indices but more narrowly-based indices as well, including those relating to particular sectors, markets, regions or industries. ETF and listed closed-end fund shares are traded like traditional equity securities on a national securities exchange or NASDAQ National Market System. The Portfolio may purchase ETF shares as a way of gaining exposure to the segments of the equity or fixed-income markets represented by the ETF’s portfolio instead of buying those portfolio securities directly. ETF shares enjoy several advantages over futures. Depending on the market, the holding period, and other factors, ETF shares can be less costly than futures. In addition, ETF shares can be purchased for smaller sums and offer exposure to market sectors and styles for which there is no suitable or liquid futures contract. Because most ETFs are investment companies, the Portfolio’s purchase of ETF shares generally are subject to the percentage limitations and risks described below under “Investment Company Securities.”
An investment in an ETF or a closed-end fund generally presents the same primary risks as an investment in a conventional open-end fund (i.e., one that is not exchange traded) that has the same investment objectives, strategies, and policies. The price of an ETF or a closed-end fund can fluctuate within a wide range, and the Portfolio could lose
| 4 |
money investing in such a fund if the prices of the stocks owned by it go down. In addition, ETFs and listed closed-end funds are subject to the following risks that do not apply to conventional open-end funds: (i) the market price of their shares may trade at a discount to their net asset value (“NAV”); (ii) an active trading market for their shares may not develop or be maintained; or (iii) trading of their shares may be halted if the listing exchange’s officials deem such action appropriate, the shares are delisted from the exchange, or the activation of market-wide “circuit breakers” (which are tied to large decreases in stock prices) halts stock trading generally.
Fixed-Income Securities
The Portfolio may invest in fixed-income securities, which are used by issuers to borrow money. Bonds, notes, debentures, asset-backed securities (including those backed by mortgages), and loan participations and assignments are common types of debt securities. Generally, issuers pay investors periodic interest and repay the amount borrowed either periodically during the life of the security and/or at maturity. Some debt securities, such as zero coupon bonds, do not pay current interest, but are purchased at a discount from their face values and their values accrete over time to face value at maturity. Some debt securities bear interest at rates that are not fixed, but that vary with changes in specified market rates or indices. The market prices of debt securities fluctuate depending on such factors as interest rates, credit quality and maturity. In general, market prices of debt securities decline when interest rates rise and, conversely, increase when interest rates fall. These fluctuations will generally be greater for longer-term debt securities than for shorter-term debt securities.
Debt securities may be sensitive to economic changes, political and corporate developments, and interest rate changes. In addition, during an economic downturn or a period of rising interest rates, issuers that are highly leveraged may experience increased financial stress that could adversely affect their ability to meet projected business goals, to obtain additional financing and to service their principal and interest payment obligations. Periods of economic change and uncertainty also can be expected to result in increased volatility of market prices and yields of certain debt securities and derivative instruments. For example, during the financial crisis of 2007-2009, the Federal Reserve implemented several economic policies that impacted interest rates and the market.
These policies, as well as potential actions by governmental entities both in and outside of the U.S., may expose fixed-income markets to heightened volatility and may reduce liquidity for certain investments, which could cause the value of the Portfolio to decline. Prices of debt securities can also be affected by financial contracts held by the issuer or third parties (such as derivatives) relating to the security or other assets or indices.
Debt securities may contain redemption or call provisions. If an issuer exercises these provisions in a lower interest rate market, the Portfolio would have to replace the security with a lower yielding security, resulting in decreased income to investors. If the issuer of a debt security defaults on its obligations to pay interest or principal or is the subject of bankruptcy proceedings, the Portfolio may incur losses or expenses in seeking recovery of amounts owed to it.
There may be little trading in the secondary market for particular debt securities, which may affect adversely the Portfolio’s ability to value accurately or dispose of such debt securities. Adverse publicity and investor perceptions, whether or not based on fundamental analysis, may decrease the value and/or liquidity of debt securities.
Fixed-income securities are subject to “credit risk” — the risk that an issuer will be unable or unwilling to make principal and interest payments when due. U.S. Government securities are generally considered to be the safest type of investment in terms of credit risk. Municipal obligations generally rank between U.S. Government securities and corporate debt securities in terms of credit safety. Corporate debt securities, particularly those rated below investment grade, may present the highest credit risk. The Advisor attempts to reduce the risks described above through diversification of Portfolio investments and by credit analysis of each issuer, as well as by monitoring broad economic trends and corporate and legislative developments, but there can be no assurance that it will be successful in doing so.
Credit ratings for debt securities provided by rating agencies reflect an evaluation of the safety of principal and interest payments, not market value risk. The rating of an issuer is a rating agency’s view of past and future potential developments related to the issuer and may not necessarily reflect actual outcomes. There can be a lag between the time of developments relating to an issuer and the time a rating is assigned and updated. Changes in an issuer’s credit rating
| 5 |
or the market’s perception of an issuer’s creditworthiness may also affect the value of the Portfolio investment in that issuer.
Bond rating agencies may assign modifiers (such as +/–) to ratings categories to signify the relative position of a credit within the rating category. Investment policies that are based on ratings categories should be read to include any security within that category, without giving consideration to the modifier except where otherwise provided. See Appendix A to this SAI for more information about credit ratings.
Foreign Securities
The Portfolio may invest in ADRs listed on the NYSE. Such investments may involve higher costs than investments in U.S. securities, including higher transaction costs and additional taxes by foreign governments. Foreign investments may also present additional risks associated with currency exchange rates, differences in accounting, auditing and financial reporting standards, holding securities in domestic and foreign custodian banks and depositories, less complete financial information about the issuers, less market liquidity, and political instability. Future political and economic developments, the possible imposition of withholding taxes on dividends, the possible seizure or nationalization of foreign holdings, the possible establishment of exchange controls, or the adoption of other governmental restrictions, might adversely affect the payment of dividends or principal and interest on foreign obligations. The Public Company Accounting Oversight Board, which regulates auditors of U.S. public companies, is unable to inspect audit work papers in certain foreign countries. Investors in foreign countries often have limited rights and few practical remedies to pursue shareholder claims, including class actions or fraud claims, and the ability of the SEC, the U.S. Department of Justice and other authorities to bring and enforce actions against foreign issuers or foreign persons is limited.
Foreign securities markets also have different clearance and settlement procedures, and in certain markets there have been times when settlements have been unable to keep pace with the volume of securities transactions, making it difficult to conduct such transactions. Delays in settlement could result in temporary periods when assets of the Portfolio are uninvested and no return is earned. The inability of the Portfolio to make intended security purchases due to these and other settlement problems could cause such Portfolio to miss attractive investment opportunities. Inability to dispose of portfolio securities due to settlement problems could result in losses to the Portfolio due to subsequent declines in value of the portfolio security or, if the Portfolio has entered into a contract to sell the security, could result in possible liability to the purchaser. Additionally, the Portfolio may encounter difficulties or be unable to pursue legal remedies and obtain judgments in foreign courts.
Although the Portfolio is permitted to invest in securities denominated in foreign currencies, the Portfolio’s value its securities and other assets in U.S. dollars. As a result, the NAV of the Portfolio’s shares may fluctuate with U.S. dollar exchange rates as well as with price changes of the Portfolio’s securities in the various local markets and currencies. Thus, an increase in the value of the U.S. dollar compared to the currencies in which the Portfolio makes its investments could reduce the effect of increases and magnify the effect of decreases in the prices of the Portfolio’s securities in their local markets. Conversely, a decrease in the value of the U.S. dollar will have the opposite effect of magnifying the effect of increases and reducing the effect of decreases in the prices of the Portfolio’s securities in its local markets. In addition to favorable and unfavorable currency exchange rate developments, the Portfolio is subject to the possible imposition of exchange control regulations or freezes on convertibility of currency.
International war or conflicts (including Russia’s invasion of Ukraine, as described below) and geopolitical events in foreign countries, along with instability in regions such as Asia, Eastern Europe and the Middle East, possible terrorist attacks in the United States or around the world, and other similar events could adversely affect the U.S. and foreign financial markets. As a result, whether or not the Portfolio invests in securities located in or with significant exposure to the countries directly affected, the value and liquidity of the Portfolio’s investments may be negatively impacted. Further, due to closures of certain markets and restrictions on trading certain securities, the value of certain securities held by the Portfolio could be significantly impacted.
European countries can be significantly affected by the tight fiscal and monetary controls that the European Economic and Monetary Union (“EMU”) imposes on its members. Europe’s economies are diverse, its governments are decentralized, and its cultures vary widely. Several European Union (“EU”) countries have faced budget issues, some of which may have negative long-term effects for the economies of those countries and other EU countries. There
| 6 |
is continued concern about national-level support for the euro and the accompanying coordination of fiscal and wage policy among EMU member countries. Member countries are required to maintain tight control over inflation, public debt, and budget deficit to qualify for membership in the EMU. These requirements can severely limit the ability of EMU member countries to implement monetary policy to address regional economic conditions.
In 2016, the United Kingdom (the “UK”) held a referendum election and voters elected to withdraw from the EU (commonly referred to as “Brexit”). On January 31, 2020, the UK officially withdrew from the EU and the two sides entered a transition phase that ended on December 31, 2020. On December 24, 2020, the UK and EU finalized a new trade deal with no tariffs or quotas on products, regulatory and customs cooperation mechanisms as well as provisions ensuring a level playing field for open and fair competition. In March 2021, the UK and EU put in place a regulatory dialogue on financial systems based on a separate memorandum of understanding. The agreement governs the new relationship between the UK and EU with respect to trading goods and services, but critical aspects of the relationship remain unresolved and subject to further negotiation and agreement. The full scope and nature of the consequences of Brexit are not at this time known and are unlikely to be known for a significant period of time. It is also unknown whether the UK’s exit will increase the likelihood of other countries also departing the EU. Any additional exits from the EU, or the possibility of such exits, may have a significant impact on the UK, Europe, and global economies, which may result in increased volatility and illiquidity, new legal and regulatory uncertainties and potentially lower economic growth for such economies that could potentially have an adverse effect on the value of the Portfolio’s investments.
Other economic challenges facing Europe include high levels of public debt, significant rates of unemployment, aging populations, mass migrations from the Middle East and Africa and heavy regulation in certain economic sectors. European governments have taken unprecedented steps to respond to the economic crises and to boost growth in the region, which has increased the risk that regulatory uncertainty could negatively affect the Portfolio’s investments. In addition, in February 2022, Russia commenced a military attack on Ukraine. The outbreak of hostilities between the two countries and the threat of wider-spread hostilities could have a severe adverse effect on the region and global economies, including significant negative impacts on the markets for certain securities and commodities, such as oil and natural gas. In addition, sanctions imposed on Russia by the United States and other countries, and any sanctions imposed in the future, could have a significant adverse impact on the Russian economy and related markets. The price and liquidity of investments may fluctuate widely as a result of the conflict and related events. How long the armed conflict and related events will last cannot be predicted. These tensions and any related events could have a significant impact on the Portfolio’s performance and the value of the Portfolio’s investments, even beyond any direct exposure the Portfolio may have to issuers located in these countries. The ultimate effects of these events and other socio-political or geopolitical issues are not known but could profoundly affect global economies and markets. The impact of these actions, especially if they occur in a disorderly fashion, is not clear, but could be significant and far-reaching.
Illiquid Investments
The Portfolio will not invest more than 15% of its respective net assets in investments that are illiquid. These investments are subject to the risk that should the Portfolio need to dispose of such investments, there may not be a ready market or the Portfolio may have to sell such investments at an undesirable price. Illiquid investments are any investment that the Portfolio reasonably expects cannot be sold or disposed of in current market conditions in seven calendar days or less without the sale or disposition significantly changing the market value of the investment (including repurchase agreements in excess of seven days).
Pursuant to Rule 22e-4 under the 1940 Act, the Portfolio has established a liquidity risk management program. If the limitation on illiquid securities is exceeded, other than by a change in market values, the condition will be reported to the Board and, when required, to the SEC.
Indexed Securities
An indexed security is an instrument whose price is indexed to the price of another security, security index, currency, or other financial indicators. Indexed securities typically, but not always, are debt securities or deposits whose value at maturity or coupon rate is determined by reference to a specific instrument or statistic.
The performance of indexed securities depends to a great extent on the performance of the security, currency, or other instrument to which they are indexed, and may also be influenced by interest rate changes in the United States
| 7 |
and abroad. Indexed securities may be more volatile than the underlying instruments. Indexed securities are also subject to the credit risks associated with the issuer of the security, and their values may decline substantially if the issuer’s creditworthiness deteriorates. Recent issuers of indexed securities have included banks, corporations, and certain U.S. Government agencies.
Interest Rate Risks
The Portfolio may invest in fixed-income securities. Generally, a fixed-income security will increase in value when interest rates fall and, conversely, decrease in value when interest rates rise. Longer-term securities are generally more sensitive to interest rate changes than shorter-term securities, but they usually offer higher yields to compensate investors for the greater risks. The risks associated with changing interest rates are heightened under current market conditions given that interest rates in the United States and many other countries have fluctuated in recent periods and may continue to change in the foreseeable future. If interest rates are raised again in the future, the Portfolio’s yield may not increase proportionately, and the maturities of fixed-income securities that have the ability to be prepaid or called by the issuer may be extended. Changes in market conditions and government action may have adverse effects on investments, volatility, and liquidity in debt markets and any negative impact on fixed-income securities could be swift and significant, potentially negatively impacting the Portfolio’s performance. A general rise in interest rates may cause investors to move out of fixed-income securities on a large scale, which could adversely affect the price and liquidity of fixed-income securities. Substantial redemptions from bond and other income funds may worsen that impact. Dividend paying and other types of equity securities also may be adversely affected from an increase in interest rates.
Investment Company Securities
The Portfolio may invest in securities issued by other open-end or closed-end investment companies, including ETFs. The Portfolio may invest in securities issued by such other investment companies to the extent permitted by the 1940 Act. Under the 1940 Act, the Portfolio’s investment in such securities currently is limited to, subject to certain exceptions: (i) 3% of the total voting stock of any one investment company; (ii) 5% of the Portfolio’s total assets with respect to any one investment company; and (iii) 10% of the Portfolio’s total assets with respect to investment companies in the aggregate. Investments in the securities of other investment companies will involve duplication of advisory fees and certain other expenses. Rule 12d1-1 under the 1940 Act permits the Portfolio to invest an unlimited amount of its uninvested cash in a money market fund so long as, among other things, said investment is consistent with the Portfolio’s investment objective. As a shareholder of another mutual fund, the Portfolio would bear its pro rata portion of the other investment company’s advisory fees and other expenses, in addition to the expenses the Portfolio bears directly in connection with its own operations. Furthermore, the investment company securities in which the Portfolio invests may decline in value. The SEC adopted certain regulatory changes and took other actions related to the ability of an investment company to invest in the securities of another investment company. These changes include, among other things, the rescission of certain SEC exemptive orders permitting investments in excess of the statutory limits and the withdrawal of certain related SEC staff no-action letters, and the adoption of Rule 12d1-4 under the 1940 Act, which permits the Portfolio to invest in other investment companies beyond the statutory limits, subject to certain conditions. Pursuant to Rule 12d1-4 and procedures approved by the Board, certain of the Fund’s Portfolios may invest in certain ETFs in excess of the limits described above, provided that the Glenmede Fund complies with Rule 12d1-4 and any other applicable investment limitations.
The Portfolio’s shares may be purchased by other investment companies, including other Portfolios of the Fund. An investment company’s shares purchased by the Portfolio would be limited to 10% of the outstanding voting securities of the acquired investment company. For so long as the Portfolio invests in or accepts investments by other affiliated investment companies, it will not purchase securities of other investment companies, except to the extent permitted by the 1940 Act.
Real Estate Investment Trusts
The Portfolio may invest in real estate investment trusts (“REITs”). REITs are pooled investment vehicles which invest primarily in real estate or real estate related loans. REITs are generally classified as equity REITs, mortgage REITs or a combination of equity and mortgage REITs. Equity REITs invest the majority of their assets directly in real property and derive income primarily from the collection of rents. Equity REITs can also realize capital gains by selling properties that have appreciated in value. Equity REITs may further be categorized by the type of real
| 8 |
estate securities they own, such as apartment properties, retail shopping centers, office and industrial properties, hotels, healthcare facilities, manufactured housing and mixed property types. Mortgage REITs invest the majority of their assets in real estate mortgages and derive income from the collection of interest payments. Hybrid REITs combine the characteristics of both equity and mortgage REITs. Like regulated investment companies such as the Fund’s Portfolios, REITs are not taxed on income distributed to shareholders provided they comply with certain requirements under the Internal Revenue Code of 1986, as amended (the “Code”). The Portfolio will indirectly bear its proportionate share of any expenses paid by REITs in which it invests in addition to the expenses paid by the Portfolio.
Investing in REITs involves certain unique risks. Equity REITs may be affected by changes in the value of the underlying property owned by such REITs, while mortgage REITs may be affected by the quality of any credit extended. REITs are dependent upon management skills, are not diversified (except to the extent the Code requires) and are subject to the risks of financing projects. REITs are subject to heavy cash flow dependency, default by borrowers, self-liquidation, and the possibilities of failing to qualify for the exemption from tax for distributed income under the Code and failing to maintain their exemptions from the 1940 Act. REITs (especially mortgage REITs) are also subject to interest rate risks. Investing in REITs also involves risks similar to those associated with investing in small capitalization companies. That is, they may have limited financial resources, may trade less frequently and in a limited volume and may be subject to abrupt or erratic price movements in comparison to larger capitalization companies.
In addition, the value of such securities may fluctuate in response to the market’s perception of the creditworthiness of the issuers of mortgage-related securities owned by the Portfolio. Because investments in mortgage-related securities are interest sensitive, the ability of the issuer to reinvest or to reinvest favorably in underlying mortgages may be limited by government regulation or tax policy. For example, action by the Board of Governors of the Federal Reserve System to limit the growth of the nation’s money supply may cause interest rates to rise and thereby reduce the volume of new residential mortgages. Additionally, although mortgages and mortgage-related securities are generally supported by some form of government or private guarantees and/or insurance, there is no assurance that private guarantors or insurers will be able to meet their obligation.
Repurchase Agreements
The Portfolio may enter into repurchase agreements with qualified brokers, dealers, banks and other financial institutions deemed creditworthy by the Advisor. Under normal circumstances, however, the Portfolio will not enter into repurchase agreements if entering into such agreements would cause, at the time of entering into such agreements, more than 20% of the value of the total assets of the Portfolio to be subject to repurchase agreements.
In effect, by entering into a repurchase agreement, the Portfolio is lending its funds to the seller at the agreed upon interest rate, and receiving a security as collateral for the loan. Such agreements can be entered into for periods of one day (overnight repo) or for a fixed term (term repo). Repurchase agreements are a common way to earn interest income on short-term funds.
In a repurchase agreement, the Portfolio purchases a security and simultaneously commits to resell that security at a future date to the seller (a qualified bank or securities dealer) at an agreed upon price plus an agreed upon market rate of interest (itself unrelated to the coupon rate or date of maturity of the purchased security). The seller under a repurchase agreement will be required to maintain the value of the securities which are subject to the agreement and held by the Portfolio at not less than the agreed upon repurchase price.
If the seller defaults on its repurchase obligation, the Portfolio holding such obligation will suffer a loss to the extent that the proceeds from a sale of the underlying securities (including accrued interest) were less than the repurchase price (including accrued interest) under the agreement. In the event that such a defaulting seller files for bankruptcy or becomes insolvent, disposition of such securities by the Portfolio might be delayed pending court action.
Repurchase agreements that do not provide for payment to the Portfolio within seven days after notice without taking a reduced price are considered illiquid investments.
| 9 |
Securities Lending
The Portfolio may lend its portfolio securities with a value of up to one-third of its total assets (including the value of the collateral for the loans) to qualified brokers, dealers, banks and other financial institutions who need to borrow securities in order to complete certain transactions, such as covering short sales, avoiding failures to deliver securities or completing arbitrage operations. By lending its investment securities, the Portfolio attempts to increase its income through the receipt of interest on the loan. Any gain or loss in the market price of the securities loaned that might occur during the term of the loan would be for the account of the Portfolio. The Portfolio may lend its portfolio securities only when the terms, the structure and the aggregate amount of such loans are not inconsistent with the 1940 Act or the rules and regulations or interpretations of the SEC thereunder. All relevant facts and circumstances, including the creditworthiness of the broker, dealer or institution, will be considered by the Advisor in making decisions with respect to the lending of securities, subject to review by the Board.
When lending portfolio securities, the securities may not be available to the Portfolio on a timely basis. Therefore, the Portfolio may lose the opportunity to sell the securities at a desirable price. Such loans would also involve risks of delay in receiving additional collateral if the value of the collateral decreases below the value of the securities loaned or even the loss of rights to the collateral should the borrower of the securities fail financially. Additionally, if a borrower of securities files for bankruptcy or becomes insolvent, disposition of the securities may be delayed pending court action. The Portfolio may also record realized gain or loss on securities deemed sold due to a borrower’s inability to return securities on loan. The Portfolio may, from time to time, pay negotiated fees in connection with the lending of securities. State Street Bank and Trust Company (“State Street”) serves as the Fund’s securities lending agent. For these services, the lending agent receives a fee based on the income earned on the Portfolio’s investment of cash received as collateral for the loaned securities, a portion of any loan premium paid by the borrower, and reimbursement of expenses advanced as a result of the Portfolio’s securities lending activities, if any.
The lending agent may, on behalf of the Portfolio, invest the cash collateral received in short-term money market instruments, including commercial paper, money market mutual funds, certificates of deposit, time deposits and other short-term bank obligations, securities issued by the U.S. Government, its agencies or instrumentalities, repurchase agreements and other highly rated liquid investments. These investments may include mutual funds, with respect to which State Street and/or its affiliates provide investment management or advisory, trust, custody, transfer agency, shareholder servicing and/or other services for which they are compensated.
U.S. Government Obligations
The Portfolio may invest in obligations issued or guaranteed by the U.S. Government, its agencies, authorities or instrumentalities.
Direct obligations of the U.S. Government such as Treasury bills, notes and bonds are supported by its full faith and credit. Indirect obligations issued by Federal agencies and government-sponsored entities generally are not backed by the full faith and credit of the U.S. Treasury. Some of these indirect obligations may be supported by the right of the issuer to borrow from the Treasury; others are supported by the discretionary authority of the U.S. Government to purchase the agency’s obligations; still others are supported only by the credit of the instrumentality. Please refer to Appendix A for further information about U.S. Government obligations.
“When Issued,” “Delayed Settlement” and “Forward Delivery” Securities
The Portfolio may purchase and sell securities on a “when issued,” “delayed settlement” or “forward delivery” basis. “When issued” or “forward delivery” refers to securities whose terms and indenture are available and for which a market exists, but which are not available for immediate delivery. Securities purchased or sold on a when-issued or delayed-delivery basis may be settled after a period longer than the regular settlement time of trade date plus two business days. “Delayed settlement” is a term used to describe settlement of a securities transaction in the secondary market which will occur sometime in the future.
The Portfolio will engage in “when issued” transactions to obtain what is considered to be an advantageous price and yield at the time of the transaction. When the Portfolio engages in “when issued,” “delayed settlement” or “forward delivery” transactions, it will do so for the purpose of acquiring securities consistent with its investment objective and policies and not for the purpose of speculation. The Portfolio’s “when issued,” “delayed settlement” and “forward delivery” commitments are not expected to exceed 30% of its total assets absent unusual market
| 10 |
circumstances. Subject to the Delayed-Settlement Securities Provision of Rule 18f-4 and consistent with the requirements discussed under “Derivative Instruments,” above, the Portfolio will only sell securities on a when issued, delayed settlement or forward delivery basis to offset securities purchased on a when-issued, delayed settlement or forward delivery basis.
Securities purchased or sold on a “when issued,” “delayed settlement” or “forward delivery” basis are subject to changes in value based upon changes in the general level of interest rates. In when-issued and delayed settlement transactions, the Portfolio relies on the seller to complete the transaction; the seller’s failure to do so may cause the Portfolio to miss an advantageous price or yield.
The NAV per share of each class of shares of the Portfolio is determined by dividing the total market value of its investments and other assets, less liabilities allocated to that share class, by the total number of its shares outstanding of that class.
Equity securities and options listed on a U.S. securities exchange, including ETFs, for which quotations are readily available are valued at the last quoted sale price as of the close of the exchange’s regular trading hours on the day the valuation is made. Price information on listed securities is taken from the exchange where the security is primarily traded. Unlisted U.S. equity securities and listed securities not traded on the valuation date for which market quotations are readily available are valued not in excess of the asked prices or less than the bid prices. If no sales are reported, listed options are valued at the mean of the bid and ask price. Investments in open-ended and unlisted closed-ended investment companies are valued at their respective NAVs as reported by such companies.
Marketable fixed-income securities are valued according to the broadest and most representative market, which will ordinarily be the OTC market, at the most recent quoted bid price, or when stock exchange valuations are used, at the latest quoted sale price on the day of valuation. If there is not such a reported sale, the latest quoted bid price will be used. NAV includes interest on fixed-income securities which is accrued daily. In addition, bond and other fixed-income securities may be valued on the basis of prices provided by a pricing service or by using a matrix or formula, when the Advisor believes such prices reflect the fair market value of such securities. The prices provided by a pricing service are determined without regard to bid or last sale prices, but take into account institutional size trading in similar groups of securities and any developments related to specific securities. The matrix pricing method values securities by reference to prices of comparable securities obtained from sources the Advisor deems accurate and reliable. Debt securities with maturities of 60 days or less at the time of purchase are valued at amortized cost, which does not take into account unrealized gains or losses. The amortized cost method involves valuing an instrument at its cost and thereafter assuming a constant amortization to maturity of any discount or premium, regardless of the impact of fluctuating interest rates on the market value of the instrument. While this method provides certainty in valuation, it may result in periods during which value, as determined by amortized cost, is higher or lower than the price the Portfolio would receive if it sold the instrument.
Securities listed on a foreign exchange and unlisted foreign securities are valued at the latest quoted sales price available when assets are valued. Foreign securities for which market quotations are not readily available or for which the above valuation procedures are deemed not to reflect fair value are valued in a manner that is intended to reflect their fair value as determined in accordance with procedures approved by the Board. Foreign securities may trade on days when shares of the Portfolio are not priced; as a result, the NAV of shares of the Portfolio may change on days when shareholders will not be able to purchase or redeem the Portfolio’s shares. Foreign currency amounts are translated into U.S. dollars at the bid prices of such currencies against U.S. dollars last quoted by a major bank.
When market quotations are unavailable or when events occur that make established valuation methods unreliable, the Fund’s Portfolios’ investments will be valued at fair value as determined in good faith using methods determined by the Board. The Board has designated the Advisor to serve as the valuation designee (in such capacity, the “Valuation Designee”) with respect to the Fund’s Portfolios’ securities for which valuations are not readily available. The Valuation Designee works with State Street, the Fund’s custodian, to regularly test the accuracy of the fair value prices by comparing them with values that are available from other sources. At each regularly scheduled Board meeting, a report by the Valuation Designee is submitted describing any security that has been fair valued and the basis for the fair value determination.
| 11 |
The purchase price of shares of each class of the Portfolio is the NAV next determined after receipt of the purchase order by the Portfolio. It is the responsibility of The Glenmede Trust Company, N.A., the parent company of the Advisor (“Glenmede Trust”), the Advisor or certain approved brokers, employee benefit plans or other institutions to transmit orders for share purchases to State Street, the Fund’s transfer agent, and to deliver, or provide instructions to investors for the delivery of, required funds to State Street, the Fund’s custodian, on a timely basis.
The Portfolio reserves the right in its sole discretion (i) to suspend the offering of its shares, (ii) to reject purchase orders when in the judgment of management such rejection is in the best interest of the Portfolio, (iii) to reduce or waive the minimum for initial and subsequent investments, from time to time and (iv) to close at any time to new investments or to new accounts.
At the discretion of the Fund, investors may be permitted to purchase Portfolio shares by transferring securities to the Portfolio that meets the Portfolio’s investment objective and policies.
Redemption proceeds are normally paid in cash, although the Fund has elected to be governed by Rule 18f-1 under the 1940 Act which permits them to limit each shareholder to cash redemptions of $250,000 or 1% of the Portfolio’s NAV, whichever is less, within a 90-day period or, subject to the approval of the Board, in other circumstances identified by the Advisor. Any additional redemption proceeds would be made in readily marketable securities.
The Portfolio may engage in active short-term trading to benefit from price disparities among different issues of securities or among the markets for equity securities, or for other reasons. It is anticipated that the portfolio turnover may vary greatly from year to year as well as within a particular year, and may be affected by changes in the holdings of specific issuers, changes in country and currency weightings, cash requirements for redemption of shares and by requirements which enable the Portfolio to receive favorable tax treatment. The Portfolio is not restricted by policy with regard to portfolio turnover and will make changes in their investment portfolio from time to time as business and economic conditions as well as market prices may dictate.
A high portfolio turnover rate can result in corresponding increases in brokerage commissions; however, the Advisor will not consider turnover rate a limiting factor in making investment decisions consistent with the Portfolio’s investment objective and policies.
DISCLOSURE OF PORTFOLIO HOLDINGS
The Board has adopted a policy on selective disclosure of portfolio holdings (including, but not limited to, portfolio securities holdings, asset allocations, sector allocations, and other portfolio holdings statistics, collectively referred to herein as “portfolio holdings”). The policy provides that neither the Fund, nor its advisor, administrator, transfer agent nor distributor (each, a “Fund Service Provider”) will disclose the Fund’s portfolio holdings to any person other than in accordance with the policy. Under the policy, neither the Fund, any Fund Service Provider, nor any of their affiliated persons may receive any compensation in any form, whether in cash or otherwise, in connection with the disclosure of portfolio holdings. A Fund Service Provider may provide portfolio holdings to third parties if such information has been included in the Fund’s public filings as required by the SEC or other filings, reports or disclosure documents as the SEC or other applicable regulatory authorities may require. The Advisor may post the following portfolio holdings on its website or any website maintained for the Fund or otherwise in a manner available to all shareholders: (1) no earlier than ten calendar days after the end of each month, the month-end top-ten portfolio holdings; and/or (2) no earlier than ten calendar days after the end of each calendar quarter, the complete quarter-end portfolio holdings. This information may then be separately provided to any person commencing the day after it is first published on the website. Such information shall remain available on the website at least until the Fund files with
| 12 |
the SEC its annual/semi-annual shareholder report that includes such period or its report on Form N-PORT for the last month of the Fund’s first or third fiscal quarters.
Portfolio holdings information that is not filed with the SEC or not otherwise required to be disclosed by the SEC or other applicable regulatory authorities, may be provided to third parties only if the Fund has a legitimate business purpose for doing so, the third-party recipients are required to keep all portfolio holdings information confidential and are prohibited from trading on the information they receive. In order to ensure that the disclosure of the Fund’s non-public portfolio holdings is in the best interests of the Fund’s shareholders and to avoid any potential or actual conflicts of interest with the Fund Service Providers or other affiliated persons, disclosure to such third parties must be authorized by the Fund’s President and approved in advance by the Board. Under the policy, the Board is to receive information, on a quarterly basis, regarding any disclosures of non-public portfolio holdings information that were permitted during the preceding quarter. Such authorization, pre-approval and reporting is not required for disclosure by the Fund’s administrator to providers of auditing, custody, proxy voting and other services to the Fund, as well as rating and ranking organizations. In general, each recipient of non-public portfolio holdings information must sign a confidentiality and non-trading agreement, although this requirement will not apply when the recipient is otherwise subject to a duty of confidentiality.
Under the policy, the Fund’s President has authorized the release of information regarding the Fund’s portfolio holdings on a daily basis to providers of auditing, custody, proxy voting, legal and other services to the Fund, currently including:
| (i) | State Street, in connection with the provision of services as the Fund’s custodian, administrator, transfer agent, securities lending agent and short sales lending agent; |
| (ii) | Third-party providers of proxy voting services, such as Institutional Shareholder Services Inc. (“ISS”) and mailing services such as Broadridge Financial Solutions, Inc. (“Broadridge”); |
| (iii) | Cohen & Company, Ltd., the Fund’s independent registered public accounting firm, in connection with the provision of services related to the audit of the Fund’s financial statements and certain non-audit services; |
| (iv) | Third-party providers of pricing/analytical/reconciliation services, such as FT Interactive Data Corporation, FactSet, Bloomberg Valuation Service (BVAL) and Electra Information Systems; |
| (v) | Ratings and ranking organizations, such as Morningstar, Inc. and Lipper/Thomson Reuters; |
| (vi) | Faegre Drinker Biddle & Reath LLP, in connection with the provision of services as legal counsel to the Fund; |
| (vii) | Foreside Financial Group, LLC in connection with the provision of services related to the Fund’s compliance program; |
| (viii) | Barclays Capital Inc., BTIG LLC, J.P. Morgan Securities LLC and its affiliates, Goldman Sachs Execution and Clearing LP and Goldman, Sachs & Co., in connection with the performance of brokerage and options trading and related functions; and |
| (ix) | Third-party financial printers, such as Broadridge Financial Solutions. |
The Portfolio is subject to the following restrictions. The numbered restrictions are fundamental policies and may not be changed without the approval of the lesser of: (1) 67% of the voting securities of the affected Portfolio present at a meeting if the holders of more than 50% of the outstanding voting securities of the affected Portfolio are present or represented by proxy, or (2) more than 50% of the outstanding voting securities of the affected Portfolio.
The Portfolio will not:
| (1) | invest in commodities or commodity contracts, except that the Portfolio may invest in futures contracts and options; |
| (2) | purchase or sell real estate, although it may purchase and sell securities of companies which deal in real estate and may purchase and sell securities which are secured by interests in real estate; |
| (3) | make loans, except (i) by purchasing bonds, debentures or similar obligations (including repurchase agreements, subject to the limitation described in investment limitation (9) below, and money market instruments, including bankers’ acceptances and commercial paper, and selling securities on a when |
| 13 |
issued, delayed settlement or forward delivery basis) which are publicly or privately distributed, and (ii) by lending its portfolio securities to banks, brokers, dealers and other financial institutions so long as such loans are not inconsistent with the 1940 Act or the rules and regulations or interpretations of the SEC thereunder;
| (4) | purchase on margin or sell short, except as specified above in investment limitation (1); |
| (5) | purchase more than 10% of any class of the outstanding voting securities of any issuer; |
| (6) | issue senior securities, except that the Portfolio may borrow money in accordance with investment limitation below, purchase securities on a when issued, delayed settlement or forward delivery basis and enter into reverse repurchase agreements; |
| (7) | borrow money, except as a temporary measure for extraordinary or emergency purposes, and then not in excess of 10% of its total assets at the time of the borrowing (entering into reverse repurchase agreements and purchasing securities on a when issued, delayed settlement or forward delivery basis are not subject to this investment limitation); |
| (8) | pledge, mortgage, or hypothecate any of its assets to an extent greater than 10% of its total assets at fair market value, except as described in the Prospectus and this SAI and in connection with entering into futures contracts, but the deposit of assets in a segregated account in connection with the writing of covered put and call options and the purchase of securities on a when issued, delayed settlement or forward delivery basis and collateral arrangements with respect to initial or variation margin for futures contracts will not be deemed to be pledges of the Portfolio’s assets or the purchase of any securities on margin for purposes of this investment limitation; |
| (9) | underwrite the securities of other issuers or invest more than an aggregate of 15% of the total assets of the Portfolio, at the time of purchase, in securities for which there are no readily available markets, including repurchase agreements which have maturities of more than seven days or, in the case of the Portfolio, securities subject to legal or contractual restrictions on resale; |
| (10) | invest for the purpose of exercising control over management of any company; |
| (11) | invest its assets in securities of any investment company, except in connection with mergers, acquisitions of assets or consolidations and except as may otherwise be permitted by the 1940 Act; |
| (12) | acquire any securities of companies within one industry if, as a result of such acquisition, more than 25% of the value of the Portfolio’s net assets would be invested in securities of companies within such industry; provided, however, that there shall be no limitation on the purchase of obligations issued or guaranteed by the U.S. Government, its agencies, enterprises or instrumentalities; |
| (13) | write or acquire options or interests in oil, gas or other mineral exploration or development programs; and |
| (14) | with respect to 75% of its total assets, invest more than 5% of its total assets at the time of purchase in the securities of any single issuer (other than obligations issued or guaranteed by the U.S. Government, its agencies, enterprises or instrumentalities). |
If the Portfolio’s borrowings are in excess of 5% (excluding overdrafts) of its total net assets, additional portfolio purchases will not be made until the amount of such borrowing is reduced to 5% or less.
Borrowings including reverse repurchase agreements and securities purchased on a when issued, delayed settlement or forward delivery basis may not exceed 331∕3% of the Portfolio’s total net assets.
In addition, with respect to investment limitation (12), (a) there is no limitation with respect to (i) instruments issued or guaranteed by the United States, any state, territory or possession of the United States, the District of Columbia or any of their authorities, agencies, instrumentalities or political subdivisions, and (ii) repurchase agreements secured by the instruments described in clause (i); (b) wholly-owned finance companies will be considered to be in the industries of their parents if their activities are primarily related to financing the activities of the parents; and (c) utilities will be divided according to their services; for example, gas, gas transmission, electric and gas, electric and telephone will each be considered a separate industry.
With regard to limitation (13), the purchase of securities of a corporation, a subsidiary of which has an interest in oil, gas or other mineral exploration or development programs shall not be deemed to be prohibited by the limitation.
If a percentage restriction is adhered to at the time an investment is made, a later increase in percentage resulting from a change in value or assets will not constitute a violation of such restriction except as to limitations on borrowings.
| 14 |
The Fund’s officers, under the supervision of the Board, manage the day-to-day operations of the Fund. The Board members set broad policies for the Fund and choose its officers. The Fund’s Board member holds office until the earliest of (i) the next meeting of shareholders, if any, called for the purpose of considering the election or re-election of such member and until the election and qualification of his/her successor, if any, elected at such meeting, or (ii) the date he or she dies, resigns or retires, or is removed by the Board or shareholders. The Fund’s officers are elected by the Board and hold office for the term of one year and until his or her successor is duly elected and qualified, or until he or she dies, resigns, is removed, or becomes disqualified.
Board Members and Officers
The following is a list of the Board members and officers of the Fund, their ages, their principal occupations during the past five years, the number of currently-offered portfolios that they oversee in the Fund’s complex, and other directorships they hold. The Fund is considered to be a member of the same fund complex as the Glenmede Portfolios, as defined in Form N-1A under the 1940 Act. Unless otherwise indicated below, the address of each Board member and officer is c/o Glenmede Investment Management LP, 1650 Market Street, Suite 4000, Philadelphia, PA 19103.
| Name and Year of Birth | Position with the Fund and Time Served | Principal Occupations(s) During Past 5 Years | Number of Portfolios in Fund Complex Overseen | Other Directorships Held in the Past Five Years | ||||
|
Interested Directors(1) |
||||||||
|
Susan W. Catherwood Year of Birth: 1943 |
Director of Glenmede Fund (since February 2007) | Director (since 1988) and Member of the Investment Review/ Relationship Oversight Committee (since 2001), Compensation Committee (since 1993) and Nominating Committee (since 2018), Glenmede Trust; Director, The Glenmede Corporation (since 1988); Board Member, The Pew Charitable Trusts; Charter Trustee, The University of Pennsylvania; Chairman Emeritus, The University Museum of The University of Pennsylvania; Chairman of the Board of Managers, The Christopher Ludwick Foundation; Board Member, Monell Chemical Senses Center; Director: Thomas Skelton Harrison Foundation and The Catherwood Foundation; Fellow and serves on Finance and Investment Committees, and former Board member, College of Physicians of Philadelphia; Former Member and Chair, The Women’s Committee and Penn Museum Board of Overseers of the University of Pennsylvania; Former Board Chair, University of Pennsylvania Health System (1991-1999). | 14 | None |
| 15 |
| Name and Year of Birth | Position with the Fund and Time Served | Principal Occupations(s) During Past 5 Years | Number of Portfolios in Fund Complex Overseen | Other Directorships Held in the Past Five Years | ||||
|
Mary Ann B. Wirts Year of Birth: 1951 |
Director of Glenmede Fund (since June 2020) | Managing Director and Chief Administrative Officer of Glenmede Trust (until 2020); Managing Director and Chief Administrative Officer of Glenmede Investment Management LP (2006-2020); First Vice President and Managing Director of Fixed Income of Glenmede Advisers (2000-2006). | 14 | None | ||||
| Independent Directors(2) | ||||||||
|
Andrew Phillips Year of Birth: 1962 |
Director of Glenmede Fund (since September 2022) |
Adjunct Professor - College of Management (since 2021), Long Island University; Senior Performance Officer (2013 - 2015), Global Head of Institutional and Alternatives Product Strategy (2012 - 2013), Global Chief Performance Officer (2010 - 2012), Global Chief Operating Officer (2007 - 2010) and Managing Director - Americas Fixed Income Executive Team, BlackRock, Inc. |
14 | None | ||||
|
H. Franklin Allen, Ph.D. Year of Birth: 1956 |
Director of Glenmede Fund (since March 1991)
|
Vice Dean Research and Faculty of the Imperial College Business School (since 2019), Professor of Finance and Economics and Executive Director of the Brevan Howard Centre for Financial Analysis at the Imperial College London (since 2014); Professor Emeritus of Finance, The Wharton School of The University of Pennsylvania since June 2016; Professor of Finance and Economics (1990-1994); Vice Dean and Director of Wharton Doctoral Programs (1990-1993); Employed by The University of Pennsylvania (from 1980-2016). |
14 | None | ||||
|
William L. Cobb, Jr. Year of Birth: 1947 |
Director of Glenmede Fund (since February 2007) Chairman of Glenmede Fund (since December 2021) | Former Executive Vice President and Former Chief Investment Officer, The Church Pension Fund (defined benefit plan for retired clergy of the Episcopal Church) (1999-2014); Chair and Member, Investment Committee, The Minister and Missionaries Benefit Board of the American Baptist Church (until 2013); Vice Chairman, J.P. Morgan Investment Management (1994 -1999). | 14 | Director, TCW Direct Lending LLC | ||||
|
Rebecca E. Duseau Year of Birth: 1963 |
Director of Glenmede Fund (since December 2023) |
Cofounder and Chief Compliance Officer (since 2000), Adamas Partners, LLC (investment firm); Chair of Investment Advisory Board (since 2020) for Boston Family Advisors (multi-family office); Member of Investment Committees of Mass General Brigham (hospital) (since 2019) and Berklee School of Music (since 2019); Chair of the Investment Committee and Member of the Finance Committee, Museum of Science (since 2023). |
14 | None |
| 16 |
| Name and Year of Birth | Position with the Fund and Time Served | Principal Occupations(s) During Past 5 Years | Number of Portfolios in Fund Complex Overseen | Other Directorships Held in the Past Five Years | ||||
|
Harry Wong Year of Birth: 1948
|
Director of Glenmede Fund (since February 2007)
|
Former Managing Director, Knight Capital Americas, L.P., an operating subsidiary of Knight Capital Group Inc. (investment banking) (2009 - 2011); Managing Director, Long Point Advisors, LLC (business consulting) (2003 - 2012); Managing Director, BIO-IB LLC (healthcare investment banking) (2004-2009) Senior Managing Director, ABN AMRO (investment banking) (1990- 2002); Adjunct Faculty Member, Sacred Heart University (2003- 2007). | 14 | None |
(1) Interested Directors are those Directors who are “interested persons” of the Fund as defined in the 1940 Act. Susan W. Catherwood and Mary Ann B. Wirts are considered to be “interested” Director of the Fund because of their current or prior affiliations with Glenmede Trust, the parent company of the Fund’s investment advisor, GIM, and/or their stock ownership in The Glenmede Corporation, of which GIM is an affiliate.
(2)Independent Directors are those Directors who are not “interested persons” of the Fund as defined in the 1940 Act.
Officers
|
Name, Address and Year of Birth |
Position with the Fund and Time Served |
Principal Occupations(s) During Past 5 Years | |
|
Elizabeth A. Eldridge 1650 Market Street, Suite 4000 Philadelphia, PA 19103 Year of Birth: 1977 |
President of Glenmede Fund since November 2024. |
President of Glenmede Investment Management LP (since 2024). Managing Director, The Glenmede Trust Company, N.A. (2020). | |
|
Kimberly C. Osborne 1650 Market Street, Suite 4000 Philadelphia, PA 19103 Year of Birth: 1966 |
Executive Vice President of Glenmede Fund since December 1997; Assistant Treasurer of the Fund since December 2020.
|
Client Service Manager of Glenmede Investment Management LP (since 2006). Vice President of Glenmede Trust and Glenmede Advisers (until 2008). Employed by Glenmede Trust (1993-2008) and Glenmede Advisers (2000-2008). | |
|
Christopher E. McGuire 1650 Market Street, Suite 4000 Philadelphia, PA 19103 Year of Birth: 1973 |
Treasurer of Glenmede Fund since December 2019. |
Director of Administration of Glenmede Investment Management LP (since October 2019); Managing Director, State Street Bank and Trust Company (from 2007- 2019). | |
|
Eimile J. Moore 3 Canal Plaza, Suite 100, 3rd Floor Portland, ME 04101 Year of Birth: 1969 |
Chief Compliance Officer of Glenmede Fund since December 2017. |
Senior Principal Consultant (since 2011). | |
|
Joshua M. Lindauer 1177 Avenue of the Americas, 41st Floor New York, NY 10036 Year of Birth: 1987 |
Secretary of Glenmede Fund since December 2024. |
Partner, Faegre Drinker Biddle & Reath LLP (law firm) (since 2024); Associate, Faegre Drinker Biddle & Reath LLP (2020-2024); Associate, Drinker Biddle & Reath LLP (law firm) 2017-2020. |
The Board believes that each Director’s experience, qualifications, attributes and skills on an individual basis and in combination with those of the other Directors lead to the conclusion that each Director should serve in such capacity.
| 17 |
Among the attributes common to all Directors is the ability to review critically, evaluate, question and discuss information provided to them, to interact effectively with the other Directors, the Advisor, other service providers, legal counsel and the independent registered public accounting firm, and to exercise effective business judgment in the performance of their duties as Directors. A Director’s ability to perform his or her duties effectively may have been attained through such person’s business, consulting and/or academic positions; experience as a board member of the Fund, other investment funds, or non-profit entities or other organizations; education or professional training; and/or other life experiences. In addition to these shared characteristics, set forth below is a brief discussion of the specific experience, qualifications, attributes or skills of each Director:
| H. Franklin Allen, Ph.D.: |
Dr. Allen has substantial experience in the areas of finance and economics through his educational background and position for many years as a professor of finance and economics at The Wharton School of The University of Pennsylvania and most recently as Vice Dean of Research and Faculty of the Imperial College London Business School and Professor of Finance and Economics and Director of the Brevan Howard Centre for Financial Analysis at the Imperial College London. |
| Susan W. Catherwood: |
Ms. Catherwood has substantial business, finance and investment management experience through her board and committee positions with the parent companies of the Advisor and her board and/or executive positions with academic entities, charitable foundations and companies. |
| William L. Cobb, Jr.: |
Mr. Cobb has substantial investment management and business experience through his senior executive, chief investment officer and/or investment committee positions with private and non-profit entities, as a senior executive officer of a global investment management firm and most recently as a board member of a business development company. |
| Rebecca E. Duseau: |
Ms. Duseau has substantial investment management, compliance, risk management and business experience as a co-founder and executive of an investment management firm. |
| Andrew Phillips: |
Mr. Phillips has substantial investment management and business experience through his executive positions with a major investment management firm. |
| Mary Ann B. Wirts: |
Ms. Wirts has substantial business, financial services and investment management experience through her senior executive positions with the Advisor and its parent companies. |
| Harry Wong: | Mr. Wong has substantial finance, investment banking and capital markets experience through his positions as an executive in investment banking businesses. |
Specific details regarding each Director’s term of office as a Director with the Fund and principal occupations during at least the past five years are included in the table above.
Leadership Structure and Oversight Responsibilities
Overall responsibility for oversight of the Fund rests with the Board. The Fund has engaged an investment adviser to manage its Portfolios on a day-to-day basis. The Board is responsible for overseeing the investment adviser and other service providers in the operations of the Fund in accordance with the provisions of the 1940 Act, applicable provisions of state and other laws and the Fund’s Charter and By-laws. The Board is currently composed of seven members, five of whom are Independent Directors. The Board meets in-person at regularly scheduled meetings four times each year. In addition, the Board may hold special in-person or telephonic meetings or informal conference calls to discuss specific matters that may arise or require action between regular meetings. The Board may also meet via videoconference. The Board and the Independent Directors have access to the Fund’s Chief Compliance Officer
| 18 |
(“CCO”), the Fund’s independent registered public accounting firm and independent legal counsel for consultation to assist them in performing their oversight responsibilities. As described below, the Board has established an Audit Committee, Valuation Committee, and Nominating Committee and may establish ad hoc committees or working groups from time to time to assist the Board in fulfilling its oversight responsibilities.
The Board has appointed William L. Cobb, Jr., an Independent Director, to serve in the role of Chairman of the Board. The Chairman’s role is to preside at all meetings of the Board and to act as liaison with the investment adviser, other service providers, counsel and other Directors generally between meetings. The Chairman may also perform such other functions as may be delegated by the Board from time to time. The Board reviews its leadership structures during their periodic self-assessments and based on that review, has determined that the Board’s leadership structure is appropriate because it allows the Board to exercise informed judgment over matters under its purview and it allocates areas of responsibility among committees of the Board and the full Board in a manner that enhances effective oversight.
The Fund is subject to a number of risks, including investment, compliance, operational and valuation risks, among others. Risk oversight forms part of the Board’s general oversight of the Fund and is addressed as part of the Board’s and its committees’ various activities. Day-to-day risk management functions are included within the responsibilities of the investment adviser and other service providers (depending on the nature of the risk), which carry out the Fund’s investment management and business affairs. The investment adviser and other service providers employ a variety of processes, procedures and controls to identify various events or circumstances that give rise to risks, to lessen the probability of their occurrence and/or to mitigate the effects of such events or circumstances if they do occur. The investment adviser and other service providers have their own independent interests in risk management, and their policies and methods of risk management will depend on their functions and business models.
The Board recognizes that it is not possible to identify all of the risks that may affect the Fund or to develop processes and controls to eliminate or mitigate their occurrence or effects. The Board requires senior officers of the Fund, including the President, Chief Financial Officer and CCO, and the investment adviser, to report to the full Board on a variety of matters at each regular meeting of the Board, including matters relating to risk management. The Board also receives reports from certain of the Fund’s other primary service providers on regular basis, including State Street as the Fund’s custodian, administrator, transfer agent and securities lending agent. The Fund’s CCO meets in executive session with the Board at each regularly scheduled meeting and meets separately with the Independent Directors at least annually to discuss relevant risk issues affecting the Fund. In addition, the CCO reports to the Chairman of the Audit Committee between meetings to discuss compliance related matters. The Audit Committee also receive regular reports from the Fund’s independent registered public accounting firm on internal control and financial reporting matters. The Board and Independent Directors meet with the Fund’s independent legal counsel each quarterly meeting and have access to legal counsel for consultation concerning any issues that may occur between regularly scheduled meetings. The Board may, at any time and in their discretion, change the manner in which it conducts risk oversight.
Standing Board Committees
Dr. Allen and Messrs. Cobb, Phillips and Wong (Chairman) and Ms. Duseau serve on the Audit Committee of the Board. The Audit Committee operates under a written charter approved by the Board. The purpose of the Audit Committee includes overseeing the accounting and financial reporting processes of the Fund and the audits of the Fund’s financial statements. Accordingly, the Committee assists the Board in its oversight of (i) the integrity of the Fund’s financial statements; (ii) the independent accountants’ qualifications and independence; and (iii) the performance of the Fund’s internal audit function and independent accountants. The Audit Committees met three times during the fiscal year ended October 31, 2024.
Dr. Allen (Chairman) and Messrs. Cobb, Wong and Phillips and Ms. Duseau serve on the Nominating Committee of the Board. The Fund’s Nominating Committee, among other things, nominates persons to fill vacancies on the Board and Board Committees. The Nominating Committees will consider nominees recommended by shareholders.
Recommendations should be submitted to the appropriate Nominating Committee in care of the Fund’s Secretary. The Nominating Committees met once during the fiscal year ended October 31, 2024.
| 19 |
Director Ownership of Fund Shares
The following table shows the Directors’ ownership of each Portfolio of the Fund and in all Portfolios of the Fund overseen by the Directors, as of December 31, 2024.
| Name of Director |
Dollar Range of Equity Securities in each Portfolio of the Fund |
Aggregate Dollar Range of Equity Securities in All Portfolios in the Fund Complex |
|
Interested Directors |
||
| Susan W. Catherwood | None | None |
| Mary Ann B. Wirts | None | None |
|
Independent Directors |
||
| H. Franklin Allen, Ph.D. | None | None |
| William L. Cobb, Jr. | None | None |
| Rebecca E. Duseau | None | None |
| Andrew Phillips | None | None |
| Harry Wong | None | None |
Remuneration of Board Members
The annual fee for each Board member, other than officers of the Advisor, is $104,000. In addition, to the annual fee, the Glenmede Fund pays each Board member, other than officers of the Advisor, $5,000 for each Board meeting attended and out-of-pocket expenses incurred in attending Board meetings, the Audit Committee Chairman receives an annual fee of $10,000 for his service as Chairman of the Audit Committee and the Chairman of the Board receives an annual fee of $15,000 for his service as Chairman of the Board. Each Director is also a Trustee of the Glenmede Portfolios, a Massachusetts business trust that does not currently offer any series. For their service on the Glenmede Portfolios’ Board, effective October 31, 2024, each Director receives an annual fee of $500 per year. Prior to October 31, 2024, each Director who served as a Trustee of Glenmede Portfolios received an annual fee of $6,000 per year. The officers of the Fund receive no compensation as officers from the Fund.
Set forth in the table below is the compensation received by Board members for the fiscal year ended October 31, 2024.
| Name of Person Position * | Aggregate Compensation from Glenmede Fund | Aggregate Compensation from Glenmede Portfolios** |
Pension Retirement Benefits Accrued as Part of Fund Expenses |
Estimated Annual Benefits upon Retirement | Total Compensation from the Fund Complex | |||||
| Interested Directors | ||||||||||
| Susan W. Catherwood | $124,000 | $6,000 | None | None | $130,000 | |||||
| Mary Ann B. Wirts | $124,000 | $6,000 | None | None | $130,000 | |||||
|
Independent Directors |
||||||||||
| H. Franklin Allen, Ph.D. | $124,000 | $6,000 | None | None | $130,000 | |||||
| William L. Cobb, Jr. | $140,918 | $6,000 | None | None | $146,918 | |||||
| Rebecca E. Duseau | $125,765 | $6,000 | None | None | $131,765 | |||||
| Andrew Phillips | $124,954 | $6,000 | None | None | $130,954 | |||||
| Harry Wong | $134,930 | $6,000 | None | None | $140,930 |
| * | Compensation includes reimbursement of out-of-pocket expenses incurred in attending Board meetings, where applicable. |
| ** | Includes $6,000 annual fee for service on the Board of Trustees of Glenmede Portfolios. |
| 20 |
Code of Ethics
The Fund and the Advisor have each adopted codes of ethics that permit personnel subject to the codes to invest in securities, including securities that may be purchased or held by the Fund.
Proxy Voting Procedures
The Fund has delegated proxy voting responsibilities to the Advisor, subject to the Board’s general oversight. In delegating proxy responsibilities, the Board has directed that proxies be voted consistent with the Fund’s and its shareholders best interests and in compliance with all applicable proxy voting rules and regulations. The Advisor has adopted its own proxy voting policies and guidelines for this purpose (collectively, the “Proxy Voting Procedures”). The Proxy Voting Procedures address, among other things, material conflicts of interest that may arise between the interests of the Fund and the interests of the Advisor and its affiliates. The Proxy Voting Procedures are provided in Appendix B of this SAI.
Information regarding how the Fund voted proxies, if any, relating to portfolio securities during the most recent twelve-month period ended June 30 is available, without charge, upon request, by calling 1-800-442-8299, and on the SEC’s website at http://www.sec.gov.
INVESTMENT ADVISORY AND OTHER SERVICES
Investment Advisor
GIM, with principal offices at One Liberty Place, 1650 Market Street, Suite 4000, Philadelphia, Pennsylvania 19103, currently serves as the investment advisor to each Portfolio. GIM, a limited partnership, is wholly-owned by Glenmede Trust. As of April 30, 2025, GIM and its affiliated companies had approximately $[●] billion in assets in the accounts for which they serve in various capacities, including as executor, trustee or investment advisor.
The Investment Advisory Agreement will continue in effect from year to year provided its continuance is approved annually (i) by the holders of a majority of each Portfolio’s outstanding voting securities or by the Board and (ii) by a majority of the Directors who are not parties to each Investment Advisory Agreement or interested persons of any such party. The Investment Advisory Agreement may be terminated on 60 days’ written notice by any such party and will terminate automatically if assigned.
The names and position with GIM of the principal executive officers and each director of GIM are as follows. The address for each is c/o GIM, One Liberty Place, 1650 Market Street, Suite 4000, Philadelphia, PA 19103.
| Name | Position with GIM |
| Peter J. Zuleba | Managing Director and Chief Executive Officer |
| Raj Tewari | Managing Director and Chief Operating Officer |
| Elizabeth A. Eldridge | Managing Director and President |
| John F. McCabe | Managing Director and General Counsel |
GIM is wholly-owned by Glenmede Trust as both its only limited partner and as the sole owner of GIM’s only general partner, Gatepost Partners, LLC. Glenmede Trust, a nationally-chartered trust company, provides fiduciary and investment services to endowment funds, foundations, employee benefit plans and other institutions and individuals. Glenmede Trust is a wholly-owned subsidiary of The Glenmede Corporation. Glenmede Trust, Gatepost Partners, LLC and The Glenmede Corporation are located at One Liberty Place, 1650 Market Street, Suite 4000, Philadelphia, Pennsylvania 19103.
The Portfolio pays management fees to the Advisor for its investment advisory services, calculated daily and paid monthly, at the following annual percentage rates of the Portfolio’s average daily net assets, as shown in the following table:
| Portfolio | Percentage of Average Dailly Net Assets1 |
| SMID Core Equity Portfolio – Advisor Shares | 0.55% |
| SMID Core Equity Portfolio – Institutional Shares | 0.55% |
| 21 |
| 1 | The Advisor has contractually agreed to waive all or a portion of its investment advisory fees and/or reimburse expenses (excluding Acquired Fund fees and expenses, brokerage commissions, extraordinary items, interest and taxes) to the extent that the total annual operating expenses of the Portfolio’s Advisor Shares, as a percentage of such Advisor Shares’ average daily net assets, exceed 0.85% of such Portfolio’s average daily net assets. The Advisor has also contractually agreed to waive all or a portion of its investment advisory fees and/or reimburse expenses (excluding Acquired Fund fees and expenses, brokerage commissions, extraordinary items, interest and taxes) to the extent that the total annual operating expenses of the Portfolio’s Institutional Shares, as a percentage of such Institutional Shares’ average daily net assets, exceed 0.65% of such Portfolio’s average daily net assets. The Advisor is not entitled to collect or make a claim for waived fees or reimbursed expenses at any time in the future. The Advisor has contractually agreed to these waivers and/or reimbursements until at least [●], 2026. You will be notified if the waivers are discontinued after that date. |
The following table sets forth the total management fees paid by the Portfolio over the past three fiscal years.
| Total Management Fees for Fiscal Year ended October 31, 2024 | Total Waived/ Reimbursed for Fiscal Year ended October 31, 2024 | Total Management Fees for Fiscal Year ended October 31, 2023 | Total Waived/ Reimbursed for Fiscal Year ended October 31, 2023 | Total Management Fees for Fiscal Year ended October 31, 2022 | Total Waived/ Reimbursed for Fiscal Year ended October 31, 2022 | |
| SMID Core Equity Portfolio (formerly, Women in Leadership U.S. Equity Portfolio) | $117,679 | $(66,668) | $119,341 | $(46,554) | $135,183 | $(49,722) |
Additionally, many shareholders in the Portfolio may be clients of Glenmede Trust or an Affiliate and, as clients, pay fees which vary depending on the capacity in which Glenmede Trust or an Affiliate provides fiduciary and investment services to the particular client. Such services may include personal trust, estate settlement, advisory, and custodian services. For example, for advisory services, Glenmede Trust charges its clients up to 1% on the first $3 million of principal, 0.75% on the next $2 million of principal, and 0.50% on the next $15 million of principal. An additional 0.25% administrative service fee is charged on accounts below $3 million. For accounts in excess of $10 million of principal, the fee would be determined by special analysis.
Portfolio Managers
Set forth below is information regarding the individuals identified in the Fund’s Prospectus as primarily responsible for the day- to- day management of the Fund’s Portfolios (“Portfolio Managers”).
As of [●], 2025, the Portfolio Managers were also primarily responsible for the day-to-day management of certain types of other portfolios and/or accounts, as indicated in the table below:
TO BE UPDATED IN A SUBSEQUENT AMENDMENT
| Glenmede Investment Management LP | Type of Accounts |
Number of Accounts Managed |
Total Assets Managed |
Number of Accounts Managed with Performance Based Advisory Fees | Total Assets Managed with Performance Based Advisory Fees | |||||
| Jordan Irving | [ ] | [ ] | [ ] | [ ] | [ ] | |||||
| [ ] | [ ] | [ ] | [ ] | [ ] | ||||||
| [ ] | [ ] | [ ] | [ ] | [ ] |
| 22 |
| Glenmede Investment Management LP | Type of Accounts |
Number of Accounts Managed |
Total Assets Managed |
Number of Accounts Managed with Performance Based Advisory Fees | Total Assets Managed with Performance Based Advisory Fees | |||||
| Matthew Shannon, CFA | [ ] | [ ] | [ ] | [ ] | [ ] | |||||
| [ ] | [ ] | [ ] | [ ] | [ ] | ||||||
| [ ] | [ ] | [ ] | [ ] | [ ] |
The following table sets forth the dollar range of equity securities beneficially owned by each Portfolio Manager in the Portfolio(s) that he or she manages as of [●], 2025:
| Portfolio Manager | Dollar Range of Shares Beneficially Owned |
| Jordan Irving | [ ] |
| Matthew Shannon, CFA | [ ] |
The compensation package for the Portfolio Managers is comprised of a base salary, annual bonus and participation in a long-term equity plan of The Glenmede Corporation. The base salary is based on a combination of factors including the Portfolio Manager’s experience, expertise, and competitive market rates. The annual bonus payment is based on a combination of the annual pre-tax financial performance of The Glenmede Corporation, revenue generated from investment management fees and achievement of non-financial strategic goals. The Glenmede Corporation’s equity plan provides an opportunity for senior management to build equity in the parent company through options and restricted stock. Participation is based on position, experience and expertise.
The Portfolio Managers may manage other accounts with investment strategies similar to those of the Portfolios of the Fund, which may suggest the potential for conflicts of interests relating to cross trading, allocation of investment opportunities, and aggregation and allocation of trades. In addition, GIM may charge varying fees to different accounts managed by their respective Portfolio Managers. Shareholders should be aware that, as with any group of portfolios and accounts managed by an investment advisor pursuant to varying fee arrangements, including performance or other incentive-based fee arrangements, there is the potential for a conflicts of interest that may result in the Portfolio Managers’ favoring those portfolios or accounts with higher or incentive-based fee arrangements. However, the Fund does not anticipate that management by the Portfolio’s Portfolio Manager of other accounts with similar investment strategy or different fee arrangement would conflict with management of any of the Portfolios of the Fund because conflicts of interest of this type are minimized by GIM’s respective investment management decision-making process and trade allocation policy. In addition, the Fund has adopted policies limiting the circumstances under which cross-trades may be effected between the Fund’s Portfolios and another client account.
Transfer Agent, Dividend Paying Agent, Custodian and Administrator
State Street, with its primary place of business located at One Congress Street, Suite 1, Boston, MA 02114, serves as the Fund’s transfer agent, dividend paying agent, custodian and administrator.
For its services, State Street is entitled to receive fees from the Fund based on a percentage of the daily net assets of all Portfolios of the Fund, which is allocated to each Portfolio based on its relative net assets, plus transaction charges for certain transactions and out-of-pocket expenses. Fees paid by the Fund to State Street for the past three fiscal years are shown in the following table.
| Portfolio | October 31, 2024 | October 31, 2023 | October 31, 2022 | ||
| SMID Core Equity Portfolio (formerly, Women in Leadership U.S. Equity Portfolio) | $33,680 | $32,379 | $39,017 |
| 23 |
State Street is also compensated for its services as the Fund’s securities lending agent and short sales lending agent and until December 2010, was also paid an annual fee plus out-of-pocket expenses for the provision of personnel and services related to the Fund’s compliance program.
Shareholder Servicing Plan
The Glenmede Fund has adopted an Amended and Restated Shareholder Servicing Plan effective January 1, 1998, and most recently amended effective May 9, 2022 (collectively, the “Plans”), under which the Fund may pay, directly or indirectly, a fee to broker/dealers, banks and other financial institutions (including Glenmede Trust and its affiliates) that are dealers of record or holders of record or which have a servicing relationship (“Servicing Agents”) with the record or beneficial owners of shares in the Portfolio. Under the Plans, Servicing Agents provide or arrange to provide shareholder support services to shareholders of the Portfolio. The fee, which is at an annual rate of 0.20% for the Portfolio, is computed monthly and is based on the average daily net assets of the shares beneficially owned by such shareholders. As of the date of this SAI, the Institutional Class of the Portfolio is not subject to the Plans and, accordingly, pay no shareholder servicing fees. All expenses incurred by a class of the Portfolio in connection with the Agreements and the implementation of the Plans shall be borne entirely by the holders of the shares of that class of the particular Portfolio involved and will result in an equivalent increase to the Portfolio’s Total Annual Portfolio Operating Expenses. The Advisor and/or Glenmede Trust may pay additional compensation from time to time, out of their assets and not as an additional charge to the Fund, to selected institutions and other persons in connection with selling Portfolio shares and/or servicing of Portfolio shareholders and other accounts managed by the Advisor or Glenmede Trust.
The services provided by or arranged to be provided by the Servicing Agents under the Agreements may include aggregating and processing purchase and redemption requests from shareholders and transmitting purchase and redemption orders to the transfer agent; providing shareholders with a service that invests the assets of their accounts in shares pursuant to specific or pre-authorized instructions; processing dividend and distribution payments from the Fund on behalf of shareholders; providing information periodically to shareholders showing their positions; arranging for bank wires; responding to shareholders’ inquiries concerning their investments; providing sub-accounting with respect to shares beneficially owned by shareholders or the information necessary for sub-accounting; if required by law, forwarding shareholder communications (such as proxies, shareholder reports, annual and semi-annual financial statements and dividend, distribution and tax notices) to shareholders; or providing such other similar services as may be reasonably requested.
Glenmede Trust has entered into Agreements with the Fund and provides or arranges to provide shareholder support services to shareholders of the Portfolio listed below. Glenmede Trust can terminate or modify this arrangement at any time. Shareholder servicing fees paid to Glenmede Trust for the past three fiscal years are shown in the following table.
|
Glenmede Trust |
October 31, 2024 | October 31, 2023 | October 31, 2022 | ||
| SMID Core Equity Portfolio – Advisor Shares | $42,793 | $43,397 | $49,158 |
Securities Lending
State Street serves as securities lending agent for the Fund’s Portfolios, and in that role administers the Portfolios’ securities lending program pursuant to the terms of a Securities Lending Authorization Agreement entered into between Fund, on behalf of its Portfolios, and State Street.
For the fiscal year ended October 31, 2024, State Street, acting as securities lending agent, provided the following services to the Fund’s Portfolios in connection with the Fund’s Portfolios’ securities lending activities: (i) locating borrowers among an approved list of prospective borrowers; (ii) monitoring applicable minimum spread requirements, lending limits and the value of the loaned securities and collateral received; (iii) seeking additional collateral, as necessary, from borrowers; (iv) receiving and holding collateral from borrowers, and facilitating the investment and reinvestment of all or substantially all cash collateral in an investment vehicle designated by the Fund’s Portfolios; (v) returning collateral to borrowers; (vi) facilitating substitute dividend, interest, and other distribution payments to the Fund’s Portfolios from borrowers; (vii) negotiating the terms of each loan of securities, including but not limited to the amount of any loan premium,
| 24 |
and monitoring the terms of securities loan agreements with prospective borrowers for consistency with the requirements of the Glenmede Fund’s Securities Lending Authorization Agreement; (viii) selecting securities, including amounts (percentages), to be loaned; (ix) maintaining such records as are reasonably necessary to account for loans that are made and the income derived therefrom; and (x) arranging for return of loaned securities to the Fund’s Portfolios in accordance with the terms of the Securities Lending Authorization Agreement.
State Street receives as compensation for its services a portion of the amount earned by the Fund’s Portfolios for lending securities.
For the fiscal year ended October 31, 2024, the Portfolio’s gross income received for securities lending activities, the fees and/or compensation paid by the Glenmede Fund Portfolio for securities lending activities, and the net income earned by the Glenmede Fund Portfolio for securities lending activities, were as follows:
| Fees and/or compensation paid for securities lending activities and related services | ||||||||
|
Gross income from securities lending activities1 |
Fees paid to securities lending agent from a revenue split | Fees paid for any cash collateral management service(including fees deducted from a pooled cash collateral reinvestment vehicle) that are not included in the revenue split | Administrative fees not included in revenue split | Indemnification fee not included in revenue split | Rebate (paid to borrower) | Other fees not included in revenue split | Aggregate fees/ compensation for securities lending activities | |
| SMID Core Equity Portfolio (formerly, Women in Leadership U.S. Equity Portfolio) | $2.94 | $0.60 | $0 | $0.00 | $0.00 | $0 | $0.00 | $0.60 |
| 1 | Includes income from cash collateral reinvestment. |
Distributor
Shares of the Fund are distributed continuously and are offered without a sales load by Quasar Distributors, LLC (“Quasar Distributors”), 3 Canal Plaza, Suite 100, Portland, ME 04101, pursuant to Distribution Agreements between the Fund and Quasar Distributors. Quasar Distributors receives no fee from the Fund for its distribution services.
Currently, the Advisor pays Quasar Distributors’ fees and out-of-pocket expenses for the distribution services Quasar Distributors provides to the Fund’s Portfolios.
Independent Registered Public Accounting Firm
[●], serves as the Fund’s independent registered public accounting firm and will audit their financial statements annually.
Counsel
Faegre Drinker Biddle & Reath LLP, One Logan Square, Suite 2000, Philadelphia, Pennsylvania 19103-6996, serves as counsel to the Fund.
Reports
Shareholders will receive tailored shareholder reports that present information for the relevant share class of the Portfolio that they hold. The tailored shareholder reports will be provided to Portfolio shareholders for the annual and semi-annual periods.
| 25 |
The Investment Advisory Agreement authorizes the Advisor to select the brokers or dealers that will execute the purchases and sales of investment securities for the Portfolio and directs the Advisor to use its best efforts to obtain the best available price and most favorable execution with respect to all transactions for the Portfolio. The Advisor may, however, consistent with the interests of the Portfolio, select brokers on the basis of the research, statistical and pricing services they provide to the Portfolio. Information and research received from such brokers will be in addition to, and not in lieu of, the services required to be performed by the Advisor under each Investment Advisory Agreement. A commission paid to such brokers may be higher than that which another qualified broker would have charged for effecting the same transaction, provided that such commissions are paid in compliance with the Securities Exchange Act of 1934, as amended, and that the Advisor determines in good faith that such commission is reasonable in terms either of the transaction or the overall responsibility of the Advisor to the Portfolio and the Advisor’s other clients. The distribution of orders among brokers and the commission rates paid by the Portfolio of the Glenmede Fund are reviewed periodically by the Board.
The Funds are required to identify any securities of their regular brokers or dealers (as defined in Rule 10b-1 under the 1940 Act) or their parents that the Portfolio have acquired during the Funds’ most recent fiscal year. As of the fiscal year ended October 31, 2024, the Portfolio held securities of their regular broker/dealers as follows:
| Portfolio | Broker Security | Market Value | |
| SMID Core Equity Portfolio (formerly, Women in Leadership U.S. Equity Portfolio) | Citigroup Global Markets | $ 275,931 |
During the fiscal years ended October 31, 2024, 2023 and 2022, the Portfolio paid brokerage commissions as follows:
| Portfolio | October 31, 2024 | October 31, 2024 | October 31, 2024 | ||
| SMID Core Equity Portfolio (formerly, Women in Leadership U.S. Equity Portfolio) | $ 18,973 | $22,638 | $28,806 |
Significant changes in brokerage commissions paid by the Portfolio from year to year have been due to changing asset levels and/or portfolio turnover.
To the extent that the Portfolio effects brokerage transactions with a broker/dealer affiliated directly or indirectly with the Fund, the investment advisers or Quasar Distributors, such transactions will be effected in compliance with applicable law.
Some securities considered for investment by the Portfolio may also be appropriate for other clients served by the Advisor. If the purchase or sale of securities is consistent with the investment policies of the Portfolio and one or more of these other clients served by Advisor and is considered at or about the same time, transactions in such securities will be allocated among the Portfolio and clients in a manner deemed fair and reasonable by Advisor. While in some cases this practice could have a detrimental effect on the price, value or quantity of the security as far as the Portfolio is concerned, in other cases it is believed to be beneficial to the Portfolio.
ADDITIONAL INFORMATION CONCERNING TAXES
The following summarizes certain additional tax considerations generally affecting the Portfolio and its shareholders that are not described in the Prospectus. No attempt is made to present a detailed explanation of the tax treatment of the Portfolio or its shareholders, and the discussions here and in the Prospectus are not intended as a substitute for careful tax planning. Potential investors should consult their tax advisers with specific reference to their own tax situations.
The discussions of the Federal tax consequences in the Prospectus and this SAI are based on the Code, and the regulations issued under it, and court decisions and administrative interpretations as in effect on the date of this SAI.
| 26 |
Future legislative or administrative changes or court decisions may significantly alter the statements included herein, and any such changes or decisions may be retroactive.
General
The Portfolio qualified during its last taxable year and intends to continue to qualify as a regulated investment company under Subchapter M of Subtitle A, Chapter 1, of the Code. As a regulated investment company, the Portfolio generally is exempt from Federal income tax on its net investment income and realized capital gains that it distributes to shareholders. To qualify for treatment as a regulated investment company, each of the Fund’s Portfolio must meet three important tests each year.
First, the Portfolio must derive with respect to each taxable year at least 90% of its gross income from dividends, interest, certain payments with respect to securities loans, gains from the sale or other disposition of stock or securities or foreign currencies, other income derived with respect to its business of investing in such stock, securities, or currencies or net income derived from interests in qualified publicly traded partnerships.
Second, generally, at the close of each quarter of its taxable year, at least 50% of the value of the Portfolio’s assets must consist of cash and cash items, U.S. Government securities, securities of other regulated investment companies and securities of other issuers as to which the Portfolio has not invested more than 5% of the value of its total assets in securities of such issuer and as to which the Portfolio does not hold more than 10% of the outstanding voting securities of the issuer, and no more than 25% of the value of the Portfolio’s total assets may be invested in the securities of (1) any one issuer (other than U.S. Government securities and securities of other regulated investment companies), (2) two or more issuers that the Portfolio controls and which are engaged in the same or similar trades or businesses, or (3) one or more qualified publicly traded partnerships.
Third, the Portfolio must distribute an amount equal to at least the sum of 90% of its investment company taxable income (net investment income and the excess of net short-term capital gain over net long-term capital loss) before taking into account any deduction for dividends paid, and 90% of its tax-exempt income, if any, for the year.
The Portfolio intends to comply with these requirements. If the Portfolio were to fail to make sufficient distributions, it could be liable for corporate income tax and for excise tax in respect of the shortfall or, if the shortfall is large enough, the Portfolio could be disqualified as a regulated investment company. If for any taxable year the Portfolio were not to qualify as a regulated investment company, all its taxable income would be subject to tax at regular corporate rates without any deduction for distributions to shareholders. In that event, taxable shareholders would recognize dividend income on distributions to the extent of the Portfolio’s current and accumulated earnings and profits and corporate shareholders could be eligible for the dividends-received deduction.
The Code imposes a nondeductible 4% excise tax on regulated investment companies that fail to distribute each year an amount equal to specified percentages of their ordinary taxable income and capital gain net income (excess of capital gains over capital losses). The Portfolio intends to make sufficient distributions or deemed distributions each year to avoid liability for this excise tax.
Taxation of Certain Investments
The tax principles applicable to transactions in certain financial instruments, such as futures contracts and options, that may be engaged in by the Portfolio, and investments in passive foreign investment companies (“PFICs”), are complex and, in some cases, uncertain. Such transactions and investments may cause the Portfolio to recognize taxable income prior to the receipt of cash, thereby requiring the Portfolio to liquidate other positions, or to borrow money, so as to make sufficient distributions to shareholders to avoid corporate-level tax. Moreover, some or all of the taxable income recognized may be ordinary income or short-term capital gain, so that the distributions may be taxable to shareholders as ordinary income.
In addition, in the case of any shares of a PFIC in which the Portfolio invests, the Portfolio may be liable for corporate-level tax on any ultimate gain or distributions on the shares if the Portfolio fails to make an election to recognize income annually during the period of its ownership of the shares.
| 27 |
State and Local Taxes
Although the Portfolio intends to qualify as a regulated investment company and to be relieved of all or substantially all Federal income taxes, depending upon the extent of its activities in states and localities in which its offices are maintained, in which its agents or independent contractors are located, or in which it is otherwise deemed to be conducting business, the Portfolio may be subject to the tax laws of such states or localities.
SHAREHOLDERS SHOULD CONSULT THEIR TAX ADVISOR REGARDING ANY UNITED STATES FEDERAL TAX CONSEQUENCES OF HOLDING SHARES IN THE FUND’S PORTFOLIOS IN LIGHT OF THEIR INDIVIDUAL CIRCUMSTANCES AS WELL AS ANY FOREIGN, STATE AND LOCAL OR OTHER TAX CONSEQUENCES THAT MAY ARISE AS A RESULT OF HOLDING SHARES IN THE PORTFOLIO.
Description of Shares and Voting Rights
The shares of the Portfolio have no preference as to conversion, exchange, dividends, retirement or other rights, and, when issued and paid for as provided in the Prospectus, will be fully paid and non-assessable. The shares of the Portfolio have no pre-emptive rights and do not have cumulative voting rights, which means that the holders of more than 50% of the shares of the Fund voting for the election of its Board members can elect 100% of the Board of that Fund if they choose to do so. A shareholder is entitled to one vote for each full share held (and a fractional vote for each fractional share held), then standing in his or her name on the books of the particular Portfolio. The Fund will not hold annual meetings of shareholders, except as required by the 1940 Act, the next sentence and other applicable law. The Fund has undertaken that its Board will call a meeting of shareholders for the purpose of voting upon the question of removal of a Board member or members if such a meeting is requested in writing by the holders of not less than 10% of the outstanding shares of the particular Portfolio. To the extent required by the undertaking, the particular Portfolio will assist shareholder communication in such matters.
Rule 18f-2 under the 1940 Act provides that any matter required to be submitted to the holders of the outstanding voting securities of an investment company shall not be deemed to have been effectively acted upon unless approved by a majority of the outstanding shares of the Portfolio or class affected by the matter. The Portfolio or class is affected by a matter unless it is clear that the interests of the Portfolio or class in the matter are substantially identical or that the matter does not affect any interest of the Portfolio or class. Under Rule 18f-2, the approval of an investment advisory agreement or any change in a fundamental investment policy would be effectively acted upon with respect to the Portfolio only if approved by a majority of the outstanding shares of the Portfolio. However, Rule 18f-2 also provides that the ratification of independent public accountants and the election of directors or trustees may be effectively acted upon by shareholders of the Fund voting without regard to the Portfolio.
Not with standing any provision of Maryland law requiring a greater vote of the Fund’s common stock (or of the shares of the Portfolio or class voting separately as a class) in connection with any corporate action, unless otherwise provided by law (for example by Rule 18f-2 discussed above) or by the Fund’s Articles of Amendment and Restatement, the Fund may take or authorize such action upon the favorable vote of the holders of more than 50% of the outstanding common stock of the Fund entitled to vote thereon. Under Maryland law, the Board may liquidate the Portfolio or class without shareholder approval.
Certain Record Holders
To the Fund’s knowledge, the following shareholders held of record or beneficially owned 5% or more of the outstanding shares of the indicated Portfolio as of [●], 2025. Any shareholder that owns more than 25% of the outstanding shares of the Portfolio or class may be presumed to “control” (as that term is defined in the 1940 Act) the Portfolio or class. Shareholders controlling the Portfolio or class could have the ability to vote a majority of the shares of the Portfolio or class on any matter requiring approval of shareholders of the Portfolio or class. [Table to be updated in subsequent amendment]
| 28 |
| Portfolio | Name and Address of Owner | Ownership Type |
Percentage of Outstanding Shares | |||
| SMID Core Equity Portfolio |
Lauer & Co. c/o Glenmede Trust Co One Liberty Place 1650 Market ST STE 4000 Philadelphia, PA 19103 |
Record | [●]% | |||
| SMID Core Equity Portfolio |
Lauer & Co. c/o Glenmede Trust Co One Liberty Place 1650 Market ST STE 4000 Philadelphia, PA 19103 |
Record | [●]% | |||
| SMID Core Equity Portfolio |
Charles Schwab & Co., Inc. Special Custody Account For The Exclusive Benefit Of Customers Attn: Mutual Funds Operations 211 Main Street San Francisco CA 94105-1905 |
Record | [●]% | |||
| SMID Core Equity Portfolio |
Omnibus Processing Omnibus Attn Mutual Fund Ops Manager 250 Nicollet Mall, Suite 1400 Minneapolis, MN 55401 |
Record | [●]% |
As of [●], 2025, the Directors and officers of the Fund collectively owned less than 1% of the outstanding shares of each of the Fund’s Portfolios.
Dividends and Distributions
The Portfolio’s policy is to distribute substantially all of its net investment income, if any, together with any net realized capital gains in the amount and at the times that will avoid both income (including capital gains) taxes on it and the imposition of the Federal excise tax on undistributed income and gains. The amounts of any income dividends or capital gains distributions for the Portfolio cannot be predicted.
The Fund’s Financial Statements for the SMID Core Equity Portfolio, for the year ended October 31, 2024, and the financial highlights for each of the respective periods presented, appearing in the 2024 Annual Financial Statements, and the reports thereon of [●], the Fund’s independent registered public accounting firm, also appearing therein, are incorporated by reference in this SAI. No other parts of the 2024 Annual Financial Statements are incorporated herein.
The Fund’s Financial Statements for the period ended April 30, 2025, and the financial highlights for each of the respective periods presented, appearing in the [2025 Semi-Annual Financial Statements], are incorporated by reference in this SAI. No other parts of the 2025 Semi-Annual Financial Statements are incorporated herein.
The Fund’s Prospectuses and this SAI do not contain all the information included in the Registration Statement filed with the SEC under the Securities Act of 1933, as amended, with respect to the securities offered by the Prospectuses. Certain portions of the Registration Statement have been omitted from the Prospectuses and this SAI
| 29 |
pursuant to the rules and regulations of the SEC. The Registration Statement, including the exhibits filed therewith, may be examined at the office of the SEC in Washington, D.C.
Statements contained in the Prospectuses or in this SAI as to the contents of any contract or other documents referred to are not necessarily complete, and in each instance reference is made to the copy of such contract or other document filed as an exhibit to the Registration Statement of which the Prospectuses and this SAI form a part, each such statement being qualified in all respects by such reference.
The third party marks appearing above are the marks of their respective owners.
| 30 |
APPENDIX A — PROXY VOTING PROCEDURES
|
|
|
A-1 |
|
|
|
|
|
|
|
|
2025
GLENMEDE – SUSTAINABILITY PROXY VOTING GUIDELINES |
|
|
![]() |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
|
|
|
|
|
|
A-2 |
|
|
|
|
|
|
|
|
2025
GLENMEDE – SUSTAINABILITY PROXY VOTING GUIDELINES |
|
|
![]() |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
|
|
|
|
|
|
A-3 |
|
|
|
|
|
|
|
|
2025
GLENMEDE – SUSTAINABILITY PROXY VOTING GUIDELINES |
|
|
![]() |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
|
|
|
|
|
|
A-4 |
|
|
|
|
|
|
|
|
2025
GLENMEDE – SUSTAINABILITY PROXY VOTING GUIDELINES |
|
|
![]() |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
|
|
|
|
|
|
A-5 |
|
|
|
|
|
|
|
|
2025
GLENMEDE – SUSTAINABILITY PROXY VOTING GUIDELINES |
|
|
![]() |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
|
|
|
|
|
|
A-6 |
|
|
|
|
|
|
|
|
2025
GLENMEDE – SUSTAINABILITY PROXY VOTING GUIDELINES |
|
|
![]() |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
|
|
|
|
|
|
A-7 |
|
|
|
|
|
|
|
|
2025
GLENMEDE – SUSTAINABILITY PROXY VOTING GUIDELINES |
|
|
![]() |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
| ||
|
|
|
|
|
|
|
|
|
|
A-8 |
|
|
|
|
|
|
|
|
2025
GLENMEDE – SUSTAINABILITY PROXY VOTING GUIDELINES |
|
|
![]() |
|
|
|
|
|
|
1. |
Routine/Miscellaneous |
|
• |
Vote for proposals that relate specifically
to soliciting votes for a merger or transaction if supporting that merger or transaction. |
|
• |
Vote against proposals if the wording is too
vague or if the proposal includes “other business.” |
|
• |
The new quorum threshold requested; |
|
• |
The rationale presented for the reduction;
|
|
• |
The market capitalization of the company (size,
inclusion in indices); |
|
• |
The company’s ownership structure; |
|
• |
Previous voter turnout or attempts to achieve
quorum; |
|
• |
Any provisions or commitments to restore quorum
to a majority of shares outstanding, should voter turnout improve sufficiently; and |
|
• |
Other factors as appropriate. |
|
|
|
A-9 |
|
|
|
|
|
|
|
|
2025
GLENMEDE – SUSTAINABILITY PROXY VOTING GUIDELINES |
|
|
![]() |
|
|
|
|
|
|
• |
The terms of the auditor agreement--the degree
to which these agreements impact shareholders’ rights; |
|
• |
The motivation and rationale for establishing
the agreements; |
|
• |
The quality of the company’s disclosure;
and |
|
• |
The company’s historical practices in
the audit area. |
|
• |
An auditor has a financial interest in or association
with the company, and is therefore not independent; |
|
• |
There is reason to believe that the independent
auditor has rendered an opinion that is neither accurate nor indicative of the company’s financial position; |
|
• |
Poor accounting practices are identified that
rise to a serious level of concern, such as: fraud; misapplication of GAAP; and material weaknesses identified in Section 404 disclosures;
or |
|
• |
Fees for non-audit services (“Other”
fees) are excessive. |
|
• |
Non-audit (“other”) fees >
audit fees + audit-related fees + tax compliance/preparation fees |
|
|
|
A-10 |
|
|
|
|
|
|
|
|
2025
GLENMEDE – SUSTAINABILITY PROXY VOTING GUIDELINES |
|
|
![]() |
|
|
|
|
|
|
• |
The tenure of the audit firm; |
|
• |
The length of rotation specified in the proposal;
|
|
• |
Any significant audit-related issues at the
company; |
|
• |
The number of audit committee meetings held
each year; |
|
• |
The number of financial experts serving on
the committee; and |
|
• |
Whether the company has a periodic renewal
process where the auditor is evaluated for both audit quality and competitive price. |
|
2. |
Board of Directors |
|
• |
Accountability:
Boards should be sufficiently accountable to shareholders, including through transparency of the company’s governance practices
and regular board elections, by the provision of sufficient information for shareholders to be able to assess directors and board composition,
and through the ability of shareholders to remove directors. |
|
• |
Responsiveness:
Directors should respond to investor input, such as that expressed through significant opposition to management proposals, significant
support for shareholder proposals (whether binding or non- binding), and tender offers where a majority of shares are tendered. |
|
• |
Composition:
Companies should seek directors who can add value to the board through specific skills or expertise and who can devote sufficient time
and commitment to serve effectively. Boards should be of a size appropriate to accommodate diversity, expertise, and independence, while
ensuring active and collaborative participation by all members. Boards should be sufficiently diverse to ensure consideration of a wide
range of perspectives. |
|
• |
Independence:
Boards should be sufficiently independent from management (and significant shareholders) so as to ensure that they are able and motivated
to effectively supervise management’s performance for the benefit of all shareholders, including in setting and monitoring the
execution of corporate strategy, with appropriate use of shareholder capital, and in setting and monitoring executive compensation programs
that support that strategy. The chair of the board should ideally be an independent director, and all boards should have an independent
leadership position or a similar role in order to help provide appropriate counterbalance to executive management, as well as having sufficiently
independent committees that focus on key governance concerns such as audit, compensation, and nomination of directors. |
|
|
|
A-11 |
|
|
|
|
|
|
|
|
2025
GLENMEDE – SUSTAINABILITY PROXY VOTING GUIDELINES |
|
|
![]() |
|
|
|
|
|
|
• |
A classified board structure; |
|
• |
A supermajority vote requirement; |
|
• |
Either a plurality vote standard in uncontested
director elections or a majority vote standard with no plurality carve-out for contested elections; |
|
• |
The inability of shareholders to call special
meetings; |
|
• |
The inability of shareholders to act by written
consent; |
|
• |
A multi-class capital structure; and/or |
|
• |
A non–shareholder-approved poison pill.
|
|
• |
The company has a poison pill with a deadhand
or slowhand feature2; |
|
• |
The board makes a material adverse modification
to an existing pill3, including, but not limited to, extension, renewal, or lowering the trigger, without shareholder approval;
or |
|
• |
The company has a long-term poison pill (with
a term of over one year) that was not approved by the public shareholders3. |
|
• |
The trigger threshold and other terms of the
pill; |
|
• |
The disclosed rationale for the adoption; |
|
1 |
A
“new nominee” is a director who is being presented for election by shareholders for the first time. Recommendations on new
nominees who have served for less than one year are made on a case-by-case basis depending on the timing of their appointment and the
problematic governance issue in question. |
|
2 |
If
the short-term pill with a deadhand or slowhand feature is enacted but expires before the next shareholder vote, Glenmede Policy will
generally still recommend withhold/against nominees at the next shareholder meeting following its adoption. |
|
3 |
Approval
prior to, or in connection, with a company’s becoming publicly-traded, or in connection with a de-SPAC transaction, is insufficient. |
|
|
|
A-12 |
|
|
|
|
|
|
|
|
2025
GLENMEDE – SUSTAINABILITY PROXY VOTING GUIDELINES |
|
|
![]() |
|
|
|
|
|
|
• |
The context
in which the pill was adopted, (e.g.) industry factors such as the company’s size and stage of development, sudden changes in its
market capitalization, and extraordinary industry-wide or macroeconomic events); |
|
• |
A commitment to put any renewal to a shareholder
vote; and |
|
• |
The company’s
overall track record on corporate governance and responsiveness to shareholders; and |
|
• |
Other factors as relevant. |
|
• |
The board’s rationale for adopting the
bylaw/charter amendment without shareholder ratification; |
|
• |
Disclosure by the company of any significant
engagement with shareholders regarding the amendment; |
|
• |
The level of impairment of shareholders’
rights caused by the board’s unilateral amendment to the bylaws/charter; |
|
• |
The board’s track record with regard
to unilateral board action on bylaw/charter amendments or other entrenchment provisions; |
|
• |
The company’s ownership structure; |
|
• |
The company’s existing governance provisions;
|
|
• |
The timing of the board’s amendment
to the bylaws/charter in connection with a significant business development; and, |
|
• |
Other factors, as deemed appropriate, that
may be relevant to determine the impact of the amendment on shareholders. |
|
• |
Classified the board; |
|
• |
Adopted supermajority vote requirements to
amend the bylaws or charter; |
|
• |
Eliminated shareholders’ ability to
amend bylaws; |
|
• |
Adopted a fee-shifting provision; or |
|
• |
Adopted another provision deemed egregious.
|
|
• |
Supermajority vote requirements to amend the
bylaws or charter; |
|
• |
A classified board structure; or |
|
4 |
Includes
companies that emerge from bankruptcy, SPAC transactions, spin-offs, direct listings, and those who complete a traditional initial public
offering. |
|
|
|
A-13 |
|
|
|
|
|
|
|
|
2025
GLENMEDE – SUSTAINABILITY PROXY VOTING GUIDELINES |
|
|
![]() |
|
|
|
|
|
|
• |
Other egregious provisions. |
|
• |
Newly-public companies6
with a sunset provision of no more than seven years from the date of going public; |
|
• |
Limited Partnerships and the Operating Partnership
(OP) unit structure of REITs; |
|
• |
Situations where the unequal voting rights
are considered de minimis; or |
|
• |
The company provides sufficient protections
for minority shareholders, such as allowing minority shareholders a regular binding vote on whether the capital structure should be maintained.
|
|
• |
The presence of a shareholder proposal addressing
the same issue on the same ballot; |
|
• |
The board’s rationale for seeking ratification;
|
|
• |
Disclosure of actions to be taken by the board
should the ratification proposal fail; |
|
• |
Disclosure of shareholder engagement regarding
the board’s ratification request; |
|
• |
The level of impairment to shareholders’
rights caused by the existing provision; |
|
• |
The history of management and shareholder proposals
on the provision at the company’s past meetings; |
|
• |
Whether the current provision was adopted in
response to the shareholder proposal; |
|
• |
The company’s ownership structure; and
|
|
• |
Previous use of ratification proposals to exclude
shareholder proposals. |
|
• |
The company’s governing documents impose
undue restrictions on shareholders’ ability to amend the bylaws. Such restrictions include but are not limited to: outright prohibition
on the submission of binding shareholder proposals, or share ownership requirements, subject matter restrictions, or time holding requirement
in excess of SEC Rule 14a-8. Vote against or withhold on an ongoing basis. |
|
5 |
This
generally includes classes of common stock that have additional votes per share than other shares; classes of shares that are not entitled
to vote on all the same ballot items or nominees; or stock with time-phased voting rights (“loyalty shares”). |
|
6 |
Newly-public
companies generally include companies that emerge from bankruptcy, SPAC transactions, spin-offs, direct listings, and those who complete
a traditional initial public offering. |
|
|
|
A-14 |
|
|
|
|
|
|
|
|
2025
GLENMEDE – SUSTAINABILITY PROXY VOTING GUIDELINES |
|
|
![]() |
|
|
|
|
|
|
• |
The non-audit fees paid to the auditor are
excessive (see discussion under “Auditor Ratification”); |
|
• |
The company receives an adverse opinion on
the company’s financial statements from its auditor; or |
|
• |
There is persuasive evidence that the audit
committee entered into an inappropriate indemnification agreement with its auditor that limits the ability of the company, or its shareholders,
to pursue legitimate legal recourse against the audit firm. |
|
• |
Poor accounting practices are identified that
rise to a level of serious concern, such as: fraud; misapplication of GAAP; and material weaknesses identified in Section 404 disclosures.
Examine the severity, breadth, chronological sequence, and duration, as well as the company’s efforts at remediation or corrective
actions, in determining whether withhold/against votes are warranted. |
|
• |
There is a significant misalignment between
CEO pay and company performance (pay for performance); |
|
• |
The company maintains significant problematic
pay practices; |
|
• |
The board exhibits a significant level of poor
communication and responsiveness to shareholders; |
|
• |
The company fails to include a Say on Pay ballot
item when required under SEC provisions, or under the company’s declared frequency of say on pay; or |
|
• |
The company fails to include a Frequency of
Say on Pay ballot item when required under SEC provisions. |
|
• |
The presence of an anti-pledging policy, disclosed
in the proxy statement, that prohibits future pledging activity; |
|
• |
The magnitude of aggregate pledged shares in
terms of total common shares outstanding, market value, and trading volume; |
|
• |
Disclosure of progress or lack thereof in reducing
the magnitude of aggregate pledged shares over time; |
|
• |
Disclosure in the proxy statement that shares
subject to stock ownership and holding requirements do not include pledged company stock; and |
|
• |
Any other relevant factors. |
|
|
|
A-15 |
|
|
|
|
|
|
|
|
2025
GLENMEDE – SUSTAINABILITY PROXY VOTING GUIDELINES |
|
|
![]() |
|
|
|
|
|
|
• |
Material failures of governance, stewardship,
risk oversight7, or fiduciary responsibilities at the company, including failure to
adequately guard against or manage ESG risks; |
|
• |
A lack of sustainability reporting in the company’s
public documents and/or website in conjunction with a failure to adequately manage or mitigate ESG risks; |
|
• |
Failure to replace management as appropriate;
or |
|
• |
Egregious actions related to a director’s
service on other boards that raise substantial doubt about his or her ability to effectively oversee management and serve the best interests
of shareholders at any company. |
|
• |
The company has detailed disclosure of climate-related
risks, such as according to the framework established by the Task Force on Climate-related Financial Disclosures (TCFD), including: |
|
• |
Board governance measures; |
|
• |
Corporate strategy; |
|
• |
Risk management analyses; and |
|
• |
Metrics and targets |
|
• |
The company has declared a Net Zero target
by 2050 or sooner and the target includes scope 1, 2, and relevant scope 3 emissions. |
|
• |
The company has set a medium-term target for
reducing its GHG emissions and the targets include scope 1, 2, and relevant scope 3 emissions. |
|
• |
The company
has a decarbonization strategy in place, with a defined set of quantitative and qualitative actions to reach Net Zero targets. |
|
7 |
Examples
of failure of risk oversight include, but are not limited to: bribery; large or serial fines or sanctions from regulatory bodies; demonstrably
poor risk oversight of environmental and social issues, including climate change; significant environmental incidents including spills
and pollution; large scale or repeat workplace fatalities or injuries; significant adverse legal judgments or settlements; or hedging
of company stock. |
|
8 |
For
2025, companies defined as “significant GHG emitters” will be those on the current Climate Action 100+ Focus Group list. |
|
|
|
A-16 |
|
|
|
|
|
|
|
|
2025
GLENMEDE – SUSTAINABILITY PROXY VOTING GUIDELINES |
|
|
![]() |
|
|
|
|
|
|
• |
The board failed to act on a shareholder proposal
that received the support of a majority of the shares cast in the previous year or failed to act on a management proposal seeking to ratify
an existing charter/bylaw provision that received opposition of a majority of the shares cast in the previous year. Factors that will
be considered are: |
|
• |
Disclosed outreach efforts by the board to
shareholders in the wake of the vote; |
|
• |
Rationale provided in the proxy statement for
the level of implementation; |
|
• |
The subject matter of the proposal; |
|
• |
The level of support for and opposition to
the resolution in past meetings; |
|
• |
Actions taken by the board in response to the
majority vote and its engagement with shareholders; |
|
• |
The continuation of the underlying issue as
a voting item on the ballot (as either shareholder or management proposals); and |
|
• |
Other factors as appropriate. |
|
• |
The board failed to act on takeover offers
where the majority of shares are tendered; |
|
• |
At the previous board election, any director
received more than 50 percent withhold/against votes of the shares cast and the company has failed to address the issue(s) that caused
the high withhold/against vote. |
|
• |
The company’s previous say-on-pay received
the support of less than 70 percent of votes cast. Factors that will be considered are: |
|
• |
The company’s response, including: |
|
• |
Disclosure of engagement efforts with major
institutional investors regarding the issues that contributed to the low level of support (including the timing and frequency of engagements
and whether independent directors participated); |
|
• |
Disclosure of the specific concerns voiced
by dissenting shareholders that led to the say-on-pay opposition; |
|
• |
Disclosure of specific and meaningful actions
taken to address shareholders’ concerns; |
|
• |
Other recent compensation actions taken by
the company; |
|
• |
Whether the issues raised are recurring or
isolated; |
|
• |
The company’s ownership structure; and
|
|
• |
Whether the support level was less than 50
percent, which would warrant the highest degree of responsiveness. |
|
• |
The board implements an advisory vote on executive
compensation on a less frequent basis than the frequency that received the plurality of votes cast. |
|
|
|
A-17 |
|
|
|
|
|
|
|
|
2025
GLENMEDE – SUSTAINABILITY PROXY VOTING GUIDELINES |
|
|
![]() |
|
|
|
|
|
|
• |
Medical issues/illness; |
|
• |
Family emergencies; and |
|
• |
Missing only one meeting (when the total of
all meetings is three or fewer). |
|
• |
In cases of chronic poor attendance without
reasonable justification, in addition to voting against the director(s) with poor attendance, generally vote against or withhold from
appropriate members of the nominating/governance committees or the full board. |
|
• |
Sit on more than five public company boards;
or |
|
• |
Are CEOs of public companies who sit on the
boards of more than two public companies besides their own—withhold only at their outside boards10.
|
|
• |
Independent directors comprise 50 percent or
less of the board; |
|
• |
The non-independent director serves on the
audit, compensation, or nominating committee; |
|
• |
The company lacks an audit, compensation, or
nominating committee so that the full board functions as that committee; or |
|
• |
The company lacks a formal nominating committee,
even if the board attests that the independent directors fulfill the functions of such a committee. |
|
9 |
Nominees
who served for only part of the fiscal year are generally exempted from the attendance policy. |
|
10 |
Although
all of a CEO’s subsidiary boards will be counted as separate boards, Glenmede Policy will not recommend a withhold vote for the
CEO of a parent company board or any of the controlled (>50 percent ownership) subsidiaries of that parent, but may do so at subsidiaries
that are less than 50 percent controlled and boards outside the parent/subsidiary relationships. |
|
11 |
Underrepresented
gender identity includes directors who identify as women or as non-binary. |
|
12 |
Aggregate
diversity statistics provided by the board will only be considered if specific to racial and/or ethnic diversity. |
|
|
|
A-18 |
|
|
|
|
|
|
|
|
2025
GLENMEDE – SUSTAINABILITY PROXY VOTING GUIDELINES |
|
|
![]() |
|
|
|
|
|
|
1. |
Executive Director
|
|
1.1. |
Current officer[1]
of the company or one of its affiliates[2]. |
|
2. |
Non-Independent Non-Executive Director |
|
2.1. |
Director identified as not independent by the
board. |
|
2.2. |
Beneficial owner of more than 50 percent of
the company’s voting power (this may be aggregated if voting power is distributed among more than one member of a group). |
|
2.3. |
Non-officer employee of the firm (including
employee representatives). |
|
2.4. |
Officer[1],
former officer, or general or limited partner of a joint venture or partnership with the company. |
|
2.5. |
Former CEO of the company.[3],[4] |
|
2.6. |
Former non-CEO officer[1]
of the company or an affiliate[2] within the past five years. |
|
2.7. |
Former officer[1]
of an acquired company within the past five years[4]. |
|
2.8. |
Officer[1]of
a former parent or predecessor firm at the time the company was sold or split off within the past five years. |
|
2.9. |
Former interim officer if the service was longer
than 18 months. If the service was between 12 and 18 months an assessment of the interim officer’s employment agreement will be
made.[5] |
|
2.10. |
Immediate family member[6]
of a current or former officer[1] of the company or its affiliates[2]
within the last five years. |
|
2.11. |
Immediate family member[6]
of a current employee of company or its affiliates[2] where additional factors
raise concern (which may include, but are not limited to, the following: a director related to numerous employees; the company or its
affiliates employ relatives of numerous board members; or a non-Section 16 officer in a key strategic role). |
|
2.12. |
Director who (or whose immediate family member[6])
currently provides professional services[7] in excess
of $10,000 per year to: the company, an affiliate[2],
or an individual officer of the company or an affiliate; either directly or is (or whose family member is) a partner, employee, or controlling
shareholder of an organization which provides the services. |
|
2.13. |
Director who (or whose immediate family member[6])
currently has any material transactional relationship[8]with the company or its affiliates[2];
or who is (or whose immediately family member[6] is) a partner in, or a controlling
shareholder or an executive officer of, an organization which has the material transactional relationship[8]
(excluding investments in the company through a private placement). |
|
2.14. |
Director who (or whose immediate family member[6])
is a trustee, director, or employee of a charitable or non-profit organization that receives material grants or endowments[8]
from the company or its affiliates[2]. |
|
|
|
A-19 |
|
|
|
|
|
|
|
|
2025
GLENMEDE – SUSTAINABILITY PROXY VOTING GUIDELINES |
|
|
![]() |
|
|
|
|
|
|
2.15. |
Party to a voting agreement[9]
to vote in line with management on proposals being brought to shareholder vote. |
|
2.16. |
Has (or an immediate family member[6]
has) an interlocking relationship as defined by the SEC involving members of the board of directors or its Compensation Committee[10]. |
|
2.17. |
Founder[11]
of the company but not currently an employee. |
|
2.18. |
Director with pay comparable to Named Executive
Officers. |
|
2.19. |
Any material[12]
relationship with the company. |
|
3. |
Independent Director |
|
3.1. |
No material[12]
connection to the company other than a board seat. |
|
[1] |
The
definition of officer will generally follow that of a “Section 16 officer” (officers subject to Section 16 of
the Securities and Exchange Act of 1934) and includes the chief executive, operating, financial, legal, technology, and accounting officers
of a company (including the president, treasurer, secretary, controller, or any vice president in charge of a principal business unit,
division, or policy function). Current interim officers are included in this category. For private companies, the equivalent positions
are applicable. A non-employee director serving as an officer due to statutory requirements (e.g. corporate secretary) will be classified
as an Affiliated Outsider under “Any material relationship with the company.” However, if the company provides explicit
disclosure that the director is not receiving additional compensation in excess of $10,000 per year for serving in that capacity, then
the director will be classified as an Independent Outsider. |
|
[2] |
“Affiliate”
includes a subsidiary, sibling company, or parent company. Glenmede Policy uses 50 percent control ownership by the parent company as
the standard for applying its affiliate designation. The manager/advisor of an externally managed issuer (EMI) is considered an affiliate.
|
|
[3] |
Includes
any former CEO of the company prior to the company’s initial public offering (IPO). |
|
[4] |
When
there is a former CEO of a special purpose acquisition company (SPAC) serving on the board of an acquired company, Glenmede Policy will
generally classify such directors as independent unless determined otherwise taking into account the following factors: the applicable
listing standards determination of such director’s independence; any operating ties to the firm; and the existence of any other
conflicting relationships or related party transactions. |
|
[5] |
Glenmede
Policy will look at the terms of the interim officer’s employment contract to determine if it contains severance pay, long-term
health and pension benefits, or other such standard provisions typically contained in contracts of permanent, non-temporary CEOs. Glenmede
Policy will also consider if a formal search process was under way for a full-time officer at the time. |
|
[6] |
“Immediate
family member” follows the SEC’s definition of such and covers spouses, parents, children, step-parents, step-children,
siblings, in-laws, and any person (other than a tenant or employee) sharing the household of any director, nominee for director, executive
officer, or significant shareholder of the company. |
|
[7] |
Professional
services can be characterized as advisory in nature, generally involve access to sensitive company information or to strategic decision-making,
and typically have a commission- or fee-based payment structure. Professional services generally include, but are not limited to the following:
investment banking/financial advisory services; commercial banking (beyond deposit services); investment services; insurance services;
accounting/audit services; consulting services; marketing services; legal services; property management services; realtor services; lobbying
services; executive search services; and IT consulting services. The following would generally be considered transactional relationships
and not professional services: deposit services; IT tech support services; educational services; and construction services. The case of
participation in a banking syndicate by a non-lead bank should be considered a transactional (and hence subject to the associated materiality
test) rather than a professional relationship. “Of Counsel” relationships are only considered immaterial if the individual
does not receive any form of compensation (in excess of $10,000 per year) from, or is a retired partner of, the firm providing the professional
service. The case of a company providing a professional service to one of its directors or to an entity with which one of its directors
is affiliated, will be considered a transactional rather than a professional relationship. Insurance services and marketing services are
assumed to be professional services unless the company explains why such services are not advisory. |
|
[8] |
A
material transactional relationship, including grants to non-profit organizations, exists if the company makes annual payments to, or
receives annual payments from, another entity exceeding the greater of $200,000 or 5 percent of the recipient’s gross |
|
|
|
A-20 |
|
|
|
|
|
|
|
|
2025
GLENMEDE – SUSTAINABILITY PROXY VOTING GUIDELINES |
|
|
![]() |
|
|
|
|
|
|
[9] |
Dissident
directors who are parties to a voting agreement pursuant to a settlement or similar arrangement may be classified as independent outsiders
if an analysis of the following factors indicates that the voting agreement does not compromise their alignment with all shareholders’
interests: the terms of the agreement; the duration of the standstill provision in the agreement; the limitations and requirements of
actions that are agreed upon; if the dissident director nominee(s) is subject to the standstill; and if there any conflicting relationships
or related party transactions. |
|
[10] |
Interlocks
include: executive officers serving as directors on each other’s compensation or similar committees (or, in the absence of such
a committee, on the board); or executive officers sitting on each other’s boards and at least one serves on the other’s
compensation or similar committees (or, in the absence of such a committee, on the board). |
|
[11] |
The
operating involvement of the founder with the company will be considered; if the founder was never employed by the company, Glenmede Policy
may deem him or her an independent outsider. |
|
[12] |
For
purposes of Glenmede Policy’s director independence classification, “material” will be defined as a standard of relationship
(financial, personal or otherwise) that a reasonable person might conclude could potentially influence one’s objectivity in the
boardroom in a manner that would have a meaningful impact on an individual’s ability to satisfy requisite fiduciary standards on
behalf of shareholders. |
|
|
|
A-21 |
|
|
|
|
|
|
|
|
2025
GLENMEDE – SUSTAINABILITY PROXY VOTING GUIDELINES |
|
|
![]() |
|
|
|
|
|
|
• |
The rationale provided for adoption of the
term/tenure limit; |
|
• |
The robustness of the company’s board
evaluation process; |
|
• |
Whether the limit is of sufficient length to
allow for a broad range of director tenures; |
|
• |
Whether the limit would disadvantage independent
directors compared to non-independent directors; and |
|
• |
Whether the board will impose the limit evenly,
and not have the ability to waive it in a discriminatory manner. |
|
• |
The scope of the shareholder proposal; and
|
|
• |
Evidence of problematic issues at the company
combined with, or exacerbated by, a lack of board refreshment. |
|
• |
The reasonableness/scope of the request; and
|
|
• |
The company’s existing disclosure on
its current CEO succession planning process. |
|
|
|
A-22 |
|
|
|
|
|
|
|
|
2025
GLENMEDE – SUSTAINABILITY PROXY VOTING GUIDELINES |
|
|
![]() |
|
|
|
|
|
|
• |
The company has proxy access, thereby allowing
shareholders to nominate directors to the company’s ballot; and |
|
• |
The company has adopted a majority vote standard,
with a carve-out for plurality voting in situations where there are more nominees than seats, and a director resignation policy to address
failed elections. |
|
• |
Eliminate entirely directors’ and officers’
liability for monetary damages for violating the duty of care. |
|
• |
Eliminate directors’ and officers’
liability for monetary damages for violating the duty of loyalty. |
|
• |
Expand coverage beyond just legal expenses
to liability for acts that are more serious violations of fiduciary obligation than mere carelessness. |
|
• |
Expand the scope of indemnification to provide
for mandatory indemnification of company officials in connection with acts that previously the company was permitted to provide indemnification
for, at the discretion of the company’s board (i.e., “permissive indemnification”), but that previously the company
was not required to indemnify. |
|
• |
If the individual was found to have acted in
good faith and in a manner that the individual reasonably believed was in the best interests of the company; and |
|
• |
If only the director’s legal expenses
would be covered. |
|
• |
The company’s board committee structure,
existing subject matter expertise, and board nomination provisions relative to that of its peers; |
|
• |
The company’s existing board and management
oversight mechanisms regarding the issue for which board oversight is sought; |
|
13 |
Indemnification:
the condition of being secured against loss or damage. |
|
|
|
A-23 |
|
|
|
|
|
|
|
|
2025
GLENMEDE – SUSTAINABILITY PROXY VOTING GUIDELINES |
|
|
![]() |
|
|
|
|
|
|
• |
The company’s disclosure and performance
relating to the issue for which board oversight is sought and any significant related controversies; and |
|
• |
The scope and structure of the proposal. |
|
• |
Existing oversight mechanisms (including current
committee structure) regarding the issue for which board oversight is sought; |
|
• |
Level of disclosure regarding the issue
for which board oversight is sought; |
|
• |
Company performance related to the issue
for which board oversight is sought; |
|
• |
Board committee structure compared to that
of other companies in its industry sector; and |
|
• |
The scope and structure of the proposal. |
|
• |
Vote for proposals to restore shareholders’
ability to remove directors with or without cause. |
|
• |
Vote against proposals that provide that only
continuing directors may elect replacements to fill board vacancies. |
|
• |
Vote for proposals that permit shareholders
to elect directors to fill board vacancies. |
|
|
|
A-24 |
|
|
|
|
|
|
|
|
2025
GLENMEDE – SUSTAINABILITY PROXY VOTING GUIDELINES |
|
|
![]() |
|
|
|
|
|
|
• |
Ownership threshold:
maximum requirement not more than three percent (3%) of the voting power; |
|
• |
Ownership duration:
maximum requirement not longer than three (3) years of continuous ownership for each member of the nominating group; |
|
• |
Aggregation:
minimal or no limits on the number of shareholders permitted to form a nominating group; |
|
• |
Cap:
cap on nominees of generally twenty-five percent (25%) of the board. |
|
• |
Established a communication structure that
goes beyond the exchange requirements to facilitate the exchange of information between shareholders and members of the board; |
|
• |
Effectively disclosed information with respect
to this structure to its shareholders; |
|
• |
Company has not ignored majority-supported
shareholder proposals or a majority withhold vote on a director nominee; and |
|
• |
The company has an independent chair or a lead
director, according to Glenmede Policy’s definition. This individual must be made available for periodic consultation and direct
communication with major shareholders. |
|
|
|
A-25 |
|
|
|
|
|
|
|
|
2025
GLENMEDE – SUSTAINABILITY PROXY VOTING GUIDELINES |
|
|
![]() |
|
|
|
|
|
|
• |
Long-term financial performance of the company
relative to its industry; |
|
• |
Management’s track record; |
|
• |
Background to the contested election; |
|
• |
Nominee qualifications and any compensatory
arrangements; |
|
• |
Strategic plan of dissident slate and quality
of the critique against management; |
|
• |
Likelihood that the proposed goals and objectives
can be achieved (both slates); and |
|
• |
Stock ownership positions. |
|
3. |
Shareholder Rights & Defenses |
|
|
|
A-26 |
|
|
|
|
|
|
|
|
2025
GLENMEDE – SUSTAINABILITY PROXY VOTING GUIDELINES |
|
|
![]() |
|
|
|
|
|
|
|
|
A-27 |
|
|
|
|
|
|
|
|
2025
GLENMEDE – SUSTAINABILITY PROXY VOTING GUIDELINES |
|
|
![]() |
|
|
|
|
|
|
• |
The company’s stated rationale for adopting
such a provision; |
|
• |
Disclosure of past harm from duplicative shareholder
lawsuits in more than one forum; |
|
• |
The breadth of application of the charter or
bylaw provision, including the types of lawsuits to which it would apply and the definition of key terms; and |
|
• |
Governance features such as shareholders’
ability to repeal the provision at a later date (including the vote standard applied when shareholders attempt to amend the charter or
bylaws) and their ability to hold directors accountable through annual director elections and a majority vote standard in uncontested
elections. |
|
|
|
A-28 |
|
|
|
|
|
|
|
|
2025
GLENMEDE – SUSTAINABILITY PROXY VOTING GUIDELINES |
|
|
![]() |
|
|
|
|
|
|
• |
The ownership threshold (NOL protective amendments
generally prohibit stock ownership transfers that would result in a new 5-percent holder or increase the stock ownership percentage of
an existing 5-percent holder); |
|
• |
The value of the NOLs; |
|
• |
Shareholder protection mechanisms (sunset provision
or commitment to cause expiration of the protective amendment upon exhaustion or expiration of the NOL); |
|
• |
The company’s existing governance structure
including: board independence, existing takeover defenses, track record of responsiveness to shareholders, and any other problematic governance
concerns; and |
|
• |
Any other factors that may be applicable. |
|
• |
Shareholders have approved the adoption of
the plan; or |
|
• |
The board, in its exercise of its fiduciary
responsibilities, determines that it is in the best interest of shareholders under the circumstances to adopt a pill without the delay
in adoption that would result from seeking stockholder approval (i.e., the “fiduciary out”
provision). A poison pill adopted under this fiduciary out will be put to a shareholder ratification vote within 12 months of adoption
or expire. If the pill is not approved by a majority of the votes cast on this issue, the plan will immediately terminate. |
|
• |
No lower than a 20% trigger, flip-in or flip-over;
|
|
• |
A term of no more than three years; |
|
• |
No dead-hand, slow-hand, no-hand or similar
feature that limits the ability of a future board to redeem the pill; |
|
• |
Shareholder redemption feature (qualifying
offer clause); if the board refuses to redeem the pill 90 days after a qualifying offer is announced, 10 percent of the shares may call
a special meeting or seek a written consent to vote on rescinding the pill. |
|
|
|
A-29 |
|
|
|
|
|
|
|
|
2025
GLENMEDE – SUSTAINABILITY PROXY VOTING GUIDELINES |
|
|
![]() |
|
|
|
|
|
|
• |
The ownership threshold to transfer (NOL pills
generally have a trigger slightly below 5 percent); |
|
• |
The value of the NOLs; |
|
• |
Shareholder protection mechanisms (sunset provision,
or commitment to cause expiration of the pill upon exhaustion or expiration of NOLs); |
|
• |
The company’s existing governance structure
including: board independence, existing takeover defenses, track record of responsiveness to shareholders, and any other problematic governance
concerns; and |
|
• |
Any other factors that may be applicable. |
|
• |
The scope and structure of the proposal; |
|
• |
The company’s stated confidential voting
policy (or other relevant policies) and whether it ensures a “level playing field” by providing shareholder proponents
with equal access to vote information prior to the annual meeting; |
|
• |
The company’s vote standard for management
and shareholder proposals and whether it ensures consistency and fairness in the proxy voting process and maintains the integrity
of vote results; |
|
• |
Whether the company’s disclosure regarding
its vote counting method and other relevant voting policies with respect to management and shareholder proposals are consistent and clear;
|
|
• |
Any recent controversies or concerns related
to the company’s proxy voting mechanics; |
|
• |
Any unintended consequences resulting from
implementation of the proposal; and |
|
• |
Any other factors that may be relevant. |
|
|
|
A-30 |
|
|
|
|
|
|
|
|
2025
GLENMEDE – SUSTAINABILITY PROXY VOTING GUIDELINES |
|
|
![]() |
|
|
|
|
|
|
• |
The presence of a shareholder proposal addressing
the same issue on the same ballot; |
|
• |
The board’s rationale for seeking ratification;
|
|
• |
Disclosure of actions to be taken by the board
should the ratification proposal fail; |
|
• |
Disclosure of shareholder engagement regarding
the board’s ratification request; |
|
• |
The level of impairment to shareholders’
rights caused by the existing provision; |
|
• |
The history of management and shareholder proposals
on the provision at the company’s past meetings; |
|
• |
Whether the current provision was adopted in
response to the shareholder proposal; |
|
• |
The company’s ownership structure; and
|
|
• |
Previous use of ratification proposals to exclude
shareholder proposals. |
|
• |
The election of fewer than 50% of the directors
to be elected is contested in the election; |
|
• |
One or more of the dissident’s candidates
is elected; |
|
• |
Shareholders are not permitted to cumulate
their votes for directors; and |
|
• |
The election occurred, and the expenses were
incurred, after the adoption of this bylaw. |
|
• |
Reasons for reincorporation; |
|
• |
Comparison of company’s governance practices
and provisions prior to and following the reincorporation; and |
|
• |
Comparison of corporation laws of original
state and destination state. |
|
• |
Vote for reincorporation when the economic
factors outweigh any neutral or negative governance changes. |
|
|
|
A-31 |
|
|
|
|
|
|
|
|
2025
GLENMEDE – SUSTAINABILITY PROXY VOTING GUIDELINES |
|
|
![]() |
|
|
|
|
|
|
• |
Shareholders’ current right to act by
written consent; |
|
• |
The consent threshold; |
|
• |
The inclusion of exclusionary or prohibitive
language; |
|
• |
Investor ownership structure; and |
|
• |
Shareholder support of, and management’s
response to, previous shareholder proposals. |
|
• |
An unfettered14
right for shareholders to call special meetings at a 10 percent threshold; |
|
• |
A majority vote standard in uncontested director
elections; |
|
• |
No non-shareholder-approved pill; and |
|
• |
An annually elected board. |
|
• |
Shareholders’ current right to call
special meetings; |
|
• |
Minimum ownership threshold necessary to call
special meetings (10% preferred); |
|
• |
The inclusion of exclusionary or prohibitive
language; |
|
• |
Investor ownership structure; and |
|
• |
Shareholder support of, and management’s
response to, previous shareholder proposals. |
|
14 |
“Unfettered”
means no restrictions on agenda items, no restrictions on the number of shareholders who can group together to reach the 10 percent threshold,
and only reasonable limits on when a meeting can be called: no greater than 30 days after the last annual meeting and no greater than
90 prior to the next annual meeting. |
|
|
|
A-32 |
|
|
|
|
|
|
|
|
2025
GLENMEDE – SUSTAINABILITY PROXY VOTING GUIDELINES |
|
|
![]() |
|
|
|
|
|
|
• |
Ownership structure; |
|
• |
Quorum requirements; and |
|
• |
Vote requirements. |
|
• |
Scope and rationale of the proposal; and |
|
• |
Concerns identified with the company’s
prior meeting practices. |
|
4. |
Capital/Restructuring |
|
• |
If share usage (outstanding plus reserved)
is less than 50% of the current authorized shares, vote for an increase of up to 50% of current
authorized shares. |
|
• |
If share usage is 50% to 100% of the current
authorized, vote for an increase of up to 100% of current authorized shares. |
|
• |
If share usage is greater than current authorized
shares, vote for an increase of up to the current share usage. |
|
• |
In the case of a stock split, the allowable
increase is calculated (per above) based on the post-split adjusted authorization. |
|
15 |
Virtual-only
shareholder meeting” refers to a meeting of shareholders that is held exclusively using technology without a corresponding in-person
meeting. |
|
|
|
A-33 |
|
|
|
|
|
|
|
|
2025
GLENMEDE – SUSTAINABILITY PROXY VOTING GUIDELINES |
|
|
![]() |
|
|
|
|
|
|
• |
The proposal seeks to increase the number of
authorized shares of the class of common stock that has superior voting rights to other share classes; |
|
• |
On the same ballot is a proposal for a reverse
split for which support is warranted despite the fact that it would result in an excessive increase in the share authorization; |
|
• |
The company has a non-shareholder approved
poison pill (including an NOL pill); or |
|
• |
The company has previous sizeable placements
(within the past 3 years) of stock with insiders at prices substantially below market value, or with problematic voting rights, without
shareholder approval. |
|
• |
In, or subsequent to, the company’s
most recent 10-K filing, the company discloses that there is substantial doubt about its ability to continue as a going concern; |
|
• |
The company states that there is a risk of
imminent bankruptcy or imminent liquidation if shareholders do not approve the increase in authorized capital; or |
|
• |
A government body has in the past year required
the company to increase its capital ratios. |
|
• |
twice the amount needed to support the transactions
on the ballot, and |
|
• |
the allowable increase as calculated for general
issuances above. |
|
• |
The company discloses a compelling rationale
for the dual-class capital structure, such as: |
|
• |
The company’s auditor has concluded
that there is substantial doubt about the company’s ability to continue as a going concern; or |
|
• |
The new class of shares will be transitory;
|
|
• |
The new class is intended for financing purposes
with minimal or no dilution to current shareholders in both the short term and long term; and |
|
• |
The new class is not designed to preserve or
increase the voting power of an insider or significant shareholder. |
|
|
|
A-34 |
|
|
|
|
|
|
|
|
2025
GLENMEDE – SUSTAINABILITY PROXY VOTING GUIDELINES |
|
|
![]() |
|
|
|
|
|
|
• |
The size of the company; |
|
• |
The shareholder base; and |
|
• |
The liquidity of the stock. |
|
• |
If share usage (outstanding plus reserved)
is less than 50% of the current authorized shares, vote for an increase of up to 50% of current
authorized shares. |
|
• |
If share usage is 50% to 100% of the current
authorized, vote for an increase of up to 100% of current authorized shares. |
|
• |
If share usage is greater than current authorized
shares, vote for an increase of up to the current share usage. |
|
• |
In the case of a stock split, the allowable
increase is calculated (per above) based on the post-split adjusted authorization. |
|
• |
If no preferred shares are currently issued
and outstanding, vote against the request, unless the company discloses a specific use for the shares. |
|
• |
If the shares requested are blank check preferred
shares that can be used for antitakeover purposes16; |
|
• |
The company seeks to increase a class of non-convertible
preferred shares entitled to more than one vote per share on matters that do not solely affect the rights of preferred stockholders “supervoting
shares”); |
|
• |
The company seeks to increase a class of convertible
preferred shares entitled to a number of votes greater than the number of common shares into which they’re convertible (“supervoting
shares”) on matters that do not solely affect the rights of preferred stockholders; |
|
• |
The stated intent of the increase in the general
authorization is to allow the company to increase an existing designated class of supervoting preferred shares; |
|
• |
On the same ballot is a proposal for a reverse
split for which support is warranted despite the fact that it would result in an excessive increase in the share authorization; |
|
• |
The company has a non-shareholder approved
poison pill (including an NOL pill); or |
|
• |
The company has previous sizeable placements
(within the past 3 years) of stock with insiders at prices substantially below market value, or with problematic voting rights, without
shareholder approval. |
|
16 |
To
be acceptable, appropriate disclosure would be needed that the shares are “declawed”: i.e., representation by the board
that it will not, without prior stockholder approval, issue or use the preferred stock for any defensive or anti-takeover purpose or for
the purpose of implementing any stockholder rights plan. |
|
|
|
A-35 |
|
|
|
|
|
|
|
|
2025
GLENMEDE – SUSTAINABILITY PROXY VOTING GUIDELINES |
|
|
![]() |
|
|
|
|
|
|
• |
In, or subsequent to, the company’s
most recent 10-K filing, the company discloses that there is substantial doubt about its ability to continue as a going concern; |
|
• |
The company states that there is a risk of
imminent bankruptcy or imminent liquidation if shareholders do not approve the increase in authorized capital; or |
|
• |
A government body has in the past year required
the company to increase its capital ratios. |
|
• |
twice the amount needed to support the transactions
on the ballot, and |
|
• |
the allowable increase as calculated for general
issuances above. |
|
• |
More simplified capital structure; |
|
• |
Enhanced liquidity; |
|
• |
Fairness of conversion terms; |
|
• |
Impact on voting power and dividends; |
|
• |
Reasons for the reclassification; |
|
• |
Conflicts of interest; and |
|
• |
Other alternatives considered. |
|
• |
The number of authorized shares will be proportionately
reduced; or |
|
• |
The effective increase in authorized shares
is equal to or less than the allowable increase calculated in accordance with Glenmede’s Common Stock Authorization policy. |
|
|
|
A-36 |
|
|
|
|
|
|
|
|
2025
GLENMEDE – SUSTAINABILITY PROXY VOTING GUIDELINES |
|
|
![]() |
|
|
|
|
|
|
• |
Stock exchange notification to the company
of a potential delisting; |
|
• |
Disclosure of substantial doubt about the company’s
ability to continue as a going concern without additional financing; |
|
• |
The company’s rationale; or |
|
• |
Other factors as applicable. |
|
• |
Greenmail, |
|
• |
The use of buybacks to inappropriately manipulate
incentive compensation metrics, |
|
• |
Threats to the company’s long-term viability,
or |
|
• |
Other company-specific factors as warranted.
|
|
• |
Adverse governance changes; |
|
• |
Excessive increases in authorized capital stock;
|
|
• |
Unfair method of distribution; |
|
• |
Diminution of voting rights; |
|
• |
Adverse conversion features; |
|
• |
Negative impact on stock option plans; and
|
|
• |
Alternatives such as spin-off. |
|
|
|
A-37 |
|
|
|
|
|
|
|
|
2025
GLENMEDE – SUSTAINABILITY PROXY VOTING GUIDELINES |
|
|
![]() |
|
|
|
|
|
|
• |
Purchase price; |
|
• |
Fairness opinion; |
|
• |
Financial and strategic benefits; |
|
• |
How the deal was negotiated; |
|
• |
Conflicts of interest; |
|
• |
Other alternatives for the business; |
|
• |
Non-completion risk. |
|
• |
Impact on the balance sheet/working capital;
|
|
• |
Potential elimination of diseconomies; |
|
• |
Anticipated financial and operating benefits;
|
|
• |
Anticipated use of funds; |
|
• |
Value received for the asset; |
|
• |
Fairness opinion; |
|
• |
How the deal was negotiated; |
|
• |
Conflicts of interest. |
|
|
|
A-38 |
|
|
|
|
|
|
|
|
2025
GLENMEDE – SUSTAINABILITY PROXY VOTING GUIDELINES |
|
|
![]() |
|
|
|
|
|
|
• |
Dilution to existing shareholders’ positions;
|
|
• |
Terms of the offer - discount/premium in purchase
price to investor, including any fairness opinion; termination penalties; exit strategy; |
|
• |
Financial issues - company’s financial
situation; degree of need for capital; use of proceeds; effect of the financing on the company’s cost of capital; |
|
• |
Management’s efforts to pursue other
alternatives; |
|
• |
Control issues - change in management; change
in control, guaranteed board and committee seats; standstill provisions; voting agreements; veto power over certain corporate actions;
and |
|
• |
Conflict of interest - arm’s length
transaction, managerial incentives. |
|
• |
The reasons for the change; |
|
• |
Any financial or tax benefits; |
|
• |
Regulatory benefits; |
|
• |
Increases in capital structure; and |
|
• |
Changes to the articles of incorporation or
bylaws of the company. |
|
• |
Increases in common or preferred stock in excess
of the allowable maximum (see discussion under “Capital”); or |
|
• |
Adverse changes in shareholder rights. |
|
|
|
A-39 |
|
|
|
|
|
|
|
|
2025
GLENMEDE – SUSTAINABILITY PROXY VOTING GUIDELINES |
|
|
![]() |
|
|
|
|
|
|
• |
Offer price/premium; |
|
• |
Fairness opinion; |
|
• |
How the deal was negotiated; |
|
• |
Conflicts of interest; |
|
• |
Other alternatives/offers considered; and |
|
• |
Non-completion risk. |
|
• |
Whether the company has attained benefits from
being publicly-traded (examination of trading volume, liquidity, and market research of the stock); |
|
• |
Balanced interests of continuing vs. cashed-out
shareholders, taking into account the following: |
|
• |
Are all shareholders able to participate in
the transaction? |
|
• |
Will there be a liquid market for remaining
shareholders following the transaction? |
|
• |
Does the company have strong corporate governance?
|
|
• |
Will insiders reap the gains of control following
the proposed transaction? |
|
• |
Does the state of incorporation have laws requiring
continued reporting that may benefit shareholders? |
|
• |
Percentage of assets/business contributed;
|
|
• |
Percentage ownership; |
|
• |
Financial and strategic benefits; |
|
• |
Governance structure; |
|
• |
Conflicts of interest; |
|
• |
Other alternatives; and |
|
• |
Non-completion risk. |
|
• |
Management’s efforts to pursue other
alternatives; |
|
• |
Appraisal value of assets; and |
|
• |
The compensation plan for executives managing
the liquidation. |
|
|
|
A-40 |
|
|
|
|
|
|
|
|
2025
GLENMEDE – SUSTAINABILITY PROXY VOTING GUIDELINES |
|
|
![]() |
|
|
|
|
|
|
• |
Valuation
- Is the value to be received by the target shareholders (or paid by the acquirer) reasonable? While the fairness opinion may provide
an initial starting point for assessing valuation reasonableness, emphasis is placed on the offer premium, market reaction and strategic
rationale. |
|
• |
Market
reaction - How has the market responded to the proposed deal? A negative market reaction should cause closer scrutiny of
a deal. |
|
• |
Strategic
rationale - Does the deal make sense strategically? From where is the value derived? Cost and revenue synergies should not
be overly aggressive or optimistic, but reasonably achievable. Management should also have a favorable track record of successful integration
of historical acquisitions. |
|
• |
Negotiations
and process - Were the terms of the transaction negotiated at arm’s-length? Was the process fair and equitable? A
fair process helps to ensure the best price for shareholders. Significant negotiation “wins” can also signify the deal makers’
competency. The comprehensiveness of the sales process (e.g., full auction, partial auction, no
auction) can also affect shareholder value. |
|
• |
Conflicts
of interest - Are insiders benefiting from the transaction disproportionately and inappropriately as compared to non-insider
shareholders? As the result of potential conflicts, the directors and officers of the company may be more likely to vote to approve a
merger than if they did not hold these interests. Consider whether these interests may have influenced these directors and officers to
support or recommend the merger. |
|
• |
Governance
- Will the combined company have a better or worse governance profile than the current governance profiles of the respective parties to
the transaction? If the governance profile is to change for the worse, the burden is on the company to prove that other issues (such as
valuation) outweigh any deterioration in governance. |
|
• |
Dilution to existing shareholders’ position:
The amount and timing of shareholder ownership dilution should be weighed against the needs and proposed shareholder benefits of the capital
infusion. Although newly issued common stock, absent preemptive rights, is typically dilutive to existing shareholders, share price appreciation
is often the necessary event to trigger the exercise of “out of the money” warrants and convertible debt. In these instances
from a value standpoint, the negative impact of dilution is mitigated by the increase in the company’s stock price that must occur
to trigger the dilutive event. |
|
• |
Terms of the offer (discount/premium in purchase
price to investor, including any fairness opinion, conversion features, termination penalties, exit strategy): |
|
• |
The terms of the offer should be weighed against
the alternatives of the company and in light of company’s financial condition. Ideally, the conversion price for convertible debt
and the exercise price for warrants should be at a premium to the then prevailing stock price at the time of private placement. |
|
• |
When evaluating the magnitude of a private
placement discount or premium, consider factors that influence the discount or premium, such as, liquidity, due diligence costs, control
and monitoring costs, capital scarcity, information asymmetry and anticipation of future performance. |
|
|
|
A-41 |
|
|
|
|
|
|
|
|
2025
GLENMEDE – SUSTAINABILITY PROXY VOTING GUIDELINES |
|
|
![]() |
|
|
|
|
|
|
• |
Financial issues: |
|
• |
The company’s financial condition; |
|
• |
Degree of need for capital; |
|
• |
Use of proceeds; |
|
• |
Effect of the financing on the company’s
cost of capital; |
|
• |
Current and proposed cash burn rate; |
|
• |
Going concern viability and the state of the
capital and credit markets. |
|
• |
Management’s efforts to pursue alternatives
and whether the company engaged in a process to evaluate alternatives: A fair, unconstrained process helps to ensure the best price for
shareholders. Financing alternatives can include joint ventures, partnership, merger or sale of part or all of the company. |
|
• |
Control issues: |
|
• |
Change in management; |
|
• |
Change in control; |
|
• |
Guaranteed board and committee seats; |
|
• |
Standstill provisions; |
|
• |
Voting agreements; |
|
• |
Veto power over certain corporate actions;
and |
|
• |
Minority versus majority ownership and corresponding
minority discount or majority control premium |
|
• |
Conflicts of interest: |
|
• |
Conflicts of interest should be viewed from
the perspective of the company and the investor. |
|
• |
Were the terms of the transaction negotiated
at arm’s length? Are managerial incentives aligned with shareholder interests? |
|
• |
Market reaction: |
|
• |
The market’s response to the proposed
deal. A negative market reaction is a cause for concern. Market reaction may be addressed by analyzing the one day impact on the
unaffected stock price. |
|
• |
Estimated value and financial prospects of
the reorganized company; |
|
• |
Percentage ownership of current shareholders
in the reorganized company; |
|
• |
Whether shareholders are adequately represented
in the reorganization process (particularly through the existence of an official equity committee); |
|
• |
The cause(s) of the bankruptcy filing, and
the extent to which the plan of reorganization addresses the cause(s); |
|
|
|
A-42 |
|
|
|
|
|
|
|
|
2025
GLENMEDE – SUSTAINABILITY PROXY VOTING GUIDELINES |
|
|
![]() |
|
|
|
|
|
|
• |
Existence of a superior alternative to the
plan of reorganization; and |
|
• |
Governance of the reorganized company. |
|
• |
Valuation—Is
the value being paid by the SPAC reasonable? SPACs generally lack an independent fairness opinion and the financials on the target may
be limited. Compare the conversion price with the intrinsic value of the target company provided in the fairness opinion. Also, evaluate
the proportionate value of the combined entity attributable to the SPAC IPO shareholders versus the pre-merger value of SPAC. Additionally,
a private company discount may be applied to the target, if it is a private entity. |
|
• |
Market
reaction—How has the market responded to the proposed deal? A negative market reaction may be a cause for concern. Market
reaction may be addressed by analyzing the one-day impact on the unaffected stock price. |
|
• |
Deal
timing—A main driver for most transactions is that the SPAC charter typically requires the deal to be complete
within 18 to 24 months, or the SPAC is to be liquidated. Evaluate the valuation, market reaction, and potential conflicts of interest
for deals that are announced close to the liquidation date. |
|
• |
Negotiations
and process—What was the process undertaken to identify potential target companies within specified industry or location
specified in charter? Consider the background of the sponsors. |
|
• |
Conflicts
of interest—How are sponsors benefiting from the transaction compared to IPO shareholders? Potential conflicts could
arise if a fairness opinion is issued by the insiders to qualify the deal rather than a third party or if management is encouraged to
pay a higher price for the target because of an 80% rule (the charter requires that the fair market value of the target is at least
equal to 80% of net assets of the SPAC). Also, there may be sense of urgency by the management team of the SPAC to close the deal since
its charter typically requires a transaction to be completed within the 18-24 month timeframe. |
|
• |
Voting
agreements—Are the sponsors entering into enter into any voting agreements/ tender offers with shareholders who are
likely to vote against the proposed merger or exercise conversion rights? |
|
• |
Governance—What
is the impact of having the SPAC CEO or founder on key committees following the proposed merger? |
|
• |
Tax and regulatory advantages; |
|
• |
Planned use of the sale proceeds; |
|
• |
Valuation of spinoff; |
|
• |
Fairness opinion; |
|
|
|
A-43 |
|
|
|
|
|
|
|
|
2025
GLENMEDE – SUSTAINABILITY PROXY VOTING GUIDELINES |
|
|
![]() |
|
|
|
|
|
|
• |
Benefits to the parent company; |
|
• |
Conflicts of interest; |
|
• |
Managerial incentives; |
|
• |
Corporate governance changes; |
|
• |
Changes in the capital structure. |
|
• |
Hiring a financial advisor to explore strategic
alternatives; |
|
• |
Selling the company; or |
|
• |
Liquidating the company and distributing the
proceeds to shareholders. |
|
• |
Prolonged poor performance with no turnaround
in sight; |
|
• |
Signs of entrenched board and management (such
as the adoption of takeover defenses); |
|
• |
Strategic plan in place for improving value;
|
|
• |
Likelihood of receiving reasonable value in
a sale or dissolution; and |
|
• |
The company actively exploring its strategic
options, including retaining a financial advisor. |
|
|
|
A-44 |
|
|
|
|
|
|
|
|
2025
GLENMEDE – SUSTAINABILITY PROXY VOTING GUIDELINES |
|
|
![]() |
|
|
|
|
|
|
5. |
Compensation |
|
1. |
Maintain appropriate pay-for-performance alignment,
with emphasis on long-term shareholder value: This principle encompasses overall executive pay practices, which must be designed to attract,
retain, and appropriately motivate the key employees who drive shareholder value creation over the long term. It will take into consideration,
among other factors, the link between pay and performance; the mix between fixed and variable pay; performance goals; and equity-based
plan costs; |
|
2. |
Avoid arrangements that risk “pay for
failure”: This principle addresses the appropriateness of long or indefinite contracts, excessive severance packages, and guaranteed
compensation; |
|
3. |
Maintain an independent and effective compensation
committee: This principle promotes oversight of executive pay programs by directors with appropriate skills, knowledge, experience, and
a sound process for compensation decision-making (e.g., including access to independent expertise
and advice when needed); |
|
4. |
Provide shareholders with clear, comprehensive
compensation disclosures: This principle underscores the importance of informative and timely disclosures that enable shareholders to
evaluate executive pay practices fully and fairly; |
|
5. |
Avoid inappropriate pay to non-executive directors:
This principle recognizes the interests of shareholders in ensuring that compensation to outside directors does not compromise their independence
and ability to make appropriate judgments in overseeing managers’ pay and performance. At the market level, it may incorporate
a variety of generally accepted best practices. |
|
• |
There is an unmitigated misalignment between
CEO pay and company performance (pay for performance); |
|
• |
The company maintains significant problematic
pay practices; |
|
• |
The board exhibits a significant level of poor
communication and responsiveness to shareholders. |
|
• |
There is no SOP on the ballot, and an against
vote on an SOP is warranted due to pay for performance misalignment, problematic pay practices, or the lack of adequate responsiveness
on compensation issues raised previously, or a combination thereof; |
|
• |
The board fails to respond adequately to a
previous SOP proposal that received less than 70 percent support of votes cast; |
|
• |
The company has recently practiced or approved
problematic pay practices, such as option repricing or option backdating; or |
|
• |
The situation is egregious. |
|
|
|
A-45 |
|
|
|
|
|
|
|
|
2025
GLENMEDE – SUSTAINABILITY PROXY VOTING GUIDELINES |
|
|
![]() |
|
|
|
|
|
|
1. |
Peer Group18
Alignment: |
|
• |
The degree of alignment between the company’s
annualized TSR rank and the CEO’s annualized total pay rank within a peer group, each measured over a three-year period. |
|
• |
The rankings of CEO total pay and company financial
performance within a peer group, each measured over a three-year period. |
|
• |
The multiple of the CEO’s total pay
relative to the peer group median in the most recent fiscal year. |
|
2. |
Absolute Alignment19
– the absolute alignment between the trend in CEO pay and company TSR over the prior five fiscal years – i.e., the difference
between the trend in annual pay changes and the trend in annualized TSR during the period. |
|
• |
The ratio of performance- to time-based incentive
awards; |
|
• |
The overall ratio of performance-based compensation;
|
|
• |
The rigor of performance goals; |
|
• |
The complexity and risks around pay program
design; |
|
• |
The transparency and clarity of disclosure;
|
|
• |
The company’s peer group benchmarking
practices; |
|
• |
Financial/operational results, both absolute
and relative to peers; |
|
• |
Special circumstances related to, for example,
a new CEO in the prior FY or anomalous equity grant practices (e.g., bi-annual awards); |
|
• |
Realizable pay20
compared to grant pay; and |
|
• |
Any other factors deemed relevant. |
|
17 |
The
Russell 3000E Index includes approximately 4,000 of the largest U.S. equity securities.
|
|
18 |
The
revised peer group is generally comprised of 14-24 companies that are selected using market cap, revenue (or assets for certain financial
firms), GICS industry group, and company’s selected peers’ GICS industry group, with size constraints, via a process designed
to select peers that are comparable to the subject company in terms of revenue/assets and industry, and also within a market cap bucket
that is reflective of the company’s. For Oil, Gas & Consumable Fuels companies, market cap is the only size determinant. |
|
19 |
Only
Russell 3000 Index companies are subject to the Absolute Alignment analysis. |
|
20 |
Glenmede
Policy research reports include realizable pay for S&P1500 companies. |
|
|
|
A-46 |
|
|
|
|
|
|
|
|
2025
GLENMEDE – SUSTAINABILITY PROXY VOTING GUIDELINES |
|
|
![]() |
|
|
|
|
|
|
• |
Problematic practices related to non-performance-based
compensation elements; |
|
• |
Incentives that may motivate excessive risk-taking
or present a windfall risk; and |
|
• |
Pay decisions that circumvent pay-for-performance,
such as options backdating or waiving performance requirements. |
|
• |
Repricing or replacing of underwater stock
options/SARs without prior shareholder approval (including cash buyouts and voluntary surrender of underwater options); |
|
• |
Extraordinary perquisites or tax gross-ups;
|
|
• |
New or materially amended agreements that provide
for: |
|
• |
Excessive termination or CIC severance payments
(generally exceeding 3 times base salary and average/target/most recent bonus); |
|
• |
CIC severance payments without involuntary
job loss or substantial diminution of duties (“single” or “modified single” triggers) or in connection with
a problematic Good Reason definition; |
|
• |
CIC excise tax gross-up entitlements (including
“modified” gross-ups); |
|
• |
Multi-year guaranteed awards that are not at
risk due to rigorous performance conditions; |
|
• |
Liberal CIC definition combined with any single-trigger
CIC benefits; |
|
• |
Severance payments made when the termination
is not clearly disclosed as involuntary (for example, a termination without cause or resignation for good reason); |
|
• |
Insufficient executive compensation disclosure
by externally-managed issuers (EMIs) such that a reasonable assessment of pay programs and practices applicable to the EMI’s executives
is not possible; |
|
• |
Any other provision or practice deemed to be
egregious and present a significant risk to investors. |
|
• |
Reason and motive for the options backdating
issue, such as inadvertent vs. deliberate grant date changes; |
|
• |
Duration of options backdating; |
|
• |
Size of restatement due to options backdating;
|
|
• |
Corrective actions taken by the board or compensation
committee, such as canceling or re-pricing backdated options, the recouping of option gains on backdated grants; and |
|
|
|
A-47 |
|
|
|
|
|
|
|
|
2025
GLENMEDE – SUSTAINABILITY PROXY VOTING GUIDELINES |
|
|
![]() |
|
|
|
|
|
|
• |
Adoption of a grant policy that prohibits backdating,
and creates a fixed grant schedule or window period for equity grants in the future. |
|
• |
Failure to respond to majority-supported shareholder
proposals on executive pay topics; or |
|
• |
Failure to adequately respond to the company’s
previous say-on-pay proposal that received the support of less than 70 percent of votes cast, taking into account: |
|
• |
The company’s response, including: |
|
• |
Disclosure of engagement efforts with major
institutional investors regarding the issues that contributed to the low level of support (including the timing and frequency of engagements
and whether independent directors participated); |
|
• |
Disclosure of the specific concerns voiced
by dissenting shareholders that led to the say-on-pay opposition; |
|
• |
Disclosure of specific and meaningful actions
taken to address shareholders’ concerns; |
|
• |
Other recent compensation actions taken by
the company; |
|
• |
Whether the issues raised are recurring or
isolated; |
|
• |
The company’s ownership structure; and
|
|
• |
Whether the support level was less than 50
percent, which would warrant the highest degree of responsiveness. |
|
• |
Single- or modified-single-trigger cash severance;
|
|
• |
Single-trigger acceleration of unvested equity
awards; |
|
• |
Full acceleration of equity awards granted
shortly before the change in control; |
|
• |
Acceleration of performance awards above the
target level of performance without compelling rationale; |
|
• |
Excessive cash severance (>3x base salary
and bonus); |
|
• |
Excise tax gross-ups triggered and payable;
|
|
• |
Excessive golden parachute payments (on an
absolute basis or as a percentage of transaction equity value); or |
|
|
|
A-48 |
|
|
|
|
|
|
|
|
2025
GLENMEDE – SUSTAINABILITY PROXY VOTING GUIDELINES |
|
|
![]() |
|
|
|
|
|
|
• |
Recent amendments that incorporate any problematic
features (such as those above) or recent actions (such as extraordinary equity grants) that may make packages so attractive as to influence
merger agreements that may not be in the best interests of shareholders; or |
|
• |
The company’s assertion that a proposed
transaction is conditioned on shareholder approval of the golden parachute advisory vote. |
|
• |
Plan Cost:
The total estimated cost of the company’s equity plans relative to industry/market cap peers, measured by the company’s
estimated Shareholder Value Transfer (SVT) in relation to peers and considering both: |
|
• |
SVT based on new shares requested plus shares
remaining for future grants, plus outstanding unvested/unexercised grants; and |
|
• |
SVT based only on new shares requested plus
shares remaining for future grants. |
|
• |
Plan
Features: |
|
• |
Quality of disclosure around vesting upon a
change in control (CIC); |
|
• |
Discretionary vesting authority; |
|
• |
Liberal share recycling on various award types;
|
|
• |
Lack of minimum vesting period for grants made
under the plan; |
|
• |
Dividends payable prior to award vesting. |
|
• |
Grant
Practices: |
|
• |
The company’s three year burn rate relative
to its industry/market cap peers; |
|
• |
Vesting requirements in CEO’S recent
equity grants (3-year look-back); |
|
• |
The estimated duration of the plan (based on
the sum of shares remaining available and the new shares requested, divided by the average annual shares granted in the prior three years);
|
|
• |
The proportion of the CEO’s most recent
equity grants/awards subject to performance conditions; |
|
21 |
Proposals
evaluated under the EPSC policy generally include those to approve or amend (1) stock option plans for employees and/or employees and
directors, (2) restricted stock plans for employees and/or employees and directors, and (3) omnibus stock incentive plans for employees
and/or employees and directors; amended plans will be further evaluated case-by-case. |
|
|
|
A-49 |
|
|
|
|
|
|
|
|
2025
GLENMEDE – SUSTAINABILITY PROXY VOTING GUIDELINES |
|
|
![]() |
|
|
|
|
|
|
• |
Whether the company maintains a sufficient
claw-back policy; |
|
• |
Whether the company maintains sufficient post
exercise/vesting share-holding requirements. |
|
• |
Awards may vest in connection with a liberal
change-of-control definition; |
|
• |
The plan would permit repricing or cash buyout
of underwater options without shareholder approval (either by expressly permitting it – for NYSE and Nasdaq listed companies --
or by not prohibiting it when the company has a history of repricing – for non-listed companies); |
|
• |
The plan is a vehicle for problematic pay practices
or a significant pay-for-performance disconnect under certain circumstances; |
|
• |
The plan is excessively dilutive to shareholders’
holdings; |
|
• |
The plan contains an evergreen (automatic share
replenishment) feature; or |
|
• |
Any other plan features are determined to have
a significant negative impact on shareholder interests. |
|
22 |
For
plans evaluated under the Equity Plan Scorecard policy, the company’s SVT benchmark is considered along with other factors. |
|
|
|
A-50 |
|
|
|
|
|
|
|
|
2025
GLENMEDE – SUSTAINABILITY PROXY VOTING GUIDELINES |
|
|
![]() |
|
|
|
|
|
|
• |
Amend the terms of outstanding options or SARs
to reduce the exercise price of such outstanding options or SARs; |
|
• |
Cancel outstanding options or SARs in exchange
for options or SARs with an exercise price that is less than the exercise price of the original options or SARs; |
|
• |
Cancel underwater options in exchange for stock
awards; or |
|
• |
Provide cash buyouts of underwater options.
|
|
• |
Magnitude of pay misalignment; |
|
• |
Contribution of non–performance-based
equity grants to overall pay; and |
|
• |
The proportion of equity awards granted in
the last three fiscal years concentrated at the named executive officer level. |
|
|
|
A-51 |
|
|
|
|
|
|
|
|
2025
GLENMEDE – SUSTAINABILITY PROXY VOTING GUIDELINES |
|
|
![]() |
|
|
|
|
|
|
• |
Purchase price is at least 85 percent of fair
market value; |
|
• |
Offering period is 27 months or less; and |
|
• |
The number of shares allocated to the plan
is 10 percent or less of the outstanding shares. |
|
• |
Purchase price is less than 85 percent of fair
market value; or |
|
• |
Offering period is greater than 27 months;
or |
|
• |
The number of shares allocated to the plan
is more than ten percent of the outstanding shares. |
|
• |
Broad-based participation (i.e.,
all employees of the company with the exclusion of individuals with 5 percent or more of beneficial ownership of the company); |
|
• |
Limits on employee contribution, which may
be a fixed dollar amount or expressed as a percent of base salary; |
|
• |
Company matching contribution up to 25 percent
of employee’s contribution, which is effectively a discount of 20 percent from market value; |
|
|
|
A-52 |
|
|
|
|
|
|
|
|
2025
GLENMEDE – SUSTAINABILITY PROXY VOTING GUIDELINES |
|
|
![]() |
|
|
|
|
|
|
• |
No discount on the stock price on the date
of purchase when there is a company matching contribution. |
|
• |
Addresses administrative features only; or
|
|
• |
Seeks approval for Section 162(m) purposes
only, and the plan administering committee consists entirely of independent outsiders,
per Glenmede Policy’s Classification of Directors. Note that if the company is presenting the plan to shareholders for the
first time after the company’s initial public offering (IPO), or if the proposal is bundled with other material plan amendments,
then the recommendation will be case-by-case (see below). |
|
• |
Seeks approval for Section 162(m) purposes
only, and the plan administering committee does not consist entirely of independent outsiders, per Glenmede
Policy’s Classification of Directors. |
|
• |
If the proposal requests additional shares
and/or the amendments may potentially increase the transfer of shareholder value to employees, the recommendation will be based on the
Equity Plan Scorecard evaluation as well as an analysis of the overall impact of the amendments. |
|
• |
If the plan is being presented to shareholders
for the first time after the company’s IPO, whether or not additional shares are being requested, the recommendation will be based
on the Equity Plan Scorecard evaluation as well as an analysis of the overall impact of any amendments. |
|
• |
If there is no request for additional shares
and the amendments are not deemed to potentially increase the transfer of shareholder value to employees, then the recommendation will
be based entirely on an analysis of the overall impact of the amendments, and the EPSC evaluation will be shown for informational purposes.
|
|
• |
Historic trading patterns--the stock price
should not be so volatile that the options are likely to be back “in-the-money” over the near term; |
|
• |
Rationale for the re-pricing--was the stock
price decline beyond management’s control? |
|
• |
Is this a value-for-value exchange? |
|
• |
Are surrendered stock options added back to
the plan reserve? |
|
• |
Timing--repricing should occur at least one
year out from any precipitous drop in company’s stock price; |
|
• |
Option vesting--does the new option vest immediately
or is there a black-out period? |
|
|
|
A-53 |
|
|
|
|
|
|
|
|
2025
GLENMEDE – SUSTAINABILITY PROXY VOTING GUIDELINES |
|
|
![]() |
|
|
|
|
|
|
• |
Term of the option--the term should remain
the same as that of the replaced option; |
|
• |
Exercise price--should be set at fair market
or a premium to market; |
|
• |
Participants--executive officers and directors
must be excluded. |
|
• |
Executive officers and non-employee directors
are excluded from participating; |
|
• |
Stock options are purchased by third-party
financial institutions at a discount to their fair value using option pricing models such as Black-Scholes or a Binomial Option Valuation
or other appropriate financial models; |
|
• |
There is a two-year minimum holding period
for sale proceeds (cash or stock) for all participants. |
|
|
|
A-54 |
|
|
|
|
|
|
|
|
2025
GLENMEDE – SUSTAINABILITY PROXY VOTING GUIDELINES |
|
|
![]() |
|
|
|
|
|
|
• |
Eligibility; |
|
• |
Vesting; |
|
• |
Bid-price; |
|
• |
Term of options; |
|
• |
Cost of the program and impact of the TSOs
on company’s total option expense |
|
• |
Option repricing policy. |
|
• |
If the equity plan under which non-employee
director grants are made is on the ballot, whether or not it warrants support; and |
|
• |
An assessment of the following qualitative
factors: |
|
• |
The relative magnitude of director compensation
as compared to companies of a similar profile; |
|
• |
The presence of problematic pay practices relating
to director compensation; |
|
• |
Director stock ownership guidelines and holding
requirements; |
|
• |
Equity award vesting schedules; |
|
• |
The mix of cash and equity-based compensation;
|
|
• |
Meaningful limits on director compensation;
|
|
• |
The availability of retirement benefits or
perquisites; and |
|
• |
The quality of disclosure surrounding director
compensation. |
|
• |
The total estimated cost of the company’s
equity plans relative to industry/market cap peers, measured by the company’s estimated Shareholder Value Transfer (SVT) based
on new shares requested plus shares remaining for future grants, plus outstanding unvested/unexercised grants; |
|
• |
The company’s three-year burn rate relative
to its industry/market cap peers; and |
|
• |
The presence of any egregious plan features
(such as an option repricing provision or liberal CIC vesting risk). |
|
|
|
A-55 |
|
|
|
|
|
|
|
|
2025
GLENMEDE – SUSTAINABILITY PROXY VOTING GUIDELINES |
|
|
![]() |
|
|
|
|
|
|
• |
The relative magnitude of director compensation
as compared to companies of a similar profile; |
|
• |
The presence of problematic pay practices relating
to director compensation; |
|
• |
Director stock ownership guidelines and holding
requirements; |
|
• |
Equity award vesting schedules; |
|
• |
The mix of cash and equity-based compensation;
|
|
• |
Meaningful limits on director compensation;
|
|
• |
The availability of retirement benefits or
perquisites; and |
|
• |
The quality of disclosure surrounding director
compensation. |
|
• |
The company’s past practices regarding
equity and cash compensation; |
|
• |
Whether the company has a holding period or
stock ownership requirements in place, such as a meaningful retention ratio (at least 50 percent for full tenure); and |
|
• |
Whether the company has a rigorous claw-back
policy in place. |
|
|
|
A-56 |
|
|
|
|
|
|
|
|
2025
GLENMEDE – SUSTAINABILITY PROXY VOTING GUIDELINES |
|
|
![]() |
|
|
|
|
|
|
• |
The percentage/ratio of net shares required
to be retained; |
|
• |
The time period required to retain the shares;
|
|
• |
Whether the company has equity retention, holding
period, and/or stock ownership requirements in place and the robustness of such requirements; |
|
• |
Whether the company has any other policies
aimed at mitigating risk taking by executives; |
|
• |
Executives’ actual stock ownership and
the degree to which it meets or exceeds the proponent’s suggested holding period/retention ratio or the company’s existing
requirements; and |
|
• |
First, vote for shareholder proposals advocating
the use of performance-based equity awards, such as performance contingent options or restricted stock, indexed options or premium-priced
options, unless the proposal is overly restrictive or if the company has demonstrated that it is using a “substantial” portion
of performance-based awards for its top executives. Standard stock options and performance-accelerated awards do not meet the criteria
to be considered as performance-based awards. Further, premium-priced options should have a meaningful premium to be considered performance-based
awards. |
|
|
|
A-57 |
|
|
|
|
|
|
|
|
2025
GLENMEDE – SUSTAINABILITY PROXY VOTING GUIDELINES |
|
|
![]() |
|
|
|
|
|
|
• |
Second, assess the rigor of the company’s
performance-based equity program. If the bar set for the performance-based program is too low based on the company’s historical
or peer group comparison, generally vote for the proposal. Furthermore, if target performance results in an above target payout, vote
for the shareholder proposal due to program’s poor design. If the company does not disclose the performance metric of the performance-based
equity program, vote for the shareholder proposal regardless of the outcome of the first step to the test. |
|
• |
Set compensation targets for the plan’s
annual and long-term incentive pay components at or below the peer group median; |
|
• |
Deliver a majority of the plan’s target
long-term compensation through performance-vested, not simply time-vested, equity awards; |
|
• |
Provide the strategic rationale and relative
weightings of the financial and non-financial performance metrics or criteria used in the annual and performance-vested long-term incentive
components of the plan; |
|
• |
Establish performance targets for each plan
financial metric relative to the performance of the company’s peer companies; |
|
• |
Limit payment under the annual and performance-vested
long-term incentive components of the plan to when the company’s performance on its selected financial performance metrics exceeds
peer group median performance. |
|
• |
What aspects of the company’s annual
and long-term equity incentive programs are performance driven? |
|
• |
If the annual and long-term equity incentive
programs are performance driven, are the performance criteria and hurdle rates disclosed to shareholders or are they benchmarked against
a disclosed peer group? |
|
• |
Can shareholders assess the correlation between
pay and performance based on the current disclosure? |
|
• |
What type of industry and stage of business
cycle does the company belong to? |
|
• |
Adoption,
amendment, or termination of a 10b5-1 Plan must be disclosed in a Form 8-K; |
|
• |
Amendment
or early termination of a 10b5-1 Plan allowed only under extraordinary circumstances, as determined by the board; |
|
• |
Request
that a certain number of days that must elapse between adoption or amendment of a 10b5-1
Plan and initial trading under the plan; |
|
• |
Reports on Form 4 must identify transactions
made pursuant to a 10b5-1 Plan; |
|
• |
An executive may not trade in company stock
outside the 10b5-1 Plan; |
|
• |
Trades under a 10b5-1 Plan must be handled
by a broker who does not handle other securities transactions for the executive. |
|
|
|
A-58 |
|
|
|
|
|
|
|
|
2025
GLENMEDE – SUSTAINABILITY PROXY VOTING GUIDELINES |
|
|
![]() |
|
|
|
|
|
|
• |
If the company has adopted a formal recoupment
policy; |
|
• |
The rigor of the recoupment policy focusing
on how and under what circumstances the company may recoup incentive or stock compensation; |
|
• |
Whether the company has chronic restatement
history or material financial problems; |
|
• |
Whether the company’s policy substantially
addresses the concerns raised by the proponent; |
|
• |
Disclosure of recoupment of incentive or stock
compensation from senior executives or lack thereof; or |
|
• |
Any other relevant factors. |
|
• |
The company’s severance or change-in-control
agreements in place, and the presence of problematic features (such as excessive severance entitlements, single triggers, excise tax gross-ups,
etc.); |
|
• |
Any existing limits on cash severance payouts
or policies which require shareholder ratification of severance payments exceeding a certain level; |
|
• |
Any recent severance-related controversies;
and |
|
• |
Whether the proposal is overly prescriptive,
such as requiring shareholder approval of severance that does not exceed market norms. |
|
|
|
A-59 |
|
|
|
|
|
|
|
|
2025
GLENMEDE – SUSTAINABILITY PROXY VOTING GUIDELINES |
|
|
![]() |
|
|
|
|
|
|
• |
The frequency and timing of the company’s
share buybacks; |
|
• |
The use of per-share metrics in incentive plans;
|
|
• |
The effect of recent buybacks on incentive
metric results and payouts; and |
|
• |
Whether there is any indication of metric result
manipulation. |
|
• |
The company’s current treatment of equity
in change-of-control situations (i.e. is it double triggered, does it allow for the assumption of equity by acquiring company, the treatment
of performance shares, etc.); |
|
• |
Current employment agreements, including potential
poor pay practices such as gross-ups embedded in those agreements. |
|
|
|
A-60 |
|
|
|
|
|
|
|
|
2025
GLENMEDE – SUSTAINABILITY PROXY VOTING GUIDELINES |
|
|
![]() |
|
|
|
|
|
|
6. |
Social and Environmental Issues |
|
• |
Whether the proposal itself is well framed
and reasonable; |
|
• |
Whether adoption of the proposal would have
either a positive or negative impact on the company’s short-term or long-term share value; |
|
• |
The percentage of sales, assets and earnings
affected; |
|
• |
Whether the company has already responded in
some appropriate manner to the request embodied in a proposal; |
|
• |
Whether the company’s analysis and voting
recommendation to shareholders is persuasive; |
|
• |
Whether there are significant controversies,
fines, penalties, or litigation associated with the company’s environmental or social practices; |
|
• |
What other companies have done in response
to the issue addressed in the proposal; |
|
• |
Whether implementation of the proposal would
achieve the objectives sought in the proposal; and |
|
• |
The degree to which the company’s stated
position on the issues raised in the proposal could affect its reputation or sales, or leave it vulnerable to a boycott or selective purchasing.
|
|
• |
The company has already published a set of
animal welfare standards and monitors compliance; |
|
• |
The company’s standards are comparable
to industry peers; and |
|
• |
There are no recent significant fines, litigation,
or controversies related to the company’s and/or its suppliers’ treatment of animals. |
|
|
|
A-61 |
|
|
|
|
|
|
|
|
2025
GLENMEDE – SUSTAINABILITY PROXY VOTING GUIDELINES |
|
|
![]() |
|
|
|
|
|
|
• |
The company is conducting animal testing programs
that are unnecessary or not required by regulation; |
|
• |
The company is conducting animal testing when
suitable alternatives are commonly accepted and used by industry peers; or |
|
• |
There are recent, significant fines or litigation
related to the company’s treatment of animals. |
|
• |
The potential impact of such labeling on the
company’s business; |
|
• |
The quality of the company’s disclosure
on GE product labeling, related voluntary initiatives, and how this disclosure compares with industry peer disclosure; and |
|
• |
Company’s current disclosure on the
feasibility of GE product labeling. |
|
• |
Whether the company has adequately disclosed
mechanisms in place to prevent abuses; |
|
• |
Whether the company has adequately disclosed
the financial risks of the products/practices in question; |
|
• |
Whether the company has been subject to violations
of related laws or serious controversies; and |
|
• |
Peer companies’ policies/practices in
this area. |
|
|
|
A-62 |
|
|
|
|
|
|
|
|
2025
GLENMEDE – SUSTAINABILITY PROXY VOTING GUIDELINES |
|
|
![]() |
|
|
|
|
|
|
• |
Whether the company has adequately disclosed
mechanisms in place to prevent abusive lending practices; |
|
• |
Whether the company has adequately disclosed
the financial risks of the lending products in question; |
|
• |
Whether the company has been subject to violations
of lending laws or serious lending controversies; and |
|
• |
Peer companies’ policies to prevent
abusive lending practices. |
|
• |
The potential for reputational, market, and
regulatory risk exposure; |
|
• |
Existing disclosure of relevant policies; |
|
• |
Deviation from established industry norms;
|
|
• |
Relevant company initiatives to provide research
and/or products to disadvantaged consumers; |
|
• |
Whether the proposal focuses on specific products
or geographic regions; |
|
• |
The potential burden and scope of the requested
report; and |
|
• |
Recent significant controversies, litigation,
or fines at the company. |
|
• |
The scope of the company’s operations
in the affected/relevant area(s); |
|
• |
The company’s existing healthcare policies,
including benefits and healthcare access; and |
|
• |
Company donations to relevant healthcare providers.
|
|
|
|
A-63 |
|
|
|
|
|
|
|
|
2025
GLENMEDE – SUSTAINABILITY PROXY VOTING GUIDELINES |
|
|
![]() |
|
|
|
|
|
|
• |
Recent related fines, controversies, or significant
litigation; |
|
• |
Whether the company complies with relevant
laws and regulations on the marketing of tobacco; |
|
• |
Whether the company’s advertising restrictions
deviate from those of industry peers; |
|
• |
Whether the company entered into the Master
Settlement Agreement, which restricts marketing of tobacco to youth; and |
|
• |
Whether restrictions on marketing to youth
extend to foreign countries. |
|
• |
Whether the company complies with all laws
and regulations; |
|
• |
The degree that voluntary restrictions beyond
those mandated by law might hurt the company’s competitiveness; and |
|
• |
The risk of any health-related liabilities.
|
|
|
|
A-64 |
|
|
|
|
|
|
|
|
2025
GLENMEDE – SUSTAINABILITY PROXY VOTING GUIDELINES |
|
|
![]() |
|
|
|
|
|
|
• |
Vote for shareholder proposals seeking information
on the financial, physical, or regulatory risks it faces related to climate change- on its operations and investments, or on how the company
identifies, measures, and manage such risks. |
|
• |
Vote for shareholder proposals calling for
the reduction of GHG emissions. |
|
• |
Vote for shareholder proposals seeking reports
on responses to regulatory and public pressures surrounding climate change, and for disclosure of research that aided in setting company
policies around climate change. |
|
• |
Vote for shareholder proposals requesting a
report/disclosure of goals on GHG emissions from company operations and/or products. |
|
• |
Vote for
shareholder proposals that request the company to disclose a report on reducing methane emissions and to assess the reliability of the
company’s methane emission disclosures. |
|
• |
The completeness,
feasibility, and rigor of the company’s financed emissions disclosure; |
|
• |
Whether
the company’s decarbonization targets and climate transition plan are in alignment with the Paris Agreement, the International
Energy Agency’s (IEA) Net Zero Emissions by 2050 Scenario, and other internationally recognized frameworks; |
|
• |
Whether
the company’s methodology is in alignment with the Greenhouse Gas Protocol (GHG Protocol), the Partnership for Carbon Accounting
Financials (PCAF), and other generally accepted calculation and reporting methodologies; and |
|
• |
Whether
the proposal’s request is unduly burdensome (scope or timeframe) or overly prescriptive. |
|
|
|
A-65 |
|
|
|
|
|
|
|
|
2025
GLENMEDE – SUSTAINABILITY PROXY VOTING GUIDELINES |
|
|
![]() |
|
|
|
|
|
|
• |
The completeness,
feasibility, and rigor of the company’s natural capital-related disclosure; |
|
• |
Whether
the company’s natural capital disclosure adequately incorporate governance, strategy, risk and impact management, and metrics and
targets; |
|
• |
Whether
the company’s targets and climate transition plan are in alignment with TNFD, the Global Biodiversity Framework, the Paris Agreement,
and other internationally recognized frameworks; and |
|
• |
Whether
the proposal’s request is unduly burdensome (scope or timeframe) or overly prescriptive. |
|
• |
The extent to which the company’s climate
related disclosures are in line with TCFD recommendations and meet other market standards; |
|
• |
Disclosure of its operational and supply chain
GHG emissions (Scopes 1, 2, and 3); |
|
23 |
Variations
of this request also include climate transition related ambitions, or commitment to reporting on the implementation of a climate plan. |
|
|
|
A-66 |
|
|
|
|
|
|
|
|
2025
GLENMEDE – SUSTAINABILITY PROXY VOTING GUIDELINES |
|
|
![]() |
|
|
|
|
|
|
• |
The completeness, feasibility
and rigor of company’s short-, medium-, and long-term targets for reducing operational and supply chain GHG emissions in
line with Paris Agreement goals (Scopes 1, 2, and 3 if relevant); |
|
• |
Whether the company has sought and received
third-party approval that its targets are science-based; |
|
• |
Whether the company has made a commitment to
be “net zero” for operational and supply chain emissions (Scopes 1, 2, and 3) by 2050; |
|
• |
Whether the company discloses a commitment
to report on the implementation of its plan in subsequent years; |
|
• |
Whether the company’s climate data has
received third-party assurance; |
|
• |
Disclosure of how the company’s lobbying
activities and its capital expenditures align with company strategy; |
|
• |
Whether there are specific industry decarbonization
challenges; and |
|
• |
The company’s related commitment, disclosure,
and performance compared to its industry peers. |
|
• |
The completeness,
feasibility and rigor of the company’s climate-related disclosure; |
|
• |
The company’s actual GHG emissions performance; |
|
• |
The company's
alignment with relevant internationally recognized frameworks such as the Paris Agreement and IEA's Net Zero Emissions by 2050 Scenario; |
|
• |
Whether the company has been the subject of
recent, significant violations, fines, litigation, or controversy related to its GHG emissions; and |
|
• |
Whether the proposal’s request is unduly
burdensome (scope or timeframe) or overly prescriptive. |
|
• |
The gender and racial minority representation
of the company’s board is reasonably inclusive in relation to companies of similar size and business; and |
|
|
|
A-67 |
|
|
|
|
|
|
|
|
2025
GLENMEDE – SUSTAINABILITY PROXY VOTING GUIDELINES |
|
|
![]() |
|
|
|
|
|
|
• |
The board already reports on its nominating
procedures and gender and racial minority initiatives on the board and within the company. |
|
• |
The company’s current policies and disclosure
related to both its diversity and inclusion policies and practices and its compensation philosophy and fair and equitable compensation
practices; |
|
• |
Whether the company has been the subject of
recent controversy, litigation, or regulatory actions related to gender, race, or ethnicity pay gap issues; |
|
• |
The company’s disclosure regarding gender,
race, or ethnicity pay gap policies or initiatives compared to its industry peers; and |
|
• |
Local laws regarding categorization of race
and/or ethnicity and definitions of ethnic and/or racial minorities. |
|
• |
The company’s compliance with applicable
regulations and guidelines; |
|
• |
The company’s current level of disclosure
regarding its security and safety policies, procedures, and compliance monitoring; and |
|
• |
The existence of recent, significant violations,
fines, or controversy regarding the safety and security of the company’s operations and/or facilities. |
|
|
|
A-68 |
|
|
|
|
|
|
|
|
2025
GLENMEDE – SUSTAINABILITY PROXY VOTING GUIDELINES |
|
|
![]() |
|
|
|
|
|
|
• |
Operations in the specified regions are not
permitted by current laws or regulations; |
|
• |
The company does not currently have operations
or plans to develop operations in these protected regions; or |
|
• |
The company’s disclosure of its operations
and environmental policies in these regions is comparable to industry peers. |
|
• |
The nature of the company’s business;
|
|
• |
The current level of disclosure of the company’s
existing related programs; |
|
• |
The timetable and methods of program implementation
prescribed by the proposal; |
|
• |
The company’s ability to address the
issues raised in the proposal; and |
|
• |
How the company’s recycling programs
compare to similar programs of its industry peers. |
|
|
|
A-69 |
|
|
|
|
|
|
|
|
2025
GLENMEDE – SUSTAINABILITY PROXY VOTING GUIDELINES |
|
|
![]() |
|
|
|
|
|
|
• |
Vote for shareholder proposals seeking greater
disclosure on the company’s environmental and social practices, and/or associated risks and liabilities. |
|
• |
Vote for shareholder proposals asking companies
to report in accordance with the Global Reporting Initiative (GRI). |
|
• |
Vote for shareholder proposals seeking the
preparation of sustainability reports. |
|
• |
Vote for shareholder proposals to study or
implement the CERES Roadmap 2030. |
|
• |
Vote for shareholder proposals to study or
implement the Equator Principles. |
|
• |
The company’s current disclosure of
relevant policies, initiatives, oversight mechanisms, and water usage metrics; |
|
• |
Whether or not the company’s existing
water-related policies and practices are consistent with relevant internationally recognized standards and national/local regulations;
|
|
• |
The potential financial impact or risk to the
company associated with water-related concerns or issues; and |
|
• |
Recent, significant company controversies,
fines, or litigation regarding water use by the company and its suppliers. |
|
24 |
https://equator-principles.com/signatories-epfis-reporting/ |
|
|
|
A-70 |
|
|
|
|
|
|
|
|
2025
GLENMEDE – SUSTAINABILITY PROXY VOTING GUIDELINES |
|
|
![]() |
|
|
|
|
|
|
• |
The level of disclosure of company policies
and procedures relating to data security, privacy, freedom of speech, information access and management, and Internet censorship; |
|
• |
Engagement in dialogue with governments or
relevant groups with respect to data security, privacy, or the free flow of information on the Internet; |
|
• |
The scope of business involvement and of investment
in countries whose governments censor or monitor the Internet and other telecommunications; |
|
• |
Applicable market-specific laws or regulations
that may be imposed on the company; and |
|
• |
Controversies, fines, or litigation related
to data security, privacy, freedom of speech, or Internet censorship. |
|
|
|
A-71 |
|
|
|
|
|
|
|
|
2025
GLENMEDE – SUSTAINABILITY PROXY VOTING GUIDELINES |
|
|
![]() |
|
|
|
|
|
|
• |
Generally vote for proposals requesting a report
on company or company supplier labor and/or human rights standards and policies. |
|
• |
Vote for shareholder proposals to implement
human rights standards and workplace codes of conduct. |
|
• |
Vote for shareholder proposals calling for
the implementation and reporting on ILO codes of conduct, SA 8000 Standards, or human rights due diligence
standards. |
|
• |
Vote for shareholder proposals that call for
the adoption and/or enforcement of principles or codes relating to countries in which there are systematic violations of human rights.
|
|
• |
Vote for shareholder proposals that call for
independent monitoring programs in conjunction with local and respected religious and human rights groups to monitor supplier and licensee
compliance with codes. |
|
• |
Vote for shareholder proposals that seek publication
of a “Code of Conduct” to the company’s domestic and international suppliers
and licensees, requiring they satisfy all applicable standards and laws protecting employees’ wages, benefits, working conditions,
freedom of association, and other rights. |
|
• |
Vote for shareholder proposals seeking reports
on, or the adoption of, vendor standards including: reporting on incentives to encourage suppliers to raise standards rather than terminate
contracts and providing public disclosure of contract supplier reviews on a regular basis. |
|
• |
Vote for shareholder proposals to adopt labor
standards for foreign and domestic suppliers to ensure that the company will not do business with any
suppliers that manufacture products for sale using forced labor, child labor, or that fail to comply with applicable laws protecting employee’s
wages and working conditions. |
|
• |
Vote for proposals requesting that a company
conduct an assessment of the human rights risks in its operations or in its supply chain, or report on its human rights risk assessment
process. |
|
• |
The company’s current policies and practices
related to the use of mandatory arbitration agreements on workplace claims; |
|
• |
Whether the company has been the subject of
recent controversy, litigation, or regulatory actions related to the use of mandatory arbitration agreements on workplace claims; and
|
|
• |
The company’s disclosure of its policies
and practices related to the use of mandatory arbitration agreements compared to its peers. |
|
|
|
A-72 |
|
|
|
|
|
|
|
|
2025
GLENMEDE – SUSTAINABILITY PROXY VOTING GUIDELINES |
|
|
![]() |
|
|
|
|
|
|
• |
Alignment
of current disclosure of applicable company policies,
metrics, risk assessment report(s) and risk management procedures with any relevant, broadly
accepted reporting frameworks; |
|
• |
The of regulatory non-compliance, litigation,
remediation, or reputational loss that may be associated with failure to manage the company’s operations in question, including
the management of relevant community and stakeholder impact relations; |
|
• |
The nature, purpose, and scope of the company’s
operations in the specific region(s); |
|
• |
The degree to which company policies and procedures
are consistent with industry norms; and |
|
• |
Scope of the resolution. |
|
• |
The nature, purpose, and scope of the operations
and business involved that could be affected by social or political disruption; |
|
• |
Current disclosure of applicable risk assessment(s)
and risk management procedures; |
|
• |
Compliance with U.S. sanctions and laws; |
|
• |
Consideration of other international policies,
standards, and laws; and |
|
• |
Whether the company has been recently involved
in recent, significant controversies, fines or litigation related to its operations in “high-risk” markets. |
|
|
|
A-73 |
|
|
|
|
|
|
|
|
2025
GLENMEDE – SUSTAINABILITY PROXY VOTING GUIDELINES |
|
|
![]() |
|
|
|
|
|
|
• |
Controversies surrounding operations in the
relevant market(s); |
|
• |
The value of the requested report to shareholders;
|
|
• |
The company’s current level of disclosure
of relevant information on outsourcing and plant closure procedures; and |
|
• |
The company’s existing human rights
standards relative to industry peers. |
|
• |
The company’s current policies, practices,
oversight mechanisms related to preventing workplace sexual harassment; |
|
• |
Whether the company has been the subject of
recent controversy, litigation, or regulatory actions related to workplace sexual harassment issues; and |
|
• |
The company’s disclosure regarding workplace
sexual harassment policies or initiatives compared to its industry peers. |
|
• |
The company’s current disclosure of
relevant lobbying policies, and management and board oversight; |
|
• |
The company’s disclosure regarding trade
associations or other groups that it supports, or is a member of, that engage in lobbying activities; and |
|
• |
Recent significant controversies, fines, or
litigation regarding the company’s lobbying-related activities. |
|
|
|
A-74 |
|
|
|
|
|
|
|
|
2025
GLENMEDE – SUSTAINABILITY PROXY VOTING GUIDELINES |
|
|
![]() |
|
|
|
|
|
|
• |
The company’s policies, and management
and board oversight related to its direct political contributions and payments to trade associations or other groups that may be used
for political purposes; |
|
• |
The company’s disclosure regarding its
support of, and participation in, trade associations or other groups that may make political contributions; and |
|
• |
Recent significant controversies, fines, or
litigation related to the company’s political contributions or political activities. |
|
• |
There are no recent, significant controversies,
fines, or litigation regarding the company’s political contributions or trade association spending; and |
|
• |
The company has procedures in place to ensure
that employee contributions to company-sponsored political action committees (PACs) are strictly voluntary and prohibit coercion. |
|
• |
The company’s policies, management,
board oversight, governance processes, and level of disclosure related to direct political contributions, lobbying activities, and payments
to trade associations, political action committees, or other groups that may be used for political purposes; |
|
• |
The company’s disclosure regarding:
the reasons for its support of candidates for public offices; the reasons for support of and participation in trade associations or other
groups that may make political contributions; and other political activities; |
|
• |
Any incongruencies identified between a company’s
direct and indirect political expenditures and its publicly stated values and priorities; |
|
• |
Recent significant controversies related to
the company’s direct and indirect lobbying, political contributions, or political activities. |
|
|
|
A-75 |
|
|
|
|
|
|
|
|
2025
GLENMEDE – SUSTAINABILITY PROXY VOTING GUIDELINES |
|
|
![]() |
|
|
|
|
|
|
7. |
Mutual Fund Proxies |
|
• |
Past performance as a closed-end fund; |
|
• |
Market in which the fund invests; |
|
• |
Measures taken by the board to address the
discount; and |
|
• |
Past shareholder activism, board activity,
and votes on related proposals. |
|
• |
Past performance relative to its peers; |
|
• |
Market in which fund invests; |
|
• |
Measures taken by the board to address the
issues; |
|
• |
Past shareholder activism, board activity,
and votes on related proposals; |
|
• |
Strategy of the incumbents versus the dissidents;
|
|
• |
Independence of directors; |
|
• |
Experience and skills of director candidates;
|
|
• |
Governance profile of the company; |
|
• |
Evidence of management entrenchment. |
|
• |
Proposed and current fee schedules; |
|
• |
Fund category/investment objective; |
|
• |
Performance benchmarks; |
|
• |
Share price performance as compared with peers;
|
|
|
|
A-76 |
|
|
|
|
|
|
|
|
2025
GLENMEDE – SUSTAINABILITY PROXY VOTING GUIDELINES |
|
|
![]() |
|
|
|
|
|
|
• |
Resulting fees relative to peers; |
|
• |
Assignments (where the advisor undergoes a
change of control). |
|
• |
Stated specific financing purpose; |
|
• |
Possible dilution for common shares; |
|
• |
Whether the shares can be used for antitakeover
purposes. |
|
• |
Potential competitiveness; |
|
• |
Regulatory developments; |
|
• |
Current and potential returns; and |
|
• |
Current and potential risk. |
|
• |
The fund’s target investments; |
|
• |
The reasons given by the fund for the change;
and |
|
• |
The projected impact of the change on the portfolio.
|
|
• |
Political/economic changes in the target market;
|
|
• |
Consolidation in the target market; and |
|
• |
Current asset composition. |
|
|
|
A-77 |
|
|
|
|
|
|
|
|
2025
GLENMEDE – SUSTAINABILITY PROXY VOTING GUIDELINES |
|
|
![]() |
|
|
|
|
|
|
• |
Potential competitiveness; |
|
• |
Current and potential returns; |
|
• |
Risk of concentration; |
|
• |
Consolidation in target industry. |
|
• |
The proposal to allow share issuances below
NAV has an expiration date no more than one year from the date shareholders approve the underlying proposal, as required under the Investment
Company Act of 1940; |
|
• |
The sale is deemed to be in the best interests
of shareholders by (1) a majority of the company’s independent directors and (2) a majority of the company’s directors who
have no financial interest in the issuance; and |
|
• |
The company has demonstrated responsible past
use of share issuances by either: |
|
• |
Outperforming peers in its 8-digit GICS group
as measured by one- and three-year median TSRs; or |
|
• |
Providing disclosure that its past share issuances
were priced at levels that resulted in only small or moderate discounts to NAV and economic dilution to existing non-participating shareholders.
|
|
• |
Strategies employed to salvage the company;
|
|
• |
The fund’s past performance; |
|
• |
The terms of the liquidation. |
|
• |
The degree of change implied by the proposal;
|
|
• |
The efficiencies that could result; |
|
• |
The state of incorporation; |
|
• |
Regulatory standards and implications. |
|
• |
Removal of shareholder approval requirement
to reorganize or terminate the trust or any of its series; |
|
• |
Removal of shareholder approval requirement
for amendments to the new declaration of trust; |
|
|
|
A-78 |
|
|
|
|
|
|
|
|
2025
GLENMEDE – SUSTAINABILITY PROXY VOTING GUIDELINES |
|
|
![]() |
|
|
|
|
|
|
• |
Removal of shareholder approval requirement
to amend the fund’s management contract, allowing the contract to be modified by the investment manager and the trust management,
as permitted by the 1940 Act; |
|
• |
Allow the trustees to impose other fees in
addition to sales charges on investment in a fund, such as deferred sales charges and redemption fees that may be imposed upon redemption
of a fund’s shares; |
|
• |
Removal of shareholder approval requirement
to engage in and terminate subadvisory arrangements; |
|
• |
Removal of shareholder approval requirement
to change the domicile of the fund. |
|
• |
Regulations of both states; |
|
• |
Required fundamental policies of both states;
|
|
• |
The increased flexibility available. |
|
• |
Fees charged to comparably sized funds with
similar objectives; |
|
• |
The proposed distributor’s reputation
and past performance; |
|
• |
The competitiveness of the fund in the industry;
|
|
• |
The terms of the agreement. |
|
• |
Resulting fee structure; |
|
• |
Performance of both funds; |
|
• |
Continuity of management personnel; |
|
• |
Changes in corporate governance and their impact
on shareholder rights. |
|
|
|
A-79 |
|
|
|
|
|
|
|
|
2025
GLENMEDE – SUSTAINABILITY PROXY VOTING GUIDELINES |
|
|
![]() |
|
|
|
|
|
|
• |
Performance of the fund’s Net Asset
Value (NAV); |
|
• |
The fund’s history of shareholder relations;
|
|
• |
The performance of other funds under the advisor’s
management. |
|
8. |
Foreign Private Issuers Listed on U.S. Exchanges
|
|
|
|
A-80 |
|
|
THE GLENMEDE FUND, INC.
PART C. OTHER INFORMATION
Item 28. Exhibits
| Item 29. | Persons Controlled by or Under Common Control with Registrant |
Registrant is not controlled by or under common control with any person. Registrant is controlled by its Board of Directors.
| Item 30. | Indemnification |
Reference is made to Article Ten of the Registrant’s Amended and Restated Articles of Incorporation, incorporated herein by reference to Exhibit (a)(1). Insofar as indemnification for liability arising under the Securities Act of 1933, as amended, may be permitted to directors, officers and controlling persons of the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of the SEC such indemnification is against public policy as expressed in the Act and is, therefore, unenforceable. In the event a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer or controlling person of the Registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of counsel the matter has been settled by controlling precedent, submit to court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Act and will be governed by the final adjudication of such issue.
| Item 31. | Business and Other Connections of Investment Advisor |
Glenmede Investment Management LP
Reference is made to the caption of “Investment Advisor” in the Prospectuses in Part A of this Registration Statement and “Investment Advisory and Other Services” in Part B of this Registration Statement.
Set forth below is a list of all of the directors, senior officers and those officers primarily responsible for Registrant’s affairs and, with respect to each such person, the name and business address of the Company (if any) with which such person has been connected at any time since October 31, 2022, as well as the capacity in which such person was connected.
| Name and Position with Glenmede Investment Management LP | Business Address of other Company | Connection with other Company | ||
| Peter Zuleba, Managing Director and Chief Executive Officer | The Glenmede Trust Company, N.A. | Chief Executive Officer, President and Board Member | ||
| Philadelphia Health Partnership | Chairperson | |||
| Philadelphia Chamber of Commerce | Board Member | |||
| Raj Tewari, Managing Director and Chief Operating Officer | The Glenmede Trust Company, N.A. | Managing Director and Chief Operating Officer | ||
| John F. McCabe, Managing Director and General Counsel | The Glenmede Trust Company, N.A. | Managing Director and General Counsel | ||
| Support Center for Child Advocates | Board Member |
| Item 32. | Principal Underwriters |
| (a) | Quasar Distributors, LLC (the “Distributor”) serves as principal underwriter for the following investment companies registered under the Investment Company Act of 1940, as amended: |
| 1. | Abacus FCF ETF Trust |
| 2. | Advisor Managed Portfolios |
| 3. | Antares Private Credit Fund |
| 4. | Capital Advisors Growth Fund, Series of Advisors Series Trust |
| 5. | Chase Growth Fund, Series of Advisors Series Trust |
| 6. | Davidson Multi Cap Equity Fund, Series of Advisors Series Trust |
| 7. | Edgar Lomax Value Fund, Series of Advisors Series Trust |
| 8. | First Sentier American Listed Infrastructure Fund, Series of Advisors Series Trust |
| 9. | First Sentier Global Listed Infrastructure Fund, Series of Advisors Series Trust |
| 10. | Huber Large Cap Value Fund, Series of Advisors Series Trust |
| 11. | Huber Mid Cap Value Fund, Series of Advisors Series Trust |
| 12. | Huber Select Large Cap Value Fund, Series of Advisors Series Trust |
| 13. | Huber Small Cap Value Fund, Series of Advisors Series Trust |
| 14. | Logan Capital Broad Innovative Growth ETF, Series of Advisors Series Trust |
| 15. | Medalist Partners MBS Total Return Fund, Series of Advisors Series Trust |
| 16. | Medalist Partners Short Duration Fund, Series of Advisors Series Trust |
| 17. | O'Shaughnessy Market Leaders Value Fund, Series of Advisors Series Trust |
| 18. | PIA BBB Bond Fund, Series of Advisors Series Trust |
| 19. | PIA High Yield (MACS) Fund, Series of Advisors Series Trust |
| 20. | PIA High Yield Fund, Series of Advisors Series Trust |
| 21. | PIA MBS Bond Fund, Series of Advisors Series Trust |
| 22. | PIA Short-Term Securities Fund, Series of Advisors Series Trust |
| 23. | Poplar Forest Cornerstone Fund, Series of Advisors Series Trust |
| 24. | Poplar Forest Partners Fund, Series of Advisors Series Trust |
| 25. | Pzena Emerging Markets Value Fund, Series of Advisors Series Trust |
| 26. | Pzena International Small Cap Value Fund, Series of Advisors Series Trust |
| 27. | Pzena International Value Fund, Series of Advisors Series Trust |
| 28. | Pzena Mid Cap Value Fund, Series of Advisors Series Trust |
| 29. | Pzena Small Cap Value Fund, Series of Advisors Series Trust |
| 30. | Reverb ETF, Series of Advisors Series Trust |
| 31. | Scharf Fund, Series of Advisors Series Trust |
| 32. | Scharf Global Opportunity Fund, Series of Advisors Series Trust |
| 33. | Scharf Multi-Asset Opportunity Fund, Series of Advisors Series Trust |
| 34. | Shenkman Capital Floating Rate High Income Fund, Series of Advisors Series Trust |
| 35. | Shenkman Capital Short Duration High Income Fund, Series of Advisors Series Trust |
| 36. | VegTech Plant-based Innovation & Climate ETF, Series of Advisors Series Trust |
| 37. | The Aegis Funds |
| 38. | Allied Asset Advisors Funds |
| 39. | Angel Oak Funds Trust |
| 40. | Angel Oak Strategic Credit Fund |
| 41. | Brookfield Infrastructure Income Fund Inc. |
| 42. | Brookfield Investment Funds |
| 43. | Buffalo Funds |
| 44. | DoubleLine Funds Trust |
| 45. | EA Series Trust (f/k/a Alpha Architect ETF Trust) |
| 46. | Ecofin Tax-Advantaged Social Impact Fund, Inc. |
| 47. | AAM Bahl & Gaynor Small/Mid Cap Income Growth ETF, Series of ETF Series Solutions |
| 48. | AAM Brentview Dividend Growth ETF, Series of ETF Series Solutions |
| 49. | AAM Low Duration Preferred and Income Securities ETF, Series of ETF Series Solutions |
| 50. | AAM S&P 500 High Dividend Value ETF, Series of ETF Series Solutions |
| 51. | AAM Sawgrass U.S. Large Cap Quality Growth ETF, Series of ETF Series Solutions |
| 52. | AAM Sawgrass U.S. Small Cap Quality Growth ETF, Series of ETF Series Solutions |
| 53. | AAM SLC Low Duration Income ETF, Series of ETF Series Solutions |
| 54. | AAM Transformers ETF, Series of ETF Series Solutions |
| 55. | Acquirers Deep Value ETF, Series of ETF Series Solutions |
| 56. | Aptus Collared Investment Opportunity ETF, Series of ETF Series Solutions |
| 57. | Aptus Defined Risk ETF, Series of ETF Series Solutions |
| 58. | Aptus Drawdown Managed Equity ETF, Series of ETF Series Solutions |
| 59. | Aptus Enhanced Yield ETF, Series of ETF Series Solutions |
| 60. | Aptus International Enhanced Yield ETF, Series of ETF Series Solutions |
| 61. | Aptus Large Cap Enhanced Yield ETF, Series of ETF Series Solutions |
| 62. | Aptus Large Cap Upside ETF, Series of ETF Series Solutions |
| 63. | Bahl & Gaynor Dividend ETF, Series of ETF Series Solutions |
| 64. | Bahl & Gaynor Income Growth ETF, Series of ETF Series Solutions |
| 65. | Bahl & Gaynor Small Cap Dividend ETF, Series of ETF Series Solutions |
| 66. | BTD Capital Fund, Series of ETF Series Solutions |
| 67. | Carbon Strategy ETF, Series of ETF Series Solutions |
| 68. | ClearShares OCIO ETF, Series of ETF Series Solutions |
| 69. | ClearShares Piton Intermediate Fixed Income Fund, Series of ETF Series Solutions |
| 70. | ClearShares Ultra-Short Maturity ETF, Series of ETF Series Solutions |
| 71. | Distillate International Fundamental Stability & Value ETF, Series of ETF Series Solutions |
| 72. | Distillate Small/Mid Cash Flow ETF, Series of ETF Series Solutions |
| 73. | Distillate U.S. Fundamental Stability & Value ETF, Series of ETF Series Solutions |
| 74. | ETFB Green SRI REITs ETF, Series of ETF Series Solutions |
| 75. | Hoya Capital High Dividend Yield ETF, Series of ETF Series Solutions |
| 76. | Hoya Capital Housing ETF, Series of ETF Series Solutions |
| 77. | LHA Market State Tactical Beta ETF, Series of ETF Series Solutions |
| 78. | LHA Market State Tactical Q ETF, Series of ETF Series Solutions |
| 79. | LHA Risk-Managed Income ETF, Series of ETF Series Solutions |
| 80. | McElhenny Sheffield Managed Risk ETF, Series of ETF Series Solutions |
| 81. | NETLease Corporate Real Estate ETF, Series of ETF Series Solutions |
| 82. | Opus Small Cap Value ETF, Series of ETF Series Solutions |
| 83. | Range Cancer Therapeutics ETF, Series of ETF Series Solutions |
| 84. | The Acquirers Fund, Series of ETF Series Solutions |
| 85. | The Brinsmere Fund - Conservative ETF, Series of ETF Series Solutions |
| 86. | The Brinsmere Fund - Growth ETF, Series of ETF Series Solutions |
| 87. | U.S. Global GO GOLD and Precious Metal Miners ETF, Series of ETF Series Solutions |
| 88. | U.S. Global JETS ETF, Series of ETF Series Solutions |
| 89. | U.S. Global Sea to Sky Cargo ETF, Series of ETF Series Solutions |
| 90. | U.S. Global Technology and Aerospace & Defense ETF, Series of ETF Series Solutions |
| 91. | US Vegan Climate ETF, Series of ETF Series Solutions |
| 92. | Vest 10 Year Interest Rate Hedge ETF, Series of ETF Series Solutions |
| 93. | Vest 2 Year Interest Rate Hedge ETF, Series of ETF Series Solutions |
| 94. | First American Funds Trust |
| 95. | FundX Investment Trust |
| 96. | The Glenmede Fund, Inc. |
| 97. | The GoodHaven Funds Trust |
| 98. | Harding, Loevner Funds, Inc. |
| 99. | Hennessy Funds Trust |
| 100. | Horizon Funds |
| 101. | Hotchkis & Wiley Funds |
| 102. | Intrepid Capital Management Funds Trust |
| 103. | Jacob Funds Inc. |
| 104. | The Jensen Quality Growth Fund Inc. |
| 105. | Kirr, Marbach Partners Funds, Inc. |
| 106. | Core Alternative ETF, Series of Listed Funds Trust |
| 107. | Wahed Dow Jones Islamic World ETF, Series of Listed Funds Trust |
| 108. | Wahed FTSE USA Shariah ETF, Series of Listed Funds Trust |
| 109. | LKCM Funds |
| 110. | LoCorr Investment Trust |
| 111. | MainGate Trust |
| 112. | ATAC Rotation Fund, Series of Managed Portfolio Series |
| 113. | Coho Relative Value Equity Fund, Series of Managed Portfolio Series |
| 114. | Coho Relative Value ESG Fund, Series of Managed Portfolio Series |
| 115. | Cove Street Capital Small Cap Value Fund, Series of Managed Portfolio Series |
| 116. | Ecofin Global Water ESG Fund, Series of Managed Portfolio Series |
| 117. | Jackson Square Large-Cap Growth Fund, Series of Managed Portfolio Series |
| 118. | Jackson Square SMID-Cap Growth Fund, Series of Managed Portfolio Series |
| 119. | Kensington Active Advantage Fund, Series of Managed Portfolio Series |
| 120. | Kensington Defender Fund, Series of Managed Portfolio Series |
| 121. | Kensington Dynamic Growth Fund, Series of Managed Portfolio Series |
| 122. | Kensington Hedged Premium Income ETF, Series of Managed Portfolio Series |
| 123. | Kensington Managed Income Fund, Series of Managed Portfolio Series |
| 124. | LK Balanced Fund, Series of Managed Portfolio Series |
| 125. | Leuthold Core ETF, Series of Managed Portfolio Series |
| 126. | Leuthold Core Investment Fund, Series of Managed Portfolio Series |
| 127. | Leuthold Global Fund, Series of Managed Portfolio Series |
| 128. | Leuthold Grizzly Short Fund, Series of Managed Portfolio Series |
| 129. | Leuthold Select Industries ETF, Series of Managed Portfolio Series |
| 130. | Muhlenkamp Fund, Series of Managed Portfolio Series |
| 131. | Nuance Concentrated Value Fund, Series of Managed Portfolio Series |
| 132. | Nuance Mid Cap Value Fund, Series of Managed Portfolio Series |
| 133. | Olstein All Cap Value Fund, Series of Managed Portfolio Series |
| 134. | Olstein Strategic Opportunities Fund, Series of Managed Portfolio Series |
| 135. | Port Street Quality Growth Fund, Series of Managed Portfolio Series |
| 136. | Principal Street High Income Municipal Fund, Series of Managed Portfolio Series |
| 137. | Principal Street Short Term Municipal Fund, Series of Managed Portfolio Series |
| 138. | Reinhart Genesis PMV Fund, Series of Managed Portfolio Series |
| 139. | Reinhart International PMV Fund, Series of Managed Portfolio Series |
| 140. | Reinhart Mid Cap PMV Fund, Series of Managed Portfolio Series |
| 141. | Tortoise Energy Infrastructure and Income Fund, Series of Managed Portfolio Series |
| 142. | Tortoise Energy Infrastructure Total Return Fund, Series of Managed Portfolio Series |
| 143. | Tortoise North American Pipeline Fund, Series of Managed Portfolio Series |
| 144. | Tremblant Global ETF, Series of Managed Portfolio Series |
| 145. | Greenspring Income Opportunities Fund, Series of Manager Directed Portfolios |
| 146. | Hood River International Opportunity Fund, Series of Manager Directed Portfolios |
| 147. | Hood River New Opportunities Fund, Series of Manager Directed Portfolios |
| 148. | Hood River Small-Cap Growth Fund, Series of Manager Directed Portfolios |
| 149. | SanJac Alpha Core Plus Bond ETF, Series of Manager Directed Portfolios |
| 150. | SanJac Alpha Low Duration ETF, Series of Manager Directed Portfolios |
| 151. | SWP Growth & Income ETF, Series of Manager Directed Portfolios |
| 152. | Vert Global Sustainable Real Estate ETF, Series of Manager Directed Portfolios |
| 153. | Mason Capital Fund Trust |
| 154. | Matrix Advisors Funds Trust |
| 155. | Monetta Trust |
| 156. | Nicholas Equity Income Fund, Inc. |
| 157. | Nicholas Fund, Inc. |
| 158. | Nicholas II, Inc. |
| 159. | Nicholas Limited Edition, Inc. |
| 160. | Oaktree Diversified Income Fund Inc. |
| 161. | Permanent Portfolio Family of Funds |
| 162. | Perritt Funds, Inc. |
| 163. | Procure ETF Trust II |
| 164. | Professionally Managed Portfolios |
| 165. | Prospector Funds, Inc. |
| 166. | Provident Mutual Funds, Inc. |
| 167. | Abbey Capital Futures Strategy Fund, Series of The RBB Fund, Inc. |
| 168. | Abbey Capital Multi-Asset Fund, Series of The RBB Fund, Inc. |
| 169. | Adara Smaller Companies Fund, Series of The RBB Fund, Inc. |
| 170. | Aquarius International Fund, Series of The RBB Fund, Inc. |
| 171. | Boston Partners All Cap Value Fund, Series of The RBB Fund, Inc. |
| 172. | Boston Partners Emerging Markets Dynamic Equity Fund, Series of The RBB Fund, Inc. |
| 173. | Boston Partners Global Equity Fund, Series of The RBB Fund, Inc. |
| 174. | Boston Partners Global Sustainability Fund, Series of The RBB Fund, Inc. |
| 175. | Boston Partners Long/Short Equity Fund, Series of The RBB Fund, Inc. |
| 176. | Boston Partners Long/Short Research Fund, Series of The RBB Fund, Inc. |
| 177. | Boston Partners Small Cap Value Fund II, Series of The RBB Fund, Inc. |
| 178. | Campbell Systematic Macro Fund, Series of The RBB Fund, Inc. |
| 179. | F/m 10-Year Investment Grade Corporate Bond ETF, Series of The RBB Fund, Inc. |
| 180. | F/m 2-Year Investment Grade Corporate Bond ETF, Series of The RBB Fund, Inc. |
| 181. | F/m 3-Year Investment Grade Corporate Bond ETF, Series of The RBB Fund, Inc. |
| 182. | F/m Emerald Life Sciences Innovation ETF, Series of The RBB Fund, Inc. |
| 183. | F/m High Yield 100 ETF, Series of The RBB Fund, Inc. |
| 184. | F/m Investments Large Cap Focused Fund Series of The RBB Fund, Inc. |
| 185. | F/m Opportunistic Income ETF, Series of The RBB Fund, Inc. |
| 186. | F/m Ultrashort Treasury Inflation-Protected Security (TIPS) ETF Series of The RBB Fund, Inc. |
| 187. | Motley Fool 100 Index ETF, Series of The RBB Fund, Inc. |
| 188. | Motley Fool Capital Efficiency 100 Index ETF, Series of The RBB Fund, Inc. |
| 189. | Motley Fool Global Opportunities ETF, Series of The RBB Fund, Inc. |
| 190. | Motley Fool Mid-Cap Growth ETF, Series of The RBB Fund, Inc. |
| 191. | Motley Fool Next Index ETF, Series of The RBB Fund, Inc. |
| 192. | Motley Fool Small-Cap Growth ETF, Series of The RBB Fund, Inc. |
| 193. | Optima Strategic Credit Fund, Series of The RBB Fund, Inc. |
| 194. | SGI Dynamic Tactical ETF, Series of The RBB Fund, Inc. |
| 195. | SGI Enhanced Core ETF, Series of The RBB Fund, Inc. |
| 196. | SGI Enhanced Global Income ETF, Series of The RBB Fund, Inc. |
| 197. | SGI Global Equity Fund, Series of The RBB Fund, Inc. |
| 198. | SGI Peak Growth Fund, Series of The RBB Fund, Inc. |
| 199. | SGI Prudent Growth Fund, Series of The RBB Fund, Inc. |
| 200. | SGI Small Cap Core Fund, Series of The RBB Fund, Inc. |
| 201. | SGI U.S. Large Cap Core ETF, Series of The RBB Fund, Inc. |
| 202. | SGI U.S. Large Cap Equity Fund, Series of The RBB Fund, Inc. |
| 203. | SGI U.S. Small Cap Equity Fund, Series of The RBB Fund, Inc. |
| 204. | US Treasury 10 Year Note ETF, Series of The RBB Fund, Inc. |
| 205. | US Treasury 12 Month Bill ETF, Series of The RBB Fund, Inc. |
| 206. | US Treasury 2 Year Note ETF, Series of The RBB Fund, Inc. |
| 207. | US Treasury 20 Year Bond ETF, Series of The RBB Fund, Inc. |
| 208. | US Treasury 3 Month Bill ETF, Series of The RBB Fund, Inc. |
| 209. | US Treasury 3 Year Note ETF, Series of The RBB Fund, Inc. |
| 210. | US Treasury 30 Year Bond ETF, Series of The RBB Fund, Inc. |
| 211. | US Treasury 5 Year Note ETF, Series of The RBB Fund, Inc. |
| 212. | US Treasury 6 Month Bill ETF, Series of The RBB Fund, Inc. |
| 213. | US Treasury 7 Year Note ETF, Series of The RBB Fund, Inc. |
| 214. | WPG Partners Select Hedged Fund, Series of The RBB Fund, Inc. |
| 215. | WPG Partners Select Small Cap Value Fund, Series of The RBB Fund, Inc. |
| 216. | WPG Partners Small Cap Value Diversified Fund, Series of The RBB Fund, Inc. |
| 217. | The RBB Fund Trust |
| 218. | RBC Funds Trust |
| 219. | Rockefeller Municipal Opportunities Fund |
| 220. | Series Portfolios Trust |
| 221. | Tax-Exempt Private Credit Fund, Inc. |
| 222. | Thompson IM Funds, Inc. |
| 223. | Tortoise Capital Series Trust |
| 224. | Bright Rock Mid Cap Growth Fund, Series of Trust for Professional Managers |
| 225. | Bright Rock Quality Large Cap Fund, Series of Trust for Professional Managers |
| 226. | CrossingBridge Low Duration High Income Fund, Series of Trust for Professional Managers |
| 227. | CrossingBridge Nordic High Income Bond Fund, Series of Trust for Professional Managers |
| 228. | CrossingBridge Responsible Credit Fund, Series of Trust for Professional Managers |
| 229. | CrossingBridge Ultra-Short Duration Fund, Series of Trust for Professional Managers |
| 230. | RiverPark Strategic Income Fund, Series of Trust for Professional Managers |
| 231. | Dearborn Partners Rising Dividend Fund, Series of Trust for Professional Managers |
| 232. | Jensen Global Quality Growth Fund, Series of Trust for Professional Managers |
| 233. | Jensen Quality MidCap Fund, Series of Trust for Professional Managers |
| 234. | Rockefeller Climate Solutions Fund, Series of Trust for Professional Managers |
| 235. | Rockefeller US Small Cap Core Fund, Series of Trust for Professional Managers |
| 236. | USQ Core Real Estate Fund |
| 237. | Wall Street EWM Funds Trust |
| 238. | Wisconsin Capital Funds, Inc. |
| (b) | The following are the Officers and Manager of the Distributor, the Registrant’s underwriter. The Distributor’s main business address is Three Canal Plaza, Suite 100, Portland, Maine 04101. |
| Name | Address | Position with Underwriter | Position with Registrant |
| Teresa Cowan |
Three Canal Plaza, Suite 100, Portland, ME 04101 |
President/Manager | None |
| Chris Lanza |
Three Canal Plaza, Suite 100, Portland, ME 04101 |
Vice President
|
None
|
|
Kate Macchia
|
Three Canal Plaza, Suite 100, Portland, ME 04101 |
Vice President | None |
| Susan L. LaFond | Three Canal Plaza, Suite 100, Portland, ME 04101 |
Vice President and Chief Compliance Officer and Treasurer |
None |
|
Kelly B. Whetstone
|
Three Canal Plaza, Suite 100, Portland, ME 04101 |
Secretary | None |
| Weston Sommers | Three Canal Plaza, Suite 100, Portland, ME 04101 | Financial and Operations Principal and Chief Financial Officer | None |
(c) Not applicable.
| Item 33. | Location of Accounts and Records |
All accounts, books and other documents required to be maintained by Section 31(a) of the 1940 Act, and the Rules thereunder will be maintained at the offices of:
(1) Glenmede Investment Management LP
One Liberty Place 1650 Market Street, Suite 4000
Philadelphia, Pennsylvania 19103
(records relating to its functions as investment advisor)
(2) State Street Bank and Trust Company
1 Congress Street, Suite 1
Boston, MA 02114
(records relating to its functions as custodian, administrator, transfer agent, dividend disbursing agent, securities lending agent and short sales lending agent)
(3) Quasar Distributors, LLC
Three Canal Plaza Suite 100
Portland, ME 04101
(records relating to its functions as distributor)
(4) Faegre Drinker Biddle & Reath LLP
One Logan Square Suite 2000
Philadelphia, Pennsylvania 19103-6996
(Registrant’s minute books)
| Item 34. | Management Services |
Not applicable.
| Item 35. | Undertakings |
(a) Registrant undertakes to comply with the provisions of Section 16(c) of the 1940 Act in regard to shareholders’ right to call a meeting of shareholders for the purpose of voting on the removal of directors and to assist in shareholder communications in such matters, to the extent required by law. Specifically, the Registrant will, if requested to do so by the holders of at least 10% of the Registrant’s outstanding shares, call a meeting of shareholders for the purpose of voting upon the question of the removal of directors, and the Registrant will assist in shareholder communications as required by Section 16(c) of the 1940 Act.
(b) Registrant undertakes to furnish to each person to whom a prospectus is delivered, a copy of Registrant’s latest annual report to shareholders, upon request and without charge.
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, as amended, and the Investment Company Act of 1940, as amended, the Registrant has duly caused this Post-Effective Amendment No. 124 to its Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Philadelphia, and Commonwealth of Pennsylvania on the 30th day of June, 2025.
THE GLENMEDE FUND, INC.
| By | /s/ Elizabeth A. Eldridge | |
| Elizabeth A. Eldridge President |
Pursuant to the requirements of the Securities Act of 1933, as amended, this Post-Effective Amendment No. 124 to the Registration Statement has been signed below by the following persons in the capacities indicated on the 30th day of June, 2025.
| Signature | Title | Date | ||
| * | ||||
| William L. Cobb, Jr. | Chairman | June 30, 2025 | ||
|
/s/ Elizabeth A. Eldridge |
President | June 30, 2025 | ||
| Elizabeth A. Eldridge | ||||
| * | ||||
| H. Franklin Allen, Ph.D. | Director | June 30, 2025 | ||
| * | ||||
| Susan W. Catherwood | Director | June 30, 2025 | ||
| * | ||||
| Mary Ann B. Wirts | Director | June 30, 2025 | ||
| * | ||||
| Harry Wong | Director | June 30, 2025 | ||
| * | ||||
| Andrew Phillips | Director | June 30, 2025 | ||
| * | ||||
| Rebecca Duseau | Director | June 30, 2025 | ||
|
/s/ Christopher E. McGuire Christopher E. McGuire |
(Chief Financial Officer and Principal Financial Officer) | June 30, 2025 | ||
| *By | /s/ Joshua M. Lindauer | |
| Joshua M. Lindauer, Attorney-in-fact |
Exhibit Index
ATTACHMENTS / EXHIBITS
FORM OF ARTICLES OF AMENDMENT TO THE ARTICLES OF INCORPORATION
FORM OF ARTICLES SUPPLEMENTARY TO THE ARTICLES OF INCORPORATION
FORM OF AMENDED AND RESTATED AMENDED SHAREHOLDER SERVICING PLAN AND RELATED AGREEMENT
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- From Living Rooms to Garages: GARVEE Expands Affordable Cooling Solutions for Summer 2026
- ChatGPT Ads Bring Context-Based Advertising to Businesses
- Storage Demand Trends Defined for Spring-Summer 2026
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share